{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Evaluate MCQ generation errors"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Imports"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import sys\n",
    "import os\n",
    "from langchain_huggingface import HuggingFaceEmbeddings\n",
    "from langchain_community.vectorstores import FAISS\n",
    "from langchain_community.vectorstores.utils import DistanceStrategy\n",
    "import torch\n",
    "from transformers import AutoTokenizer, AutoModel\n",
    "from langchain.docstore.document import Document as LangchainDocument\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter\n",
    "from langchain_huggingface import HuggingFaceEmbeddings\n",
    "from langchain_community.vectorstores import FAISS\n",
    "from langchain_community.vectorstores.utils import DistanceStrategy\n",
    "import pandas as pd\n",
    "import numpy as np \n",
    "from tqdm import tqdm\n",
    "from typing import List\n",
    "import json\n",
    "import glob\n",
    "import ollama\n",
    "from ollama import chat\n",
    "import re"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Functions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "model = 'qwen2.5:7b'"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### clean"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "def validate_json_format_mcq(llm_output, type):\n",
    "    \"\"\"\n",
    "    Attempts to extract and validate a JSON structure from the LLM output.\n",
    "\n",
    "    Parameters:\n",
    "    llm_output (str): Raw output from the LLM.\n",
    "    type (str): question or answer\n",
    "\n",
    "    Returns:\n",
    "    dict: A valid JSON object if found and correctly formatted, otherwise None.\n",
    "    \"\"\"\n",
    "\n",
    "    if type == 'question':\n",
    "        try:\n",
    "            json_match = re.search(r'\\{.*\\}', llm_output, re.DOTALL)\n",
    "            if json_match:\n",
    "                cleaned_json = json.loads(json_match.group())\n",
    "                if \"question\" in cleaned_json and \"options\" in cleaned_json:\n",
    "                    return cleaned_json\n",
    "        except json.JSONDecodeError:\n",
    "            pass\n",
    "        return None\n",
    "    \n",
    "    elif type == 'answer':\n",
    "        try:\n",
    "            json_match = re.search(r'\\{.*\\}', llm_output, re.DOTALL)\n",
    "            if json_match:\n",
    "                cleaned_json = json.loads(json_match.group())\n",
    "                if \"Answer\" in cleaned_json and \"Justification\" in cleaned_json:\n",
    "                    answer = cleaned_json[\"Answer\"]\n",
    "                    # Check if answer in 'A', 'B', 'C', or 'D'.\n",
    "                    if answer not in {'A', 'B', 'C', 'D'}:\n",
    "                        # check for a valid letter isolated\n",
    "                        match = re.search(r'\\b[A-D]\\b', answer)\n",
    "                        if match:\n",
    "                            cleaned_json[\"Answer\"] = match.group()\n",
    "                        else:\n",
    "                            return None\n",
    "                    return cleaned_json\n",
    "        except json.JSONDecodeError:\n",
    "            pass\n",
    "        return None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "def call_formatting_llm_mcq(llm_output, type):\n",
    "    \"\"\"\n",
    "    Calls an LLM specialized in formatting text into the correct JSON format.\n",
    "\n",
    "    Parameters:\n",
    "    llm_output (str): Raw output from the initial LLM.\n",
    "    type (str): question or answer\n",
    "\n",
    "    Returns:\n",
    "    dict: A valid JSON object containing the question and options.\n",
    "    \"\"\"\n",
    "    if type == 'question':\n",
    "        system_prompt = \"\"\"You are an AI specialized in converting multiple-choice legal questions into JSON format.\n",
    "        Ensure the output strictly follows this structure:\n",
    "        ```json\n",
    "        {\"question\": \"...\", \"options\": [\"A ....\", \"B ...\", \"C ...\", \"D ...\"]}\n",
    "        \"\"\"\n",
    "\n",
    "    elif type == 'answer':\n",
    "        system_prompt = \"\"\"You are an AI specialized in converting legal answer into JSON format.\n",
    "        Ensure the output strictly follows this structure:\n",
    "        ```json\n",
    "        {\n",
    "        \"Answer\": \"...\", \n",
    "        \"Justification\": \"...\"\n",
    "        }\n",
    "        \"\"\"\n",
    "\n",
    "    user_prompt = f\"\"\"\n",
    "        The following text needs to be formatted as a valid JSON:\n",
    "        {llm_output}\n",
    "        \n",
    "        Please convert it into the required JSON format.\n",
    "        \"\"\"\n",
    "\n",
    "    response = chat(model=model, messages=[\n",
    "        {\"role\": \"system\", \"content\": system_prompt},\n",
    "        {\"role\": \"user\", \"content\": user_prompt},\n",
    "    ])\n",
    "    \n",
    "    if type == 'answer':\n",
    "        return response['message']['content']\n",
    "    elif type == 'question':\n",
    "        return validate_json_format_mcq(response['message']['content'], type)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "def clean_generate_mcq_output(llm_output, type):\n",
    "    \"\"\"\n",
    "    Cleans and extracts a valid JSON multiple-choice question from the LLM output.\n",
    "    If the initial output is not valid JSON, a specialized LLM is called to correct it.\n",
    "\n",
    "    Parameters:\n",
    "    llm_output (str): Raw output from the LLM.\n",
    "\n",
    "    Returns:\n",
    "    dict: A properly formatted multiple-choice question.\n",
    "    \"\"\"\n",
    "    result = validate_json_format_mcq(llm_output, type)\n",
    "    if result:\n",
    "        return result\n",
    "    \n",
    "    # If not valid, call formatting LLM\n",
    "    formatted_result = call_formatting_llm_mcq(llm_output, type)\n",
    "    if formatted_result:\n",
    "        return formatted_result\n",
    "    \n",
    "    raise ValueError(\"Failed to convert LLM output into valid JSON format.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### get context"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_context(query: str, k: int, knowledge_vector_db: FAISS):\n",
    "    \"\"\" \n",
    "    Retrieves relevant context for a given query.\n",
    "\n",
    "    Parameters:\n",
    "    query (str): The input query for which context is needed.\n",
    "    k (int, optional): The number of relevant context elements to retrieve (default is 5).\n",
    "\n",
    "    Returns:\n",
    "    list: A list containing relevant context elements.\n",
    "    \"\"\"\n",
    "    retrieved_docs = knowledge_vector_db.similarity_search(query=query, k=k)\n",
    "    return retrieved_docs"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### embeddings loader"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_rag_embeddings(path, embeddings_model, device='cuda'):\n",
    "\n",
    "    embedding_model = HuggingFaceEmbeddings(\n",
    "        model_name=embeddings_model,\n",
    "        multi_process=True,\n",
    "        model_kwargs={\"device\": device, \"trust_remote_code\":True},  # replace 'cpu' by 'cuda' if you have Nvidia gpu\n",
    "        encode_kwargs={\"normalize_embeddings\": True},  # Set `True` for cosine similarity\n",
    "    )\n",
    "    \n",
    "    knowledge_vector_db = FAISS.load_local(path, embedding_model, allow_dangerous_deserialization=True)\n",
    "    print(\"embedding load\")\n",
    "    return knowledge_vector_db"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### generate mcq"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "MAX_OUTPUT_TOKENS = 3000"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "def generate_mcq(questions: str, knowledge_vector_db: FAISS) -> dict:\n",
    "    \"\"\"\n",
    "    Generates an MCQ question.\n",
    "\n",
    "    Parameters:\n",
    "    questions (str): String of validated mcq questions from one subcategory as exemple.\n",
    "\n",
    "    Returns:\n",
    "    question (dict): {'question': '...',\n",
    "                      'options': ['A ....', 'B ...', ...]}\n",
    "    \"\"\"\n",
    "    # Retrieve context\n",
    "    retrieved_docs = get_context(questions, 3, knowledge_vector_db)\n",
    "    context = \"\\nExtracted documents:\\n\"\n",
    "    context += \"\".join([f'Content: {doc.page_content} \\nSource: {doc.metadata['ref']}\\n\\n' for i, doc in enumerate(retrieved_docs)])\n",
    "    # context_sources = \"\".join([f'\\nSource: {doc.metadata['ref']}, Url: {doc.metadata.get('url', 'N/A')}' for i, doc in enumerate(retrieved_docs)])\n",
    "\n",
    "\n",
    "    # Build prompt\n",
    "    system_prompt = f\"\"\"\n",
    "    You are an AI specialized in generating multiple-choice legal questions based on given legal texts.\n",
    "    ### Instructions:\n",
    "    - Generate a new legal multiple-choice question based on the provided context.\n",
    "    - Ensure the question aligns with the style and complexity of the given examples.\n",
    "    - Provide four answer options (A, B, C, D), with only one being correct.\n",
    "    - Format the output strictly as a JSON object with the following structure:\n",
    "        ```json\n",
    "        {{'question': '...', 'options': ['A ....', 'B ...', 'C ...', 'D ...']}}\n",
    "    \"\"\"\n",
    "\n",
    "    user_prompt = f\"\"\"\n",
    "    ### Context:\n",
    "    {context}\n",
    "\n",
    "    ### Examples of Previous Questions:\n",
    "    {questions}\n",
    "\n",
    "    Generate a new question that follows the same format and is correct based on the context. Write it in a json.\n",
    "    \"\"\"\n",
    "\n",
    "    # Initial attempt to get the answer\n",
    "    attempt_count = 0\n",
    "    max_attempts = 5  # Limit number of attempts to prevent infinite loops\n",
    "\n",
    "    while attempt_count < max_attempts:\n",
    "        question_mcq = chat(model=model,\n",
    "                            messages=[{\"role\":\"system\", \"content\":system_prompt},\n",
    "                                      {\"role\":\"user\",\"content\":user_prompt}],\n",
    "                            options = {\"num_predict\":MAX_OUTPUT_TOKENS}\n",
    "                            )\n",
    "        \n",
    "        # Put question in correct json format\n",
    "        try:\n",
    "            cleaned_question_mcq = clean_generate_mcq_output(question_mcq['message']['content'], type='question')\n",
    "            return cleaned_question_mcq, attempt_count  # If valid, return it\n",
    "        except ValueError:\n",
    "            attempt_count += 1  # Increment attempt count\n",
    "            print(f\"Attempt {attempt_count} failed. Retrying...\")\n",
    "    \n",
    "    # If all attempts fail, raise an exception or return None\n",
    "    return 'Error', '>5'\n",
    "    raise ValueError(\"Failed to generate a valid MCQ after multiple attempts.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Evaluation"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "import random\n",
    "\n",
    "def evaluate_generate_mcq_question(save_dir: str, data_dir: str, test_name: str, model, knowledge_vector_db: FAISS, n):\n",
    "    \"\"\"\n",
    "    Evaluate generation_mcq_answer.\n",
    "\n",
    "    Parameters:\n",
    "    save_dir (str): Path to save the evaluation file.\n",
    "    data_dir (str): Folder to load the json mcq and mcs_solutions files.\n",
    "    test_name (str): Name of the test, used to save file.\n",
    "\n",
    "    Returns:\n",
    "    Nothing but save a json file in save_dir.\n",
    "    \"\"\"\n",
    "\n",
    "    # Get questions from mcq json files\n",
    "    questions = []\n",
    "    \n",
    "    for filename in os.listdir(data_dir):\n",
    "        # Ignore file containing solution or MOCK\n",
    "        if \"solution\" in filename or \"json\" not in filename or \"MOCK\" in filename or 'open' in filename or 'categories' in filename:\n",
    "            continue\n",
    "\n",
    "        # Load doc\n",
    "        filepath = os.path.join(data_dir, filename)\n",
    "        with open(filepath, 'r', encoding='utf-8') as file:\n",
    "            doc = json.load(file)\n",
    "        for elt in doc.values():\n",
    "            questions.append(elt)\n",
    "        \n",
    "    ai_questions = []\n",
    "    attempt_counts = []\n",
    "    # Generate n AI Questions\n",
    "    for i in range(n):\n",
    "        # Get 3 random question from questions\n",
    "        questions_for_generation = random.sample(questions, 3)\n",
    "        questions_for_generation_str = json.dumps(questions_for_generation, indent=4)\n",
    "        print(questions_for_generation_str)\n",
    "\n",
    "        # Generate new question\n",
    "        new_question, attempt_count = generate_mcq(questions_for_generation_str, knowledge_vector_db)\n",
    "        print(f'Question {i}: {new_question}')\n",
    "        ai_questions.append(new_question)\n",
    "        attempt_counts.append(attempt_count)\n",
    "            \n",
    "    \n",
    "    result = {'ai_questions': ai_questions,'attempt_counts': attempt_counts}\n",
    "    \n",
    "    # Save json\n",
    "    if not os.path.exists(save_dir):\n",
    "        os.makedirs(save_dir)\n",
    "    output_path = os.path.join(save_dir, f\"{test_name}.json\")\n",
    "    with open(output_path, 'w', encoding='utf-8') as file:\n",
    "        json.dump(result, file, indent=4, ensure_ascii=False)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "embedding load\n"
     ]
    }
   ],
   "source": [
    "# knowledge_vector_db = load_rag_embeddings(path=f'../embeddings/rag_embeddings_sentence-transformers_all-MiniLM-L6-v2_chunk512',\n",
    "#                                             embeddings_model='sentence-transformers/all-MiniLM-L6-v2', \n",
    "#                                             device='cuda')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[\n",
      "    {\n",
      "        \"question\": \"Which of the following statements about filing third- party observations is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The person that filed third- party observations will be a party to the proceedings before the EPO, and the applicant is obliged to respond to third- party observations\",\n",
      "            \"B. Third -party observations must be filed in writing and may not be filed anonymously\",\n",
      "            \"C. Third -party observations are considered by the examining division only if they include a statement of the grounds on which they are based, and an official fee is paid\",\n",
      "            \"D. Third -party observations can be filed after the publication of a European patent application and must be filed in an official language of the EPO\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?\",\n",
      "        \"options\": [\n",
      "            \"A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.\",\n",
      "            \"B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.\",\n",
      "            \"C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.\",\n",
      "            \"D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The opposition division revoked European patent EP -B1. The patent proprietor filed an appeal  in time . The b oard of appeal forwarded a copy of the appeal to the o pponent/ respondent with a communication dated 1 June 2023 giving it an opportunity to file comments within a period of four  months.  The opponent/respondent files comments today, 12 October 2023. What further action has to be taken ?\",\n",
      "        \"options\": [\n",
      "            \"A. The opponent/ respondent needs  to request an extension of the period for comment.\",\n",
      "            \"B. The opponent/respondent needs to pay a fee for further processing.\",\n",
      "            \"C. The opponent/respondent needs to file a substantiated request for reestablishment of rights and pay the associated fee.\",\n",
      "            \"D. None of the above.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 0: {'question': 'When must the patent proprietor file translations of any amended claims into the two official languages other than the language of the proceedings?', 'options': [\"A. Within three months after receiving the formalities officer's request.\", 'B. Within one month after the interlocutory decision becomes final or the amended text is drawn up.', 'C. Immediately upon amending the claims, regardless of any requests from the formalities officer.', 'D. At the same time as filing the amended claims with the European Patent Office.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"In which of the following cases is the applicant entitled to a reduction of the filing fee  under Rule  6 EPC ? A declaration of such entitlement has  been made by crossing the relevant box on Form  1001.\",\n",
      "        \"options\": [\n",
      "            \"A. A Spanish European patent attorney files a European patent application in Spanish for a natural person who is resident in Andorra and of Andorra n nationality .\",\n",
      "            \"B. A firm whose principal place of business is in Germany and a natural person who is resident in Germany  and of Dutch nationality  jointly file a European patent application in Dutch. The German firm employs 200 people with an annual turnover of EUR 60 million.\",\n",
      "            \"C. A natural person resident in the USA and of Belgian nationality files a European patent application in French.\",\n",
      "            \"D. A natural person resident in the USA and of Swiss nationality files a European patent application in Italian.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In which of the following situations does the EPO recommend using the EPO Contingency Upload Service?\",\n",
      "        \"options\": [\n",
      "            \"A. When you submit documents after business hours\",\n",
      "            \"B. When the EPO filing systems are functioning correctly, but you encounter a technical issue at your end\",\n",
      "            \"C. When there is a system outage at the EPO that prevents document submission via the standard filing systems\",\n",
      "            \"D. When the EPO is closed due to an official holiday\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. As no renewal fees have been paid, the application is deemed to be withdrawn .\",\n",
      "            \"B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .\",\n",
      "            \"C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .\",\n",
      "            \"D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Attempt 1 failed. Retrying...\n",
      "Question 1: {'question': 'According to Article 14(4) EPC, which of the following individuals or entities would be required to file documents in an official language other than English, French, or German, and also provide a translation into an official EPO language?', 'options': ['A. A natural person resident in Spain who files a document for an invention conceived while they were working in France.', 'B. An Italian legal entity with its principal place of business in Italy that files a document for a technical innovation related to their business operations.', 'C. A German individual resident in the UK and filing a document about a new software algorithm.', 'D. A Swiss company whose primary activities are conducted in Switzerland, but one of its employees is resident in Germany when they file a document.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .\",\n",
      "            \"B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .\",\n",
      "            \"C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .\",\n",
      "            \"D. Ms Smith can only be deleted as inventor with her consent .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 10 October 2021, European patent attorney X filed European patent application EP -A with the EPO on the applicant's behalf. Application EP -A was published on 12 April 2023, together  with the extended European search report. On 6  October 2023, the applicant contacts a new European patent attorney  Y to replace X as representative and issues Y with its instructions to reply to the extended European search report. The applicant did not inform X that he would be replaced.  What are the steps necessary to validly appoint representative Y and to avoid any loss of rights for European patent application EP -A?\",\n",
      "        \"options\": [\n",
      "            \"A. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 12 October 2023 at the latest and files in good time an authorisation signed by the applicant .\",\n",
      "            \"B. New representative Y requests a change of representative and files a response to the extended European search report with  the EPO by 12 October 2023 at the latest .\",\n",
      "            \"C. New representative Y requests a change of representative and files a response to the extended European search report with the EPO by 23 October 2023 at the latest.\",\n",
      "            \"D. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 23 October 2023 at the latest and files in good time an authorisation signed by the applicant .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Linguist filed a European patent application in Dutch and used English as language of the proceedings. When requesting unitary effect on 10 October 2024, Mr Linguist must provide a translation of the specification. Mr Linguist would like to obtain immediate registration of the unitary effect. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Mr Linguist must provide a translation of the specification into Dutch\",\n",
      "            \"B. Mr Linguist must provide a translation of the specification into an official language of any of the 18 states to which the unitary effect extends\",\n",
      "            \"C. Mr Linguist must provide a translation of the specification into an official language of any of the 24 states that have signed the UPCA\",\n",
      "            \"D. Mr Linguist may provide a translation of the specification into Spanish\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 2: {'question': 'A European patent application was filed with the EPO on 15 January 2023, and the applicant named Mr. Smith as the inventor without his knowledge or consent. If Mr. Smith later discovers this and wishes to have his name removed from the designation of inventors, which of the following statements is correct according to the provided context?', 'options': ['A. Mr. Smith can request his name be deleted if no opposition proceedings are pending.', \"B. The applicant must seek Mr. Smith's consent to remove his name as an inventor.\", 'C. Mr. Smith cannot have his name removed once the patent is granted, even if he was not involved in the invention.', \"D. Mr. Smith can request his name be deleted after notifying the EPO, but needs the current applicant's consent.\"]}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Which functionalities or services can be accessed directly from MyEPO Portfolio?\",\n",
      "        \"options\": [\n",
      "            \"A. A shared area with examiners, European Patent Register, filing via the EPO's online filing software eOLF\",\n",
      "            \"B. Mailbox, a shared area with examiners, replying to a communication under Article  94(3) EPC\",\n",
      "            \"C. Mailbox, patent search via publication server, a shared area with examiners\",\n",
      "            \"D. Filing via the EPO's Online Filing 2.0, patent search via publication server, Mailbox\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"European patent application EP -X was filed on 1  October 2020, claiming the priority of a Belgian application filed on 16 October 2019. The mention of the grant of European patent EP -X was published on 2  October 2024. The proprietor filed a request for unitary effect and was informed by communication dated 10  October 2024, that unitary effect had been registered for EP -X-C0 on the same date. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. A renewal fee still has to be paid by 31 October 2024 in respect of the 5th year for EP -X\",\n",
      "            \"B. A renewal fee is due on 31 October 2024 in respect of the 5th year for EP -X-C0\",\n",
      "            \"C. A renewal fee is due on 31 October 2024 in respect of the 6th year for EP -X-C0\",\n",
      "            \"D. No renewal fee has to be paid on 31 October 2024\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The applicant received a communication pursuant to Article 90(3) EPC and Rule  60 EPC, requesting them to file a designation of inventor but missed the time limit for filing a response. After expiry of the time limit, the Receiving Section issued a decision to refuse the European patent application, dated 10  October 2024. What can the applicant do to remedy the situation?\",\n",
      "        \"options\": [\n",
      "            \"A. File a notice of appeal against the decision within four months of notification of the decision\",\n",
      "            \"B. File a request for further processing within two months of notification of the decision\",\n",
      "            \"C. File, within two months of notification of the decision, a request for re-establishment of rights in respect of the time limit for filing the designation of inventor\",\n",
      "            \"D. A, B and C are correct\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 3: {'question': 'A European patent application EP-Y was filed on 25 June 2018, claiming priority from a U.S. application filed on 26 June 2017. The decision to grant EP-Y was issued on 30 November 2024. If the applicant wishes to file a request for unitary effect, by what latest date must they do so?', 'options': ['A. 31 December 2024', 'B. 30 May 2025', 'C. 30 November 2024', 'D. 30 June 2025']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Last week Greta validly filed the international patent application PCT -G with the German Patent and Trade mark Office ( DPMA ) and appointed Hassan to represent her. Hassan is entitled to act before the DPMA  but he is not a European patent attorney. Greta and Hassan are resident in Germany.  Which of the following statements is not correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Hassan can represent Greta before the EPO acting as the International Searching Authority for PCT -G.\",\n",
      "            \"B. In order for Hassan to be able to act before the EPO acting as the International Searching Authority , he needs to submit a power of attorney signed by Greta.\",\n",
      "            \"C. According to the provisions of the PCT, it is mandatory that the d emand for international preliminary examination is signed by Greta or Hassan.\",\n",
      "            \"D. According to the provisions of the PCT, an international application can only be withdrawn by the applicant or an agent appointed by a power of attorney.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 10 October 2024, an applicant files a request for entry into the European phase, together with a debit order, according to which the filing fee, the designation fee, the examination fee and the renewal fee for the third year are to be debited from the applicant's deposit account. It is specified that the debit order is to be executed on 18 October 2024. On the evening of 10 October 2024, the applicant notices that the renewal fee is not yet due and should not be debited from the deposit account. What is the latest point in time for revoking the order to debit the renewal fee in Central Fee Payment (CFP)?\",\n",
      "        \"options\": [\n",
      "            \"A. 10 October 2024\",\n",
      "            \"B. 17 October 2024\",\n",
      "            \"C. 18 October 2024\",\n",
      "            \"D. A debit order cannot be revoked in part\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicants may request processing of their international application under PCT Direct by filing a letter (\\\"PCT Direct letter\\\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing\",\n",
      "            \"B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0\",\n",
      "            \"C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0\",\n",
      "            \"D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 4: {'question': \"In the case described by J 4/94, which of the following statements accurately reflects the Legal Board's decision regarding the interpretation of the demand for international preliminary examination (IPEA) and the European Patent Office (EPO)?\", 'options': ['A. The EPO was considered an elected Office in this case due to its involvement in the interpretation of the demand.', \"B. The IPEA's interpretation of the demand took precedence over any subsequent interpretation by the EPO, as per Art. 31(4)(a) PCT principles.\", 'C. The Legal Board held that the EPO did not become an elected Office in this case because it interpreted the demand differently from the IPEA.', \"D. The applicant was required to formally correct the deficiency in the demand by adding 'EP' next to the handwritten indication, before the IPEA could proceed.\"]}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Which functionalities or services can be accessed directly from MyEPO Portfolio?\",\n",
      "        \"options\": [\n",
      "            \"A. A shared area with examiners, European Patent Register, filing via the EPO's online filing software eOLF\",\n",
      "            \"B. Mailbox, a shared area with examiners, replying to a communication under Article  94(3) EPC\",\n",
      "            \"C. Mailbox, patent search via publication server, a shared area with examiners\",\n",
      "            \"D. Filing via the EPO's Online Filing 2.0, patent search via publication server, Mailbox\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You filed an international patent application on 6 June 2024, claiming the priority of a European patent application filed on 7  July 2023. You received a communication dated 25 September 2024 from the EPO acting as International Searching Authority (ISA), stating that the requirement of unity of invention has not been complied with. The ISA identifies three inventions. You are invited to pay two additional search fees. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. You must pay two additional search fees by 25 October 2024\",\n",
      "            \"B. You do not need to file a response to the provisional opinion accompanying the partial search results\",\n",
      "            \"C. If you pay two additional search fees under protest, you must pay two protest fees within the time limit\",\n",
      "            \"D. If you do not pay any additional search fees within the time limit, the international patent application will be deemed to be withdrawn\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Attempt 1 failed. Retrying...\n",
      "Question 5: {'question': 'For an international application filed before 1 July 2005, which authority can dispense with drawing up a supplementary European search report?', 'options': ['A. Swedish Intellectual Property Office', 'B. Austrian Patent Office', 'C. Spanish Patent and Trademark Office', 'D. European Patent Office as ISA or SISA']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .\",\n",
      "            \"B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .\",\n",
      "            \"C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .\",\n",
      "            \"D. Ms Smith can only be deleted as inventor with her consent .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicant Korhonen is a Finnish national resident in Finland. He filed a European patent application in Finnish and provided an English translation in time. In response to the extended European search report (EESR), Korhonen wishes to file amended claims t ogether with a request for examination. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Korhonen must file the amended claims in Finnish and must then  provide a translation into English, in time\",\n",
      "            \"B. Korhonen is allowed to file the amended claims in Finnish if he then provides a\",\n",
      "            \"translation into any official language of the EPO, in time C. Korhonen is allowed to file the amended claims in Finnish if he then provides a translation into English, in time\",\n",
      "            \"D. Korhonen is not allowed to file the amended claims in Finnish\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 6: {'question': 'If an application for a European patent was erroneously filed with incorrect documents, under what circumstances can the applicant withdraw the correct application documents or parts to avoid having them deemed not to have been made?', 'options': ['A. The withdrawal must be made within one month of the notification by the European Patent Office.', 'B. Within one month of the notification from the European Patent Office, the applicant can withdraw the correct documents and it will not be redated.', 'C. The application cannot be withdrawn once incorrect documents are filed.', 'D. Withdrawal is only possible if the application has been published in the European Patent Bulletin.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The applicant received a communication pursuant to Article 90(3) EPC and Rule  60 EPC, requesting them to file a designation of inventor but missed the time limit for filing a response. After expiry of the time limit, the Receiving Section issued a decision to refuse the European patent application, dated 10  October 2024. What can the applicant do to remedy the situation?\",\n",
      "        \"options\": [\n",
      "            \"A. File a notice of appeal against the decision within four months of notification of the decision\",\n",
      "            \"B. File a request for further processing within two months of notification of the decision\",\n",
      "            \"C. File, within two months of notification of the decision, a request for re-establishment of rights in respect of the time limit for filing the designation of inventor\",\n",
      "            \"D. A, B and C are correct\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 7: {'question': 'If an applicant fails to reply within the time limit set by Rule 100(2) EPC after receiving a communication requesting the designation of additional Member States for a European patent application, and subsequently receives a decision refusing the application, what action can the applicant take to seek reconsideration?', 'options': ['A. File a notice of appeal against the decision within four months of notification of the decision', 'B. Submit a request for further processing within two months of notification of the decision', 'C. Request re-establishment of rights in respect of the time limit for designation, within one month of notification of the decision', 'D. A and B are correct']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicants may request processing of their international application under PCT Direct by filing a letter (\\\"PCT Direct letter\\\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing\",\n",
      "            \"B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0\",\n",
      "            \"C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0\",\n",
      "            \"D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. As no renewal fees have been paid, the application is deemed to be withdrawn .\",\n",
      "            \"B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .\",\n",
      "            \"C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .\",\n",
      "            \"D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 8: {'question': 'An applicant has filed an international PCT application with priority claiming documents originally filed in German, now wishing to have the application examined in English. According to Rule 159(1)(a) of the EPC, which of the following actions is required within 31 months from the earliest priority date to ensure that the language of proceedings can be changed to English?', 'options': ['A. No action is needed as the language change can occur automatically.', 'B. The applicant must file a translation into German within 31 months.', 'C. The applicant must provide a translation into English within 31 months.', 'D. The applicant should request examination in English directly with no need for translations.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Company M, which has  its principal place of business in Tijuana, Mexico, validly filed an international patent application PCT -M with the Mexican Institute of Industrial Property. The application was filed in Spanish. A few days later, the applicant files an English translati on of the application.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant can choose the EPO as ISA and the USPTO as IPEA.\",\n",
      "            \"B. The applicant can choose the USPTO as ISA and the EPO as IPEA.\",\n",
      "            \"C. The applicant can choose the Austrian Patent Offic e as ISA and the\",\n",
      "            \"EPO as IPEA.\",\n",
      "            \"D. The applicant can choose the EPO as ISA and the Intellectual Property\",\n",
      "            \"Office of Singapore as IPEA.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international application is published , together  with the search report drawn up by the CNIPA , 18 m onths + 1 day after the filing date (no priority claimed). The application has no more than 35 pages and 15 claims. Which statement reflects all actions the CN  applicant  needs to take for entry into the EP phase 25 months  after the filing date ? A request for early processing has been filed.\",\n",
      "        \"options\": [\n",
      "            \"A. Complete and file Form 1200 and pay the filing fee and the search fee\",\n",
      "            \"B. Complete and file Form 1200 and pay the filing fee, the search fee and the renewal fee for the third year\",\n",
      "            \"C. Complete and file Form 1200, pay the filing fee and the search fee and appoint a representative\",\n",
      "            \"D. None of the above statements\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 9: {'question': 'An international application was filed in French and has now entered the European phase under Art. 153(7) of the EPO regulations. The applicant wishes to amend the application documents before receiving the search report. Under which circumstance can this amendment be made?', 'options': ['A. The applicant cannot make any amendments until after receiving the search report.', 'B. The applicant can make amendments if they pay an additional processing fee and request early examination.', 'C. The applicant can make minor amendments before receiving the search report to correct typographical errors or improve clarity.', 'D. The applicant can make substantial amendments before receiving the search report as part of the filing process.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Mr Linguist filed a European patent application in Dutch and used English as language of the proceedings. When requesting unitary effect on 10 October 2024, Mr Linguist must provide a translation of the specification. Mr Linguist would like to obtain immediate registration of the unitary effect. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Mr Linguist must provide a translation of the specification into Dutch\",\n",
      "            \"B. Mr Linguist must provide a translation of the specification into an official language of any of the 18 states to which the unitary effect extends\",\n",
      "            \"C. Mr Linguist must provide a translation of the specification into an official language of any of the 24 states that have signed the UPCA\",\n",
      "            \"D. Mr Linguist may provide a translation of the specification into Spanish\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 10 October 2021, European patent attorney X filed European patent application EP -A with the EPO on the applicant's behalf. Application EP -A was published on 12 April 2023, together  with the extended European search report. On 6  October 2023, the applicant contacts a new European patent attorney  Y to replace X as representative and issues Y with its instructions to reply to the extended European search report. The applicant did not inform X that he would be replaced.  What are the steps necessary to validly appoint representative Y and to avoid any loss of rights for European patent application EP -A?\",\n",
      "        \"options\": [\n",
      "            \"A. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 12 October 2023 at the latest and files in good time an authorisation signed by the applicant .\",\n",
      "            \"B. New representative Y requests a change of representative and files a response to the extended European search report with  the EPO by 12 October 2023 at the latest .\",\n",
      "            \"C. New representative Y requests a change of representative and files a response to the extended European search report with the EPO by 23 October 2023 at the latest.\",\n",
      "            \"D. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 23 October 2023 at the latest and files in good time an authorisation signed by the applicant .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 10: {'question': 'Ms. Green filed a European patent application EP-app in German, but requested examination in French. She did not file a French translation of the application. The Receiving Section has now issued a noting of loss of rights. Which of the following statements is correct?', 'options': ['A. Ms. Green can remedy the deficiency by filing a French translation of EP-app within two months of notification of the communication under Rule 112(1) EPC.', 'B. The deficiency cannot be remedied, and Ms. Green will lose her rights.', 'C. Ms. Green needs to file a French translation of EP-app together with a request for further processing.', 'D. Ms. Green needs to file a French translation of EP-app together with a request for re-establishment of rights.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?\",\n",
      "        \"options\": [\n",
      "            \"A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.\",\n",
      "            \"B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.\",\n",
      "            \"C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.\",\n",
      "            \"D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In which of the following situations does the EPO recommend using the EPO Contingency Upload Service?\",\n",
      "        \"options\": [\n",
      "            \"A. When you submit documents after business hours\",\n",
      "            \"B. When the EPO filing systems are functioning correctly, but you encounter a technical issue at your end\",\n",
      "            \"C. When there is a system outage at the EPO that prevents document submission via the standard filing systems\",\n",
      "            \"D. When the EPO is closed due to an official holiday\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 11: {'question': 'During opposition proceedings, the proprietor of the patent received an annotated copy suggesting amendments to address objections raised by the examining division. According to the guidelines, which of the following actions is required from the proprietor?', 'options': ['A. The proprietor must submit a completely retyped document containing all suggested amendments.', 'B. The proprietor can choose to indicate any desired amendments on the annotated copy separately from the comments of the examining division.', 'C. The proprietor should only resubmit the said copy if the amendments are extensive and affect the legibility of the copies, otherwise, no action is needed.', 'D. The proprietor must file a formally compliant version of the entire document within one month.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You filed an international patent application on 6 June 2024, claiming the priority of a European patent application filed on 7  July 2023. You received a communication dated 25 September 2024 from the EPO acting as International Searching Authority (ISA), stating that the requirement of unity of invention has not been complied with. The ISA identifies three inventions. You are invited to pay two additional search fees. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. You must pay two additional search fees by 25 October 2024\",\n",
      "            \"B. You do not need to file a response to the provisional opinion accompanying the partial search results\",\n",
      "            \"C. If you pay two additional search fees under protest, you must pay two protest fees within the time limit\",\n",
      "            \"D. If you do not pay any additional search fees within the time limit, the international patent application will be deemed to be withdrawn\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 12: {'question': 'According to EPC Rule 56a, if the applicant files correct application documents or parts under paragraph 3 after the European Patent Office has begun to draw up the search report, what is required within one month?', 'options': ['A. The applicant must withdraw the correct application documents or parts filed.', 'B. The European Patent Office shall inform the applicant that no further action is needed.', 'C. The applicant may pay a further search fee and the application will continue as normal.', \"D. The applicant must file an appeal against the European Patent Office's decision.\"]}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 10 October 2024, an applicant files a request for entry into the European phase, together with a debit order, according to which the filing fee, the designation fee, the examination fee and the renewal fee for the third year are to be debited from the applicant's deposit account. It is specified that the debit order is to be executed on 18 October 2024. On the evening of 10 October 2024, the applicant notices that the renewal fee is not yet due and should not be debited from the deposit account. What is the latest point in time for revoking the order to debit the renewal fee in Central Fee Payment (CFP)?\",\n",
      "        \"options\": [\n",
      "            \"A. 10 October 2024\",\n",
      "            \"B. 17 October 2024\",\n",
      "            \"C. 18 October 2024\",\n",
      "            \"D. A debit order cannot be revoked in part\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Which of the following statements about filing third- party observations is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The person that filed third- party observations will be a party to the proceedings before the EPO, and the applicant is obliged to respond to third- party observations\",\n",
      "            \"B. Third -party observations must be filed in writing and may not be filed anonymously\",\n",
      "            \"C. Third -party observations are considered by the examining division only if they include a statement of the grounds on which they are based, and an official fee is paid\",\n",
      "            \"D. Third -party observations can be filed after the publication of a European patent application and must be filed in an official language of the EPO\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 13: {'question': \"If a renewal fee for a European patent application was debited from an applicant's deposit account on 15 August 2024, but it should have been validly paid after 31 July 2020 under Rule 51(1), what is the latest date by which the additional fee can be paid without incurring any penalties according to the Guidelines for Examination in the EPO?\", 'options': ['A. 15 August 2024', 'B. 31 January 2025', 'C. 31 July 2025', 'D. The additional fee cannot be paid after the renewal fee was debited']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. As no renewal fees have been paid, the application is deemed to be withdrawn .\",\n",
      "            \"B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .\",\n",
      "            \"C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .\",\n",
      "            \"D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?\",\n",
      "        \"options\": [\n",
      "            \"A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO\",\n",
      "            \"B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application\",\n",
      "            \"C. File an electronic certified copy of the Luxembourg patent application with the EPO\",\n",
      "            \"D. File a certified copy of the Luxembourg patent application with the International Bureau\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In which of the following cases is the applicant entitled to a reduction of the filing fee  under Rule  6 EPC ? A declaration of such entitlement has  been made by crossing the relevant box on Form  1001.\",\n",
      "        \"options\": [\n",
      "            \"A. A Spanish European patent attorney files a European patent application in Spanish for a natural person who is resident in Andorra and of Andorra n nationality .\",\n",
      "            \"B. A firm whose principal place of business is in Germany and a natural person who is resident in Germany  and of Dutch nationality  jointly file a European patent application in Dutch. The German firm employs 200 people with an annual turnover of EUR 60 million.\",\n",
      "            \"C. A natural person resident in the USA and of Belgian nationality files a European patent application in French.\",\n",
      "            \"D. A natural person resident in the USA and of Swiss nationality files a European patent application in Italian.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 14: {'question': \"A European patent application was filed on 15 January 2023. The applicant did not pay any renewal fees for the first two years. On 10 June 2024, the communication under Rule 71(3) EPC was issued stating that the application would proceed to grant. Which of the following statements is correct regarding the payment of the third year's renewal fee?\", 'options': ['A. The renewal fee for the third year can be validly paid without any additional fee by 9 July 2024.', 'B. The renewal fee for the third year can be validly paid with an additional fee by 31 January 2025.', 'C. The renewal fee for the third year cannot be paid until after grant.', 'D. The application is deemed withdrawn due to non-payment of fees.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"In which of the following situations does the EPO recommend using the EPO Contingency Upload Service?\",\n",
      "        \"options\": [\n",
      "            \"A. When you submit documents after business hours\",\n",
      "            \"B. When the EPO filing systems are functioning correctly, but you encounter a technical issue at your end\",\n",
      "            \"C. When there is a system outage at the EPO that prevents document submission via the standard filing systems\",\n",
      "            \"D. When the EPO is closed due to an official holiday\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?\",\n",
      "        \"options\": [\n",
      "            \"A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO\",\n",
      "            \"B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application\",\n",
      "            \"C. File an electronic certified copy of the Luxembourg patent application with the EPO\",\n",
      "            \"D. File a certified copy of the Luxembourg patent application with the International Bureau\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicants may request processing of their international application under PCT Direct by filing a letter (\\\"PCT Direct letter\\\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing\",\n",
      "            \"B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0\",\n",
      "            \"C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0\",\n",
      "            \"D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 15: {'question': 'In which of the following ways can priority documents be filed according to the Guidelines for Examination in the EPO?', 'options': ['A. By fax, as long as the document is in an accepted format', 'B. Via the EPO web-form filing service or Contingency Upload Service', 'C. Electronically using OLFEPO Online Filing or Online Filing 2.0 only if they are in an accepted document format and digitally signed by the issuing authority', 'D. By mail to any of the patent offices listed, regardless of their signature acceptance']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Applicant Korhonen is a Finnish national resident in Finland. He filed a European patent application in Finnish and provided an English translation in time. In response to the extended European search report (EESR), Korhonen wishes to file amended claims t ogether with a request for examination. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Korhonen must file the amended claims in Finnish and must then  provide a translation into English, in time\",\n",
      "            \"B. Korhonen is allowed to file the amended claims in Finnish if he then provides a\",\n",
      "            \"translation into any official language of the EPO, in time C. Korhonen is allowed to file the amended claims in Finnish if he then provides a translation into English, in time\",\n",
      "            \"D. Korhonen is not allowed to file the amended claims in Finnish\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Last week Greta validly filed the international patent application PCT -G with the German Patent and Trade mark Office ( DPMA ) and appointed Hassan to represent her. Hassan is entitled to act before the DPMA  but he is not a European patent attorney. Greta and Hassan are resident in Germany.  Which of the following statements is not correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Hassan can represent Greta before the EPO acting as the International Searching Authority for PCT -G.\",\n",
      "            \"B. In order for Hassan to be able to act before the EPO acting as the International Searching Authority , he needs to submit a power of attorney signed by Greta.\",\n",
      "            \"C. According to the provisions of the PCT, it is mandatory that the d emand for international preliminary examination is signed by Greta or Hassan.\",\n",
      "            \"D. According to the provisions of the PCT, an international application can only be withdrawn by the applicant or an agent appointed by a power of attorney.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The opposition division revoked European patent EP -B1. The patent proprietor filed an appeal  in time . The b oard of appeal forwarded a copy of the appeal to the o pponent/ respondent with a communication dated 1 June 2023 giving it an opportunity to file comments within a period of four  months.  The opponent/respondent files comments today, 12 October 2023. What further action has to be taken ?\",\n",
      "        \"options\": [\n",
      "            \"A. The opponent/ respondent needs  to request an extension of the period for comment.\",\n",
      "            \"B. The opponent/respondent needs to pay a fee for further processing.\",\n",
      "            \"C. The opponent/respondent needs to file a substantiated request for reestablishment of rights and pay the associated fee.\",\n",
      "            \"D. None of the above.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 16: {'question': 'An applicant from Switzerland filed a European patent application in French and provided an English translation within the required time frame. The applicant now wishes to file amended claims together with a request for examination. According to the EPO rules, which of the following statements is correct?', 'options': ['A. The applicant must file the amended claims in any non-official language and then provide an English translation.', 'B. The applicant can file the amended claims in French but must subsequently provide a translation into English within one month.', 'C. The applicant can file the amended claims in French, provided they are accompanied by a translation into any official language of the EPO within two months.', 'D. The applicant is not allowed to file the amended claims in French and must use an official EPO language.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?\",\n",
      "        \"options\": [\n",
      "            \"A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO\",\n",
      "            \"B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application\",\n",
      "            \"C. File an electronic certified copy of the Luxembourg patent application with the EPO\",\n",
      "            \"D. File a certified copy of the Luxembourg patent application with the International Bureau\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 20  June 2023, applicant P validly filed an international patent application PCT-P, claiming priority from European patent application EP -I filed on 7 July 2022. Today, 12 October 2023, he discovers that he should also have claimed priority from EP -II filed on 3 July 2022. Can the missing priority claim still be validly added?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, the time  limit for adding the priority claim expires on 3  November 2023.\",\n",
      "            \"B. Yes, the time limit for adding the priority claim expires on 7  November 2023.\",\n",
      "            \"C. Yes, the time  limit for adding the priority claim expires on 20 October 2023.\",\n",
      "            \"D. No, the time  limit for adding the priority claim expired on 3 July 2023.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Which functionalities or services can be accessed directly from MyEPO Portfolio?\",\n",
      "        \"options\": [\n",
      "            \"A. A shared area with examiners, European Patent Register, filing via the EPO's online filing software eOLF\",\n",
      "            \"B. Mailbox, a shared area with examiners, replying to a communication under Article  94(3) EPC\",\n",
      "            \"C. Mailbox, patent search via publication server, a shared area with examiners\",\n",
      "            \"D. Filing via the EPO's Online Filing 2.0, patent search via publication server, Mailbox\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 17: {'question': 'An applicant filed a European patent application claiming priority from an earlier French national application. The French application was filed on 15 March 2023, but no certified copy of this application was submitted with the European patent application filed on 14 September 2023. According to EPC Rule 53 and the Guidelines for Examination in the EPO, what must the applicant do within the subsequent months to ensure compliance with priority requirements?', 'options': ['A. File a certified copy of the French national application by 15 March 2024', 'B. Submit a request for admission of late filing of the certified copy before 14 September 2024', 'C. Provide a valid Digital Access Service (DAS) code to obtain an electronic certified copy within six months from 14 September 2023', 'D. No action is required if the application includes a reference to the French national application']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A communication under Article 94(3) EPC, setting a four -month time limit for reply is dated 12 September 2024. The applicant receives the letter on 21 September 2024, as evidenced by the postal receipt signed by him.  What is the last day for replying to the communication?\",\n",
      "        \"options\": [\n",
      "            \"A. 13 January 2025\",\n",
      "            \"B. 12 January 2025\",\n",
      "            \"C. 22 January 2025\",\n",
      "            \"D. 14 January 2025\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Which functionalities or services can be accessed directly from MyEPO Portfolio?\",\n",
      "        \"options\": [\n",
      "            \"A. A shared area with examiners, European Patent Register, filing via the EPO's online filing software eOLF\",\n",
      "            \"B. Mailbox, a shared area with examiners, replying to a communication under Article  94(3) EPC\",\n",
      "            \"C. Mailbox, patent search via publication server, a shared area with examiners\",\n",
      "            \"D. Filing via the EPO's Online Filing 2.0, patent search via publication server, Mailbox\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international application is published , together  with the search report drawn up by the CNIPA , 18 m onths + 1 day after the filing date (no priority claimed). The application has no more than 35 pages and 15 claims. Which statement reflects all actions the CN  applicant  needs to take for entry into the EP phase 25 months  after the filing date ? A request for early processing has been filed.\",\n",
      "        \"options\": [\n",
      "            \"A. Complete and file Form 1200 and pay the filing fee and the search fee\",\n",
      "            \"B. Complete and file Form 1200 and pay the filing fee, the search fee and the renewal fee for the third year\",\n",
      "            \"C. Complete and file Form 1200, pay the filing fee and the search fee and appoint a representative\",\n",
      "            \"D. None of the above statements\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 18: {'question': 'Which service can currently be used to file certain procedural acts according to the provided guidelines?', 'options': ['A. MyEPO Portfolio', 'B. EPO Online Filing 2.0', 'C. EPO Smart Card', 'D. European Patent Register']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The applicant received a communication pursuant to Article 90(3) EPC and Rule  60 EPC, requesting them to file a designation of inventor but missed the time limit for filing a response. After expiry of the time limit, the Receiving Section issued a decision to refuse the European patent application, dated 10  October 2024. What can the applicant do to remedy the situation?\",\n",
      "        \"options\": [\n",
      "            \"A. File a notice of appeal against the decision within four months of notification of the decision\",\n",
      "            \"B. File a request for further processing within two months of notification of the decision\",\n",
      "            \"C. File, within two months of notification of the decision, a request for re-establishment of rights in respect of the time limit for filing the designation of inventor\",\n",
      "            \"D. A, B and C are correct\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"After receipt of a negative written opinion issued by the EPO acting as ISA, amendments under Art icle 19 PCT were filed during the international phase. No request for international preliminary examination was filed. Form  1200 was used,  and no further amendments were filed with the EPO upon entry into the regional phase.   What communication under Rules  161/162 EPC will be received in the regional phase?\",\n",
      "        \"options\": [\n",
      "            \"A. Form 1226AA ;  if you do not reply to it in time, the application will be deemed to be withdrawn\",\n",
      "            \"B. Form 1226BB offering the opportunity to comment and file amendments\",\n",
      "            \"C. Form 1226CC offering the opportunity to file amendments before the supplementary European search report is drawn up\",\n",
      "            \"D. Form 1226AC stating that the examination has started\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 20  June 2023, applicant P validly filed an international patent application PCT-P, claiming priority from European patent application EP -I filed on 7 July 2022. Today, 12 October 2023, he discovers that he should also have claimed priority from EP -II filed on 3 July 2022. Can the missing priority claim still be validly added?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, the time  limit for adding the priority claim expires on 3  November 2023.\",\n",
      "            \"B. Yes, the time limit for adding the priority claim expires on 7  November 2023.\",\n",
      "            \"C. Yes, the time  limit for adding the priority claim expires on 20 October 2023.\",\n",
      "            \"D. No, the time  limit for adding the priority claim expired on 3 July 2023.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 19: {'question': 'If an applicant fails to reply within the due time to an invitation from the Receiving Section under Rule 55 to remedy a deficiency under Rule 40(1)(a) or (c), what will happen?', 'options': ['A. The application will be refused without further communication.', 'B. A decision will be issued within two months of the notification, refusing the application due to non-compliance with Rule 40.', 'C. The applicant will have no opportunity to file a request for re-establishment of rights or pursue other means of redress.', 'D. The application will continue to be processed as if the deficiency had been remedied.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?\",\n",
      "        \"options\": [\n",
      "            \"A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.\",\n",
      "            \"B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.\",\n",
      "            \"C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.\",\n",
      "            \"D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"After receipt of a negative written opinion issued by the EPO acting as ISA, amendments under Art icle 19 PCT were filed during the international phase. No request for international preliminary examination was filed. Form  1200 was used,  and no further amendments were filed with the EPO upon entry into the regional phase.   What communication under Rules  161/162 EPC will be received in the regional phase?\",\n",
      "        \"options\": [\n",
      "            \"A. Form 1226AA ;  if you do not reply to it in time, the application will be deemed to be withdrawn\",\n",
      "            \"B. Form 1226BB offering the opportunity to comment and file amendments\",\n",
      "            \"C. Form 1226CC offering the opportunity to file amendments before the supplementary European search report is drawn up\",\n",
      "            \"D. Form 1226AC stating that the examination has started\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. As no renewal fees have been paid, the application is deemed to be withdrawn .\",\n",
      "            \"B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .\",\n",
      "            \"C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .\",\n",
      "            \"D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 20: {'question': 'During examination proceedings, an applicant submitted a document with handwritten amendments to address an objection from the examining division. Which of the following statements is correct regarding this situation?', 'options': ['A Upon request, the applicant must provide typed versions of all amended pages, even if they are minor, to maintain procedural economy.', 'B The examining division may invite the applicant to indicate amendments on a copy separately from comments by the examining division, as long as these can be easily legible after photocopying.', 'C Handwritten amendments will automatically lead to the rejection of the application due to lack of formal compliance with EPO rules.', 'D The examining division can request complete retyping of documents if the amendments are extensive and affect legibility, but such requests are generally not admitted under Rule 137(3).']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Mr Linguist filed a European patent application in Dutch and used English as language of the proceedings. When requesting unitary effect on 10 October 2024, Mr Linguist must provide a translation of the specification. Mr Linguist would like to obtain immediate registration of the unitary effect. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Mr Linguist must provide a translation of the specification into Dutch\",\n",
      "            \"B. Mr Linguist must provide a translation of the specification into an official language of any of the 18 states to which the unitary effect extends\",\n",
      "            \"C. Mr Linguist must provide a translation of the specification into an official language of any of the 24 states that have signed the UPCA\",\n",
      "            \"D. Mr Linguist may provide a translation of the specification into Spanish\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The applicant received a communication pursuant to Article 90(3) EPC and Rule  60 EPC, requesting them to file a designation of inventor but missed the time limit for filing a response. After expiry of the time limit, the Receiving Section issued a decision to refuse the European patent application, dated 10  October 2024. What can the applicant do to remedy the situation?\",\n",
      "        \"options\": [\n",
      "            \"A. File a notice of appeal against the decision within four months of notification of the decision\",\n",
      "            \"B. File a request for further processing within two months of notification of the decision\",\n",
      "            \"C. File, within two months of notification of the decision, a request for re-establishment of rights in respect of the time limit for filing the designation of inventor\",\n",
      "            \"D. A, B and C are correct\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 21: {'question': 'If an applicant fails to provide a translation of their international application within the 31-month time limit, what is the consequence under PCT Article 36?', 'options': ['A. The application will be automatically withdrawn.', 'B. The language of proceedings remains unchanged, but the application becomes unexamined.', 'C. The translation must be provided within six months after the initial deadline to avoid losing rights.', 'D. The international preliminary examination report and its annexes become prior art under Article 54(2) or (3) EPC.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Linguist filed a European patent application in Dutch and used English as language of the proceedings. When requesting unitary effect on 10 October 2024, Mr Linguist must provide a translation of the specification. Mr Linguist would like to obtain immediate registration of the unitary effect. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Mr Linguist must provide a translation of the specification into Dutch\",\n",
      "            \"B. Mr Linguist must provide a translation of the specification into an official language of any of the 18 states to which the unitary effect extends\",\n",
      "            \"C. Mr Linguist must provide a translation of the specification into an official language of any of the 24 states that have signed the UPCA\",\n",
      "            \"D. Mr Linguist may provide a translation of the specification into Spanish\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You filed an international patent application on 6 June 2024, claiming the priority of a European patent application filed on 7  July 2023. You received a communication dated 25 September 2024 from the EPO acting as International Searching Authority (ISA), stating that the requirement of unity of invention has not been complied with. The ISA identifies three inventions. You are invited to pay two additional search fees. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. You must pay two additional search fees by 25 October 2024\",\n",
      "            \"B. You do not need to file a response to the provisional opinion accompanying the partial search results\",\n",
      "            \"C. If you pay two additional search fees under protest, you must pay two protest fees within the time limit\",\n",
      "            \"D. If you do not pay any additional search fees within the time limit, the international patent application will be deemed to be withdrawn\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Attempt 1 failed. Retrying...\n",
      "Question 22: {'question': 'You filed a European patent application on 15 March 2023, which claims priority to an earlier filing date of 14 March 2022. You received a communication dated 31 January 2024 from the EPO stating that the application requires additional information regarding the description of the invention. The deadline for responding is 31 July 2024. Which of the following statements is correct?', 'options': [\"A. The response must be submitted by 31 July 2024, and no further action is required if it meets the EPO's requirements.\", 'B. The renewal fee for the third year can be paid until 31 October 2024, provided that the application is pending as of this date.', 'C. If the additional information is not submitted by 31 July 2024, the application will be deemed withdrawn and cannot be further prosecuted.', 'D. The renewal fee for the fourth year can be paid until 31 January 2025, but no later.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?\",\n",
      "        \"options\": [\n",
      "            \"A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.\",\n",
      "            \"B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.\",\n",
      "            \"C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.\",\n",
      "            \"D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You filed an international patent application on 6 June 2024, claiming the priority of a European patent application filed on 7  July 2023. You received a communication dated 25 September 2024 from the EPO acting as International Searching Authority (ISA), stating that the requirement of unity of invention has not been complied with. The ISA identifies three inventions. You are invited to pay two additional search fees. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. You must pay two additional search fees by 25 October 2024\",\n",
      "            \"B. You do not need to file a response to the provisional opinion accompanying the partial search results\",\n",
      "            \"C. If you pay two additional search fees under protest, you must pay two protest fees within the time limit\",\n",
      "            \"D. If you do not pay any additional search fees within the time limit, the international patent application will be deemed to be withdrawn\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 23: {'question': \"During oral proceedings before the opposition division, the patent proprietor proposed amendments to the claims and description of a European patent. Which of the following actions should the patent proprietor take to ensure compliance with the EPO's Guidelines for Examination?\", 'options': ['A. No action is required as long as the opposition division agrees with the amendments.', 'B. Submit only the amended claims, as they are sufficient for the opposition divisions consideration.', 'C. Provide a formally compliant version of the entire description and claims, even if it includes handwritten amendments during oral proceedings.', 'D. File a completely retyped document containing all amendments to both the claims and description within one month of the oral proceedings.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 10 October 2021, European patent attorney X filed European patent application EP -A with the EPO on the applicant's behalf. Application EP -A was published on 12 April 2023, together  with the extended European search report. On 6  October 2023, the applicant contacts a new European patent attorney  Y to replace X as representative and issues Y with its instructions to reply to the extended European search report. The applicant did not inform X that he would be replaced.  What are the steps necessary to validly appoint representative Y and to avoid any loss of rights for European patent application EP -A?\",\n",
      "        \"options\": [\n",
      "            \"A. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 12 October 2023 at the latest and files in good time an authorisation signed by the applicant .\",\n",
      "            \"B. New representative Y requests a change of representative and files a response to the extended European search report with  the EPO by 12 October 2023 at the latest .\",\n",
      "            \"C. New representative Y requests a change of representative and files a response to the extended European search report with the EPO by 23 October 2023 at the latest.\",\n",
      "            \"D. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 23 October 2023 at the latest and files in good time an authorisation signed by the applicant .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .\",\n",
      "            \"B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .\",\n",
      "            \"C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .\",\n",
      "            \"D. Ms Smith can only be deleted as inventor with her consent .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 24: {'question': 'Representative Y was appointed as the new representative for European patent application EP -A on 25 November 2023, replacing Representative X. To ensure that all legal steps are followed correctly and to avoid any loss of rights for EP -A, what actions must be taken according to EPC regulations?', 'options': ['A. File a request for change of representative with the European Patent Office by 15 December 2023 at the latest, and ensure that an authorization signed by the applicant is filed in good time.', 'B. File a request for change of representative with the European Patent Office by 15 December 2023 at the latest.', 'C. File a request for change of representative with the European Patent Office by 15 January 2024 at the latest, and ensure that an authorization signed by the applicant is filed in good time.', 'D. File a request for change of representative with the European Patent Office by 15 December 2023 at the latest, file a response to any pending actions such as an extended European search report by 15 January 2024 and ensure that an authorization signed by the applicant is filed in good time.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Applicant Korhonen is a Finnish national resident in Finland. He filed a European patent application in Finnish and provided an English translation in time. In response to the extended European search report (EESR), Korhonen wishes to file amended claims t ogether with a request for examination. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Korhonen must file the amended claims in Finnish and must then  provide a translation into English, in time\",\n",
      "            \"B. Korhonen is allowed to file the amended claims in Finnish if he then provides a\",\n",
      "            \"translation into any official language of the EPO, in time C. Korhonen is allowed to file the amended claims in Finnish if he then provides a translation into English, in time\",\n",
      "            \"D. Korhonen is not allowed to file the amended claims in Finnish\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 10 October 2021, European patent attorney X filed European patent application EP -A with the EPO on the applicant's behalf. Application EP -A was published on 12 April 2023, together  with the extended European search report. On 6  October 2023, the applicant contacts a new European patent attorney  Y to replace X as representative and issues Y with its instructions to reply to the extended European search report. The applicant did not inform X that he would be replaced.  What are the steps necessary to validly appoint representative Y and to avoid any loss of rights for European patent application EP -A?\",\n",
      "        \"options\": [\n",
      "            \"A. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 12 October 2023 at the latest and files in good time an authorisation signed by the applicant .\",\n",
      "            \"B. New representative Y requests a change of representative and files a response to the extended European search report with  the EPO by 12 October 2023 at the latest .\",\n",
      "            \"C. New representative Y requests a change of representative and files a response to the extended European search report with the EPO by 23 October 2023 at the latest.\",\n",
      "            \"D. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 23 October 2023 at the latest and files in good time an authorisation signed by the applicant .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 25: {'question': 'If an applicant submits a European patent application in German, which of the following statements is true regarding the submission of amended claims?', 'options': ['A. The applicant must file the amended claims in English within one month from receipt of the communication.', 'B. The applicant can file the amended claims in German and provide an English translation within the time limit for filing responses.', 'C. The applicant is required to file a French translation of the amended claims within 31 months of the priority date.', 'D. The applicant must wait until the application is published before submitting any amended claims.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You filed an international patent application on 6 June 2024, claiming the priority of a European patent application filed on 7  July 2023. You received a communication dated 25 September 2024 from the EPO acting as International Searching Authority (ISA), stating that the requirement of unity of invention has not been complied with. The ISA identifies three inventions. You are invited to pay two additional search fees. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. You must pay two additional search fees by 25 October 2024\",\n",
      "            \"B. You do not need to file a response to the provisional opinion accompanying the partial search results\",\n",
      "            \"C. If you pay two additional search fees under protest, you must pay two protest fees within the time limit\",\n",
      "            \"D. If you do not pay any additional search fees within the time limit, the international patent application will be deemed to be withdrawn\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 26: {'question': 'J12/04(OJ 1987, 536) states that when an application for a European patent contains multiple claims to inventions that do not comply with Art. 44(2) EPC, the applicant is required to pay additional search fees and to specify which of the inventions are being pursued in examination proceedings. If the applicant fails to meet this requirement within the time limit set by the EPO, what happens next?', 'options': ['A. The application will be deemed withdrawn.', 'B. The application will proceed with all claims under protest.', 'C. The EPO will contact the applicant for clarification but not take any action unless a response is received.', 'D. The EPO will automatically select one of the inventions and proceed with examination.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .\",\n",
      "            \"B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .\",\n",
      "            \"C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .\",\n",
      "            \"D. Ms Smith can only be deleted as inventor with her consent .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Linguist filed a European patent application in Dutch and used English as language of the proceedings. When requesting unitary effect on 10 October 2024, Mr Linguist must provide a translation of the specification. Mr Linguist would like to obtain immediate registration of the unitary effect. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Mr Linguist must provide a translation of the specification into Dutch\",\n",
      "            \"B. Mr Linguist must provide a translation of the specification into an official language of any of the 18 states to which the unitary effect extends\",\n",
      "            \"C. Mr Linguist must provide a translation of the specification into an official language of any of the 24 states that have signed the UPCA\",\n",
      "            \"D. Mr Linguist may provide a translation of the specification into Spanish\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 27: {'question': 'A European patent application was filed by Ms Writer, containing the title of the invention and a brief technical summary but lacking any claims or detailed description. The filing date was 1 February 2023. According to the EPC 1973, which of the following statements is correct?', 'options': ['A. The application complies with Art. 80(d) EPC 1973 and has a valid filing date.', 'B. The application lacks essential elements as required by Art. 80(d) EPC 1973 and does not have a valid filing date.', 'C. The application is acceptable if Ms Writer submits claims and a detailed description within three months of the filing date.', 'D. The application can be filed in any admissible non-EPO language as long as it includes a translation to an EPO official language.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Last week Greta validly filed the international patent application PCT -G with the German Patent and Trade mark Office ( DPMA ) and appointed Hassan to represent her. Hassan is entitled to act before the DPMA  but he is not a European patent attorney. Greta and Hassan are resident in Germany.  Which of the following statements is not correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Hassan can represent Greta before the EPO acting as the International Searching Authority for PCT -G.\",\n",
      "            \"B. In order for Hassan to be able to act before the EPO acting as the International Searching Authority , he needs to submit a power of attorney signed by Greta.\",\n",
      "            \"C. According to the provisions of the PCT, it is mandatory that the d emand for international preliminary examination is signed by Greta or Hassan.\",\n",
      "            \"D. According to the provisions of the PCT, an international application can only be withdrawn by the applicant or an agent appointed by a power of attorney.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicants may request processing of their international application under PCT Direct by filing a letter (\\\"PCT Direct letter\\\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing\",\n",
      "            \"B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0\",\n",
      "            \"C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0\",\n",
      "            \"D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In which of the following situations does the EPO recommend using the EPO Contingency Upload Service?\",\n",
      "        \"options\": [\n",
      "            \"A. When you submit documents after business hours\",\n",
      "            \"B. When the EPO filing systems are functioning correctly, but you encounter a technical issue at your end\",\n",
      "            \"C. When there is a system outage at the EPO that prevents document submission via the standard filing systems\",\n",
      "            \"D. When the EPO is closed due to an official holiday\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 28: {'question': 'According to Rule 161 of the EPC, which entity is responsible for issuing the International Preliminary Report on Patentability?', 'options': ['A. The European Patent Office (EPO) acting as the International Searching Authority', \"B. The designated national patent office of the applicant's choice\", 'C. The appointed representative for the applicant', 'D. The International Bureau of WIPO'], 'answer': 'D. The International Bureau of WIPO'}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Which functionalities or services can be accessed directly from MyEPO Portfolio?\",\n",
      "        \"options\": [\n",
      "            \"A. A shared area with examiners, European Patent Register, filing via the EPO's online filing software eOLF\",\n",
      "            \"B. Mailbox, a shared area with examiners, replying to a communication under Article  94(3) EPC\",\n",
      "            \"C. Mailbox, patent search via publication server, a shared area with examiners\",\n",
      "            \"D. Filing via the EPO's Online Filing 2.0, patent search via publication server, Mailbox\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In which of the following cases is the applicant entitled to a reduction of the filing fee  under Rule  6 EPC ? A declaration of such entitlement has  been made by crossing the relevant box on Form  1001.\",\n",
      "        \"options\": [\n",
      "            \"A. A Spanish European patent attorney files a European patent application in Spanish for a natural person who is resident in Andorra and of Andorra n nationality .\",\n",
      "            \"B. A firm whose principal place of business is in Germany and a natural person who is resident in Germany  and of Dutch nationality  jointly file a European patent application in Dutch. The German firm employs 200 people with an annual turnover of EUR 60 million.\",\n",
      "            \"C. A natural person resident in the USA and of Belgian nationality files a European patent application in French.\",\n",
      "            \"D. A natural person resident in the USA and of Swiss nationality files a European patent application in Italian.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In which of the following situations does the EPO recommend using the EPO Contingency Upload Service?\",\n",
      "        \"options\": [\n",
      "            \"A. When you submit documents after business hours\",\n",
      "            \"B. When the EPO filing systems are functioning correctly, but you encounter a technical issue at your end\",\n",
      "            \"C. When there is a system outage at the EPO that prevents document submission via the standard filing systems\",\n",
      "            \"D. When the EPO is closed due to an official holiday\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 29: {'question': 'According to Article 94(1) EPC, which of the following statements is true regarding the examination request for a European patent application?', 'options': ['A. The examination request must be filed within two months after the publication of the application.', 'B. The examination request becomes valid only if it is accompanied by all required fees and documentation.', 'C. The examination request can be made at any time during the pendency of the application, provided that all necessary fees are paid in due time.', 'D. The examination request must be submitted within one month after the filing date of the application.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"EP-1 is a regular European patent application (Euro -direct application) .  Which one of the following missed time limits can be remedied for EP -1 before the EPO by requesting re- establishment of rights ?\",\n",
      "        \"options\": [\n",
      "            \"A. T ime limit for pay ing the designation fee\",\n",
      "            \"B. T ime limit for requesting examination\",\n",
      "            \"C. T ime limit for filing the application within the priority period\",\n",
      "            \"D. T ime limit for paying the fee for re- establishment of rights\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Company M, which has  its principal place of business in Tijuana, Mexico, validly filed an international patent application PCT -M with the Mexican Institute of Industrial Property. The application was filed in Spanish. A few days later, the applicant files an English translati on of the application.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant can choose the EPO as ISA and the USPTO as IPEA.\",\n",
      "            \"B. The applicant can choose the USPTO as ISA and the EPO as IPEA.\",\n",
      "            \"C. The applicant can choose the Austrian Patent Offic e as ISA and the\",\n",
      "            \"EPO as IPEA.\",\n",
      "            \"D. The applicant can choose the EPO as ISA and the Intellectual Property\",\n",
      "            \"Office of Singapore as IPEA.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Last week Greta validly filed the international patent application PCT -G with the German Patent and Trade mark Office ( DPMA ) and appointed Hassan to represent her. Hassan is entitled to act before the DPMA  but he is not a European patent attorney. Greta and Hassan are resident in Germany.  Which of the following statements is not correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Hassan can represent Greta before the EPO acting as the International Searching Authority for PCT -G.\",\n",
      "            \"B. In order for Hassan to be able to act before the EPO acting as the International Searching Authority , he needs to submit a power of attorney signed by Greta.\",\n",
      "            \"C. According to the provisions of the PCT, it is mandatory that the d emand for international preliminary examination is signed by Greta or Hassan.\",\n",
      "            \"D. According to the provisions of the PCT, an international application can only be withdrawn by the applicant or an agent appointed by a power of attorney.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 30: {'question': 'If a European patent application was filed according to Art. 14(2) in a non-EPO language, what must be done within two months of the filing date?', 'options': ['A. File a declaration that the translation is complete.', 'B. Request an extension for priority claiming.', 'C. File a translation of the application into an official EPO language.', 'D. Pay the designation fee for entering the national phase.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"EP-1 is a regular European patent application (Euro -direct application) .  Which one of the following missed time limits can be remedied for EP -1 before the EPO by requesting re- establishment of rights ?\",\n",
      "        \"options\": [\n",
      "            \"A. T ime limit for pay ing the designation fee\",\n",
      "            \"B. T ime limit for requesting examination\",\n",
      "            \"C. T ime limit for filing the application within the priority period\",\n",
      "            \"D. T ime limit for paying the fee for re- establishment of rights\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 20  June 2023, applicant P validly filed an international patent application PCT-P, claiming priority from European patent application EP -I filed on 7 July 2022. Today, 12 October 2023, he discovers that he should also have claimed priority from EP -II filed on 3 July 2022. Can the missing priority claim still be validly added?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, the time  limit for adding the priority claim expires on 3  November 2023.\",\n",
      "            \"B. Yes, the time limit for adding the priority claim expires on 7  November 2023.\",\n",
      "            \"C. Yes, the time  limit for adding the priority claim expires on 20 October 2023.\",\n",
      "            \"D. No, the time  limit for adding the priority claim expired on 3 July 2023.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicants may request processing of their international application under PCT Direct by filing a letter (\\\"PCT Direct letter\\\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing\",\n",
      "            \"B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0\",\n",
      "            \"C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0\",\n",
      "            \"D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 31: {'question': \"If an applicant's priority claim dates back more than twelve months before the filing date of their European patent application, what must they do to maintain their right to priority according to the guidelines?\", 'options': ['A. Do nothing as the priority claim is automatically valid.', 'B. Pay a special fee for late priority claims immediately after filing.', 'C. File a declaration within six months from the filing date of the European patent application, stating that they wish to rely on the priority claim and providing additional information if necessary.', 'D. Request re-establishment of rights before any examination proceedings begin.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Which functionalities or services can be accessed directly from MyEPO Portfolio?\",\n",
      "        \"options\": [\n",
      "            \"A. A shared area with examiners, European Patent Register, filing via the EPO's online filing software eOLF\",\n",
      "            \"B. Mailbox, a shared area with examiners, replying to a communication under Article  94(3) EPC\",\n",
      "            \"C. Mailbox, patent search via publication server, a shared area with examiners\",\n",
      "            \"D. Filing via the EPO's Online Filing 2.0, patent search via publication server, Mailbox\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 32: {'question': 'If a new European patent application is filed under Article 61, paragraph 1(b) EPC, after which point can the designation fee be refunded if no further processing has been initiated?', 'options': ['A. Within six months of filing the new application', 'B. After the start of substantive examination on the new application', 'C. At any time before the application is deemed withdrawn or abandoned', 'D. Once a communication under Article 94(3) EPC has been issued']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?\",\n",
      "        \"options\": [\n",
      "            \"A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO\",\n",
      "            \"B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application\",\n",
      "            \"C. File an electronic certified copy of the Luxembourg patent application with the EPO\",\n",
      "            \"D. File a certified copy of the Luxembourg patent application with the International Bureau\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .\",\n",
      "            \"B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .\",\n",
      "            \"C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .\",\n",
      "            \"D. Ms Smith can only be deleted as inventor with her consent .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 33: {'question': \"A European patent application was filed on 15 March 2024, claiming priority from an earlier French national application filed on 16 April 2023. A certified copy of the French application was not submitted with the European filing. Which of the following actions is permissible according to the EPO's regulations?\", 'options': ['A. Submit a valid Digital Access Service (DAS) code to the EPO to obtain a certified copy of the French national application.', 'B. Request the French National Intellectual Property Office to prepare and send a certified copy of the French national application to the EPO.', 'C. File an electronic certified copy of the French national application with the EPO.', 'D. Submit the French application directly to the EPO without any additional steps.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. As no renewal fees have been paid, the application is deemed to be withdrawn .\",\n",
      "            \"B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .\",\n",
      "            \"C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .\",\n",
      "            \"D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In which of the following situations does the EPO recommend using the EPO Contingency Upload Service?\",\n",
      "        \"options\": [\n",
      "            \"A. When you submit documents after business hours\",\n",
      "            \"B. When the EPO filing systems are functioning correctly, but you encounter a technical issue at your end\",\n",
      "            \"C. When there is a system outage at the EPO that prevents document submission via the standard filing systems\",\n",
      "            \"D. When the EPO is closed due to an official holiday\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 34: {'question': 'A European patent application was filed in German, but part of the description was originally submitted in French without an official translation into one of the EPOs official languages. Which of the following statements is correct according to the given context?', 'options': ['A. The application will be rejected as it does not comply with Article 14(2) EPC.', 'B. The deficiency can be remedied by filing an official French translation within two months of notification under Rule 112(1) EPC.', \"C. The application is valid, and the French part will be considered as it is a contracting state's language.\", 'D. No action is required as long as the claims are in one of the EPOs official languages.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Applicants may request processing of their international application under PCT Direct by filing a letter (\\\"PCT Direct letter\\\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing\",\n",
      "            \"B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0\",\n",
      "            \"C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0\",\n",
      "            \"D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .\",\n",
      "            \"B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .\",\n",
      "            \"C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .\",\n",
      "            \"D. Ms Smith can only be deleted as inventor with her consent .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 35: {'question': 'If an applicant has amended their international application during the international phase, they have the option to enter the European phase with either the amended or original documents. According to which rule can the applicant choose whether to proceed with the amended documents or retain the original ones, and when is this decision typically made?', 'options': ['A. Rule 159(2), during the international preliminary examination', 'B. Rule 159(1)(b), after receiving the international search report', 'C. Rule 161(2), before filing the European patent application', 'D. Rule 153(7), upon entering the national phase']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"In which of the following cases is the applicant entitled to a reduction of the filing fee  under Rule  6 EPC ? A declaration of such entitlement has  been made by crossing the relevant box on Form  1001.\",\n",
      "        \"options\": [\n",
      "            \"A. A Spanish European patent attorney files a European patent application in Spanish for a natural person who is resident in Andorra and of Andorra n nationality .\",\n",
      "            \"B. A firm whose principal place of business is in Germany and a natural person who is resident in Germany  and of Dutch nationality  jointly file a European patent application in Dutch. The German firm employs 200 people with an annual turnover of EUR 60 million.\",\n",
      "            \"C. A natural person resident in the USA and of Belgian nationality files a European patent application in French.\",\n",
      "            \"D. A natural person resident in the USA and of Swiss nationality files a European patent application in Italian.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Linguist filed a European patent application in Dutch and used English as language of the proceedings. When requesting unitary effect on 10 October 2024, Mr Linguist must provide a translation of the specification. Mr Linguist would like to obtain immediate registration of the unitary effect. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Mr Linguist must provide a translation of the specification into Dutch\",\n",
      "            \"B. Mr Linguist must provide a translation of the specification into an official language of any of the 18 states to which the unitary effect extends\",\n",
      "            \"C. Mr Linguist must provide a translation of the specification into an official language of any of the 24 states that have signed the UPCA\",\n",
      "            \"D. Mr Linguist may provide a translation of the specification into Spanish\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The applicant received a communication pursuant to Article 90(3) EPC and Rule  60 EPC, requesting them to file a designation of inventor but missed the time limit for filing a response. After expiry of the time limit, the Receiving Section issued a decision to refuse the European patent application, dated 10  October 2024. What can the applicant do to remedy the situation?\",\n",
      "        \"options\": [\n",
      "            \"A. File a notice of appeal against the decision within four months of notification of the decision\",\n",
      "            \"B. File a request for further processing within two months of notification of the decision\",\n",
      "            \"C. File, within two months of notification of the decision, a request for re-establishment of rights in respect of the time limit for filing the designation of inventor\",\n",
      "            \"D. A, B and C are correct\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 36: {'question': 'A company with its principal place of business in Spain, which has Spanish as an official language, wishes to file a European patent application. Under which circumstances can they submit the application in Spanish and still comply with Article 14 EPC?', 'options': ['A. The company files the application in Spanish and also provides a translation into one of the official languages of the EPO.', 'B. The company files the application in Spanish but does not provide any translation as Spanish is an admissible non-EPO language.', 'C. The company files the application in English, which is one of the official languages of the EPO, and provides a Spanish version for the description only.', 'D. The company files the application in French, another official language of the EPO, without any additional translations.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The opposition division revoked European patent EP -B1. The patent proprietor filed an appeal  in time . The b oard of appeal forwarded a copy of the appeal to the o pponent/ respondent with a communication dated 1 June 2023 giving it an opportunity to file comments within a period of four  months.  The opponent/respondent files comments today, 12 October 2023. What further action has to be taken ?\",\n",
      "        \"options\": [\n",
      "            \"A. The opponent/ respondent needs  to request an extension of the period for comment.\",\n",
      "            \"B. The opponent/respondent needs to pay a fee for further processing.\",\n",
      "            \"C. The opponent/respondent needs to file a substantiated request for reestablishment of rights and pay the associated fee.\",\n",
      "            \"D. None of the above.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"EP-1 is a regular European patent application (Euro -direct application) .  Which one of the following missed time limits can be remedied for EP -1 before the EPO by requesting re- establishment of rights ?\",\n",
      "        \"options\": [\n",
      "            \"A. T ime limit for pay ing the designation fee\",\n",
      "            \"B. T ime limit for requesting examination\",\n",
      "            \"C. T ime limit for filing the application within the priority period\",\n",
      "            \"D. T ime limit for paying the fee for re- establishment of rights\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 37: {'question': 'If an applicant fails to reply within the time limit for requesting further processing of a European patent application, what action must be taken to ensure the request is valid?', 'options': ['A. The applicant should wait for two months before taking any action.', 'B. The applicant needs to file a substantiated request for reestablishment of rights and pay the associated fee.', 'C. The applicant must pay the prescribed fee for further processing within two months and complete the omitted act within that period.', 'D. The application will automatically proceed without any further action.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 10 October 2024, an applicant files a request for entry into the European phase, together with a debit order, according to which the filing fee, the designation fee, the examination fee and the renewal fee for the third year are to be debited from the applicant's deposit account. It is specified that the debit order is to be executed on 18 October 2024. On the evening of 10 October 2024, the applicant notices that the renewal fee is not yet due and should not be debited from the deposit account. What is the latest point in time for revoking the order to debit the renewal fee in Central Fee Payment (CFP)?\",\n",
      "        \"options\": [\n",
      "            \"A. 10 October 2024\",\n",
      "            \"B. 17 October 2024\",\n",
      "            \"C. 18 October 2024\",\n",
      "            \"D. A debit order cannot be revoked in part\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicant Korhonen is a Finnish national resident in Finland. He filed a European patent application in Finnish and provided an English translation in time. In response to the extended European search report (EESR), Korhonen wishes to file amended claims t ogether with a request for examination. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Korhonen must file the amended claims in Finnish and must then  provide a translation into English, in time\",\n",
      "            \"B. Korhonen is allowed to file the amended claims in Finnish if he then provides a\",\n",
      "            \"translation into any official language of the EPO, in time C. Korhonen is allowed to file the amended claims in Finnish if he then provides a translation into English, in time\",\n",
      "            \"D. Korhonen is not allowed to file the amended claims in Finnish\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 38: {'question': 'If, three months after the beginning of an interruption of proceedings, the European Patent Office has not been informed of the renewal fee for the third year, what is the consequence according to the guidelines provided?', 'options': ['A. The application will be automatically withdrawn', 'B. The applicant can still pay the renewal fee within six months from the end of the grace period without additional fees', 'C. The applicant has no further opportunity to pay the renewal fee and the application will lapse', 'D. The application is placed on hold until the fee is paid']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"European patent application EP -X was filed on 1  October 2020, claiming the priority of a Belgian application filed on 16 October 2019. The mention of the grant of European patent EP -X was published on 2  October 2024. The proprietor filed a request for unitary effect and was informed by communication dated 10  October 2024, that unitary effect had been registered for EP -X-C0 on the same date. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. A renewal fee still has to be paid by 31 October 2024 in respect of the 5th year for EP -X\",\n",
      "            \"B. A renewal fee is due on 31 October 2024 in respect of the 5th year for EP -X-C0\",\n",
      "            \"C. A renewal fee is due on 31 October 2024 in respect of the 6th year for EP -X-C0\",\n",
      "            \"D. No renewal fee has to be paid on 31 October 2024\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A communication under Article 94(3) EPC, setting a four -month time limit for reply is dated 12 September 2024. The applicant receives the letter on 21 September 2024, as evidenced by the postal receipt signed by him.  What is the last day for replying to the communication?\",\n",
      "        \"options\": [\n",
      "            \"A. 13 January 2025\",\n",
      "            \"B. 12 January 2025\",\n",
      "            \"C. 22 January 2025\",\n",
      "            \"D. 14 January 2025\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 39: {'question': 'On 24 May 2022, you filed a European patent application EP -B, which claimed priority from a French application filed on 30 May 2021. The examination of the application was completed on 24 March 2025, and the decision to grant the patent was published on 1 April 2025. If you wish to obtain unitary effect for this European patent, when should you file your request?', 'options': ['A. By 30 September 2025', 'B. Before 31 May 2026', 'C. Within three months from the date of publication of the grant decision on 1 April 2025', 'D. Within six months from the date of completion of examination on 24 March 2025']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. As no renewal fees have been paid, the application is deemed to be withdrawn .\",\n",
      "            \"B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .\",\n",
      "            \"C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .\",\n",
      "            \"D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Company M, which has  its principal place of business in Tijuana, Mexico, validly filed an international patent application PCT -M with the Mexican Institute of Industrial Property. The application was filed in Spanish. A few days later, the applicant files an English translati on of the application.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant can choose the EPO as ISA and the USPTO as IPEA.\",\n",
      "            \"B. The applicant can choose the USPTO as ISA and the EPO as IPEA.\",\n",
      "            \"C. The applicant can choose the Austrian Patent Offic e as ISA and the\",\n",
      "            \"EPO as IPEA.\",\n",
      "            \"D. The applicant can choose the EPO as ISA and the Intellectual Property\",\n",
      "            \"Office of Singapore as IPEA.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 40: {'question': 'Patent holder Firm X owns a European patent EP123456789. Opponent Y filed an opposition against this patent, arguing that claims 1 and 2 were obvious over document D1. During the opposition proceedings, opponent Z submitted additional prior art documents in support of the opposition. At the end of the opposition proceedings, the opposition division decided to revoke the patent on the basis of document D1. Which of the following statements is correct?', 'options': [\"A. Firm X can request revocation of the opposition division's decision and appeal to the EPO boards of appeal.\", \"B. Opponent Y cannot appeal the opposition division's decision as it was not a party to the appeal proceedings.\", \"C. Opponent Z, who submitted additional prior art documents, can appeal the opposition division's decision as a third party.\", 'D. Firm X can only seek redress through the national patent offices of the contracting states.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. As no renewal fees have been paid, the application is deemed to be withdrawn .\",\n",
      "            \"B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .\",\n",
      "            \"C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .\",\n",
      "            \"D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A communication under Article 94(3) EPC, setting a four -month time limit for reply is dated 12 September 2024. The applicant receives the letter on 21 September 2024, as evidenced by the postal receipt signed by him.  What is the last day for replying to the communication?\",\n",
      "        \"options\": [\n",
      "            \"A. 13 January 2025\",\n",
      "            \"B. 12 January 2025\",\n",
      "            \"C. 22 January 2025\",\n",
      "            \"D. 14 January 2025\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"EP-1 is a regular European patent application (Euro -direct application) .  Which one of the following missed time limits can be remedied for EP -1 before the EPO by requesting re- establishment of rights ?\",\n",
      "        \"options\": [\n",
      "            \"A. T ime limit for pay ing the designation fee\",\n",
      "            \"B. T ime limit for requesting examination\",\n",
      "            \"C. T ime limit for filing the application within the priority period\",\n",
      "            \"D. T ime limit for paying the fee for re- establishment of rights\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 41: {'question': 'A European patent application has a priority date of 15 March 2020 and a filing date of 31 May 2020. The third renewal fee was due on 31 May 2023, considering the priority date. According to Rule 51(1), which of the following dates is the latest by which this third-year renewal fee can be validly paid without an additional fee?', 'options': ['A. 1 January 2023', 'B. 31 May 2023', 'C. 31 December 2022', 'D. 30 November 2022']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"European patent application EP -X was filed on 1  October 2020, claiming the priority of a Belgian application filed on 16 October 2019. The mention of the grant of European patent EP -X was published on 2  October 2024. The proprietor filed a request for unitary effect and was informed by communication dated 10  October 2024, that unitary effect had been registered for EP -X-C0 on the same date. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. A renewal fee still has to be paid by 31 October 2024 in respect of the 5th year for EP -X\",\n",
      "            \"B. A renewal fee is due on 31 October 2024 in respect of the 5th year for EP -X-C0\",\n",
      "            \"C. A renewal fee is due on 31 October 2024 in respect of the 6th year for EP -X-C0\",\n",
      "            \"D. No renewal fee has to be paid on 31 October 2024\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicants may request processing of their international application under PCT Direct by filing a letter (\\\"PCT Direct letter\\\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing\",\n",
      "            \"B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0\",\n",
      "            \"C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0\",\n",
      "            \"D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Which of the following statements about filing third- party observations is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The person that filed third- party observations will be a party to the proceedings before the EPO, and the applicant is obliged to respond to third- party observations\",\n",
      "            \"B. Third -party observations must be filed in writing and may not be filed anonymously\",\n",
      "            \"C. Third -party observations are considered by the examining division only if they include a statement of the grounds on which they are based, and an official fee is paid\",\n",
      "            \"D. Third -party observations can be filed after the publication of a European patent application and must be filed in an official language of the EPO\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 42: {'question': 'If an applicant files an international application under PCT and later discovers that some pages were incorrectly filed but are allowed to be corrected by Rule 20.6 PCT, which of the following statements is correct regarding the additional fee for entering the European phase?', 'options': ['A. The additional fee calculation includes all pages, including those corrected under Rule 20.6 PCT.', 'B. The additional fee calculation does not include pages that are corrected under Rule 20.6 PCT but allows corrections within the 31-month period for entering the European phase.', 'C. The additional fee is waived if the correction of incorrectly filed pages is made before paying the additional fee, regardless of when the correction is made.', 'D. The additional fee calculation only considers pages that were initially included in the international application as published.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"EP-1 is a regular European patent application (Euro -direct application) .  Which one of the following missed time limits can be remedied for EP -1 before the EPO by requesting re- establishment of rights ?\",\n",
      "        \"options\": [\n",
      "            \"A. T ime limit for pay ing the designation fee\",\n",
      "            \"B. T ime limit for requesting examination\",\n",
      "            \"C. T ime limit for filing the application within the priority period\",\n",
      "            \"D. T ime limit for paying the fee for re- establishment of rights\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?\",\n",
      "        \"options\": [\n",
      "            \"A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.\",\n",
      "            \"B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.\",\n",
      "            \"C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.\",\n",
      "            \"D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 43: {'question': 'If the patent proprietor fails to comply with the formalities officers request for payment of the fee for publishing, filing translations of amended claims, or providing a formally compliant version of amended text passages within the specified time limit, what action will the EPO take?', 'options': ['A. The European patent will be automatically extended.', 'B. The European patent will be revoked according to Rule 82(3).', 'C. The patent proprietor will receive an additional grace period of six months.', 'D. The European patent will remain unaffected.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?\",\n",
      "        \"options\": [\n",
      "            \"A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.\",\n",
      "            \"B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.\",\n",
      "            \"C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.\",\n",
      "            \"D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicant Korhonen is a Finnish national resident in Finland. He filed a European patent application in Finnish and provided an English translation in time. In response to the extended European search report (EESR), Korhonen wishes to file amended claims t ogether with a request for examination. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Korhonen must file the amended claims in Finnish and must then  provide a translation into English, in time\",\n",
      "            \"B. Korhonen is allowed to file the amended claims in Finnish if he then provides a\",\n",
      "            \"translation into any official language of the EPO, in time C. Korhonen is allowed to file the amended claims in Finnish if he then provides a translation into English, in time\",\n",
      "            \"D. Korhonen is not allowed to file the amended claims in Finnish\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .\",\n",
      "            \"B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .\",\n",
      "            \"C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .\",\n",
      "            \"D. Ms Smith can only be deleted as inventor with her consent .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 44: {'question': 'In opposition proceedings, the opposition division makes an interlocutory decision to maintain the patent with amended claims based on documents not compliant with Rule 51(3). The patent proprietor wishes to adopt this decision and does not file any appeal. Which of the following actions is required according to the guidelines?', 'options': ['A. The patent proprietor must pay the fee for publishing a new specification, file translations of the claims, and submit a formally compliant version of the entire application within three months.', 'B. The patent proprietor will not be invited to take any action as long as no appeal is filed against the interlocutory decision.', 'C. Upon receipt of the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims, and submit a formally compliant version of the entire application within three months.', 'D. The patent proprietor must wait until the appeal procedure concludes before taking any action regarding the fees and documentation.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"In which of the following situations does the EPO recommend using the EPO Contingency Upload Service?\",\n",
      "        \"options\": [\n",
      "            \"A. When you submit documents after business hours\",\n",
      "            \"B. When the EPO filing systems are functioning correctly, but you encounter a technical issue at your end\",\n",
      "            \"C. When there is a system outage at the EPO that prevents document submission via the standard filing systems\",\n",
      "            \"D. When the EPO is closed due to an official holiday\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .\",\n",
      "            \"B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .\",\n",
      "            \"C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .\",\n",
      "            \"D. Ms Smith can only be deleted as inventor with her consent .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Which functionalities or services can be accessed directly from MyEPO Portfolio?\",\n",
      "        \"options\": [\n",
      "            \"A. A shared area with examiners, European Patent Register, filing via the EPO's online filing software eOLF\",\n",
      "            \"B. Mailbox, a shared area with examiners, replying to a communication under Article  94(3) EPC\",\n",
      "            \"C. Mailbox, patent search via publication server, a shared area with examiners\",\n",
      "            \"D. Filing via the EPO's Online Filing 2.0, patent search via publication server, Mailbox\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 45: {'question': 'If no notice of opposition is recorded within nine months from the publication of the grant mention, what action is taken according to the Guidelines for Examination in the EPO?', 'options': ['A. The European Patent Bulletin remains unchanged.', 'B. An appropriate entry is published in the European Patent Bulletin informing the patent proprietor.', 'C. The European patent is automatically revoked.', 'D. The opposition period is extended by nine months.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The opposition division revoked European patent EP -B1. The patent proprietor filed an appeal  in time . The b oard of appeal forwarded a copy of the appeal to the o pponent/ respondent with a communication dated 1 June 2023 giving it an opportunity to file comments within a period of four  months.  The opponent/respondent files comments today, 12 October 2023. What further action has to be taken ?\",\n",
      "        \"options\": [\n",
      "            \"A. The opponent/ respondent needs  to request an extension of the period for comment.\",\n",
      "            \"B. The opponent/respondent needs to pay a fee for further processing.\",\n",
      "            \"C. The opponent/respondent needs to file a substantiated request for reestablishment of rights and pay the associated fee.\",\n",
      "            \"D. None of the above.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?\",\n",
      "        \"options\": [\n",
      "            \"A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO\",\n",
      "            \"B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application\",\n",
      "            \"C. File an electronic certified copy of the Luxembourg patent application with the EPO\",\n",
      "            \"D. File a certified copy of the Luxembourg patent application with the International Bureau\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 46: {'question': \"In which language must the notice of appeal be filed if an opponent represented by a Dutch patent attorney files an opposition in Germany, even though the company's principal place of business is in the US?\", 'options': ['A. German', 'B. English', 'C. French', 'D. Dutch']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"European patent application EP -X was filed on 1  October 2020, claiming the priority of a Belgian application filed on 16 October 2019. The mention of the grant of European patent EP -X was published on 2  October 2024. The proprietor filed a request for unitary effect and was informed by communication dated 10  October 2024, that unitary effect had been registered for EP -X-C0 on the same date. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. A renewal fee still has to be paid by 31 October 2024 in respect of the 5th year for EP -X\",\n",
      "            \"B. A renewal fee is due on 31 October 2024 in respect of the 5th year for EP -X-C0\",\n",
      "            \"C. A renewal fee is due on 31 October 2024 in respect of the 6th year for EP -X-C0\",\n",
      "            \"D. No renewal fee has to be paid on 31 October 2024\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Which functionalities or services can be accessed directly from MyEPO Portfolio?\",\n",
      "        \"options\": [\n",
      "            \"A. A shared area with examiners, European Patent Register, filing via the EPO's online filing software eOLF\",\n",
      "            \"B. Mailbox, a shared area with examiners, replying to a communication under Article  94(3) EPC\",\n",
      "            \"C. Mailbox, patent search via publication server, a shared area with examiners\",\n",
      "            \"D. Filing via the EPO's Online Filing 2.0, patent search via publication server, Mailbox\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 10 October 2021, European patent attorney X filed European patent application EP -A with the EPO on the applicant's behalf. Application EP -A was published on 12 April 2023, together  with the extended European search report. On 6  October 2023, the applicant contacts a new European patent attorney  Y to replace X as representative and issues Y with its instructions to reply to the extended European search report. The applicant did not inform X that he would be replaced.  What are the steps necessary to validly appoint representative Y and to avoid any loss of rights for European patent application EP -A?\",\n",
      "        \"options\": [\n",
      "            \"A. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 12 October 2023 at the latest and files in good time an authorisation signed by the applicant .\",\n",
      "            \"B. New representative Y requests a change of representative and files a response to the extended European search report with  the EPO by 12 October 2023 at the latest .\",\n",
      "            \"C. New representative Y requests a change of representative and files a response to the extended European search report with the EPO by 23 October 2023 at the latest.\",\n",
      "            \"D. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 23 October 2023 at the latest and files in good time an authorisation signed by the applicant .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 47: {'question': 'European patent application EP -Y was filed on 15 June 2023, claiming the priority of a Belgian application filed on 14 July 2022. The mention of the grant of European patent EP -Y was published on 20 December 2026. The proprietor needs to pay the renewal fee for which year by 31 March 2027 if no request for unitary effect is filed?', 'options': ['A. Renewal fee for the 5th year of EP -Y', 'B. Renewal fee for the 6th year of EP -Y-C0', 'C. No renewal fee as unitary effect has been granted', 'D. Renewal fee for the 7th year of EP -Y']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"EP-1 is a regular European patent application (Euro -direct application) .  Which one of the following missed time limits can be remedied for EP -1 before the EPO by requesting re- establishment of rights ?\",\n",
      "        \"options\": [\n",
      "            \"A. T ime limit for pay ing the designation fee\",\n",
      "            \"B. T ime limit for requesting examination\",\n",
      "            \"C. T ime limit for filing the application within the priority period\",\n",
      "            \"D. T ime limit for paying the fee for re- establishment of rights\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In which of the following situations does the EPO recommend using the EPO Contingency Upload Service?\",\n",
      "        \"options\": [\n",
      "            \"A. When you submit documents after business hours\",\n",
      "            \"B. When the EPO filing systems are functioning correctly, but you encounter a technical issue at your end\",\n",
      "            \"C. When there is a system outage at the EPO that prevents document submission via the standard filing systems\",\n",
      "            \"D. When the EPO is closed due to an official holiday\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicant Korhonen is a Finnish national resident in Finland. He filed a European patent application in Finnish and provided an English translation in time. In response to the extended European search report (EESR), Korhonen wishes to file amended claims t ogether with a request for examination. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Korhonen must file the amended claims in Finnish and must then  provide a translation into English, in time\",\n",
      "            \"B. Korhonen is allowed to file the amended claims in Finnish if he then provides a\",\n",
      "            \"translation into any official language of the EPO, in time C. Korhonen is allowed to file the amended claims in Finnish if he then provides a translation into English, in time\",\n",
      "            \"D. Korhonen is not allowed to file the amended claims in Finnish\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Attempt 1 failed. Retrying...\n",
      "Question 48: {'question': 'What does the EPO do regarding an international application that enters the European phase before the 31-month time limit for purely administrative tasks?', 'options': ['A. Requests payment of additional fees', 'B. Registers and files necessary documents', 'C. Sends a communication requiring response to deficiencies', 'D. Schedules oral proceedings']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"After receipt of a negative written opinion issued by the EPO acting as ISA, amendments under Art icle 19 PCT were filed during the international phase. No request for international preliminary examination was filed. Form  1200 was used,  and no further amendments were filed with the EPO upon entry into the regional phase.   What communication under Rules  161/162 EPC will be received in the regional phase?\",\n",
      "        \"options\": [\n",
      "            \"A. Form 1226AA ;  if you do not reply to it in time, the application will be deemed to be withdrawn\",\n",
      "            \"B. Form 1226BB offering the opportunity to comment and file amendments\",\n",
      "            \"C. Form 1226CC offering the opportunity to file amendments before the supplementary European search report is drawn up\",\n",
      "            \"D. Form 1226AC stating that the examination has started\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 49: {'question': 'For Euro-PCT applications where the EPO acted as ISA or SISA, what should be considered to avoid delays when filing amendments in response to the communication under Rule 161(1)?', 'options': ['A. Ensure that all claims are revised for clarity and consistency', 'B. File observations alongside any amendments if necessary', 'C. Adhere to the specified time limit for filing amendments', 'D. Submit a detailed explanation of the technical aspects of each amendment']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Applicants may request processing of their international application under PCT Direct by filing a letter (\\\"PCT Direct letter\\\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing\",\n",
      "            \"B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0\",\n",
      "            \"C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0\",\n",
      "            \"D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Linguist filed a European patent application in Dutch and used English as language of the proceedings. When requesting unitary effect on 10 October 2024, Mr Linguist must provide a translation of the specification. Mr Linguist would like to obtain immediate registration of the unitary effect. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Mr Linguist must provide a translation of the specification into Dutch\",\n",
      "            \"B. Mr Linguist must provide a translation of the specification into an official language of any of the 18 states to which the unitary effect extends\",\n",
      "            \"C. Mr Linguist must provide a translation of the specification into an official language of any of the 24 states that have signed the UPCA\",\n",
      "            \"D. Mr Linguist may provide a translation of the specification into Spanish\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .\",\n",
      "            \"B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .\",\n",
      "            \"C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .\",\n",
      "            \"D. Ms Smith can only be deleted as inventor with her consent .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 50: {'question': 'An applicant filed an international application for a PCT patent under Rule 12 with the International Bureau, using Chinese as the language of filing. Which of the following statements is NOT correct?', 'options': ['A. The applicant must provide a translation of the international application into English or French if the designated Office(s) do not accept Chinese.', 'B. Any element referred to in Article 11(1)(iii)(d) or (e) provided by the applicant under Rule 20.3(b), 20.5bis(b), 20.5bis(c) or 20.6(a) must be translated into a language accepted by the designated Office(s).', 'C. If no translation is required, the applicant can proceed without any additional translations since Chinese is accepted by all designated Offices.', 'D. The International Preliminary Examining Authority will check the physical requirements of the translation if it is necessary for the international preliminary examination.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A communication under Article 94(3) EPC, setting a four -month time limit for reply is dated 12 September 2024. The applicant receives the letter on 21 September 2024, as evidenced by the postal receipt signed by him.  What is the last day for replying to the communication?\",\n",
      "        \"options\": [\n",
      "            \"A. 13 January 2025\",\n",
      "            \"B. 12 January 2025\",\n",
      "            \"C. 22 January 2025\",\n",
      "            \"D. 14 January 2025\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 10 October 2024, an applicant files a request for entry into the European phase, together with a debit order, according to which the filing fee, the designation fee, the examination fee and the renewal fee for the third year are to be debited from the applicant's deposit account. It is specified that the debit order is to be executed on 18 October 2024. On the evening of 10 October 2024, the applicant notices that the renewal fee is not yet due and should not be debited from the deposit account. What is the latest point in time for revoking the order to debit the renewal fee in Central Fee Payment (CFP)?\",\n",
      "        \"options\": [\n",
      "            \"A. 10 October 2024\",\n",
      "            \"B. 17 October 2024\",\n",
      "            \"C. 18 October 2024\",\n",
      "            \"D. A debit order cannot be revoked in part\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You filed an international patent application on 6 June 2024, claiming the priority of a European patent application filed on 7  July 2023. You received a communication dated 25 September 2024 from the EPO acting as International Searching Authority (ISA), stating that the requirement of unity of invention has not been complied with. The ISA identifies three inventions. You are invited to pay two additional search fees. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. You must pay two additional search fees by 25 October 2024\",\n",
      "            \"B. You do not need to file a response to the provisional opinion accompanying the partial search results\",\n",
      "            \"C. If you pay two additional search fees under protest, you must pay two protest fees within the time limit\",\n",
      "            \"D. If you do not pay any additional search fees within the time limit, the international patent application will be deemed to be withdrawn\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 51: {'question': 'According to Case Law III, U2749, if an applicant has filed a request for registration of a transfer under Rule 22 on 15 June 2024 and the corresponding administrative fee is paid on 20 July 2024, when would the request be deemed to have been filed?', 'options': ['A. 15 June 2024', 'B. 20 July 2024', 'C. 30 June 2024', 'D. 15 July 2024']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A communication under Article 94(3) EPC, setting a four -month time limit for reply is dated 12 September 2024. The applicant receives the letter on 21 September 2024, as evidenced by the postal receipt signed by him.  What is the last day for replying to the communication?\",\n",
      "        \"options\": [\n",
      "            \"A. 13 January 2025\",\n",
      "            \"B. 12 January 2025\",\n",
      "            \"C. 22 January 2025\",\n",
      "            \"D. 14 January 2025\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The applicant received a communication pursuant to Article 90(3) EPC and Rule  60 EPC, requesting them to file a designation of inventor but missed the time limit for filing a response. After expiry of the time limit, the Receiving Section issued a decision to refuse the European patent application, dated 10  October 2024. What can the applicant do to remedy the situation?\",\n",
      "        \"options\": [\n",
      "            \"A. File a notice of appeal against the decision within four months of notification of the decision\",\n",
      "            \"B. File a request for further processing within two months of notification of the decision\",\n",
      "            \"C. File, within two months of notification of the decision, a request for re-establishment of rights in respect of the time limit for filing the designation of inventor\",\n",
      "            \"D. A, B and C are correct\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Last week Greta validly filed the international patent application PCT -G with the German Patent and Trade mark Office ( DPMA ) and appointed Hassan to represent her. Hassan is entitled to act before the DPMA  but he is not a European patent attorney. Greta and Hassan are resident in Germany.  Which of the following statements is not correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Hassan can represent Greta before the EPO acting as the International Searching Authority for PCT -G.\",\n",
      "            \"B. In order for Hassan to be able to act before the EPO acting as the International Searching Authority , he needs to submit a power of attorney signed by Greta.\",\n",
      "            \"C. According to the provisions of the PCT, it is mandatory that the d emand for international preliminary examination is signed by Greta or Hassan.\",\n",
      "            \"D. According to the provisions of the PCT, an international application can only be withdrawn by the applicant or an agent appointed by a power of attorney.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 52: {'question': 'If an applicant fails to reply within the time limit set under Rule 100(2) EPC, resulting in their European patent application being deemed withdrawn under Rule 100(3) EPC, what can they do if they wish to re-file the application?', 'options': ['A. They cannot re-file as the application is considered withdrawn.', 'B. They must file a new application with all necessary documentation and fees.', 'C. They can simply resubmit their previous application within 12 months of deemed withdrawal.', 'D. They should appeal the decision to the Legal Board.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"EP-1 is a regular European patent application (Euro -direct application) .  Which one of the following missed time limits can be remedied for EP -1 before the EPO by requesting re- establishment of rights ?\",\n",
      "        \"options\": [\n",
      "            \"A. T ime limit for pay ing the designation fee\",\n",
      "            \"B. T ime limit for requesting examination\",\n",
      "            \"C. T ime limit for filing the application within the priority period\",\n",
      "            \"D. T ime limit for paying the fee for re- establishment of rights\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 10 October 2024, an applicant files a request for entry into the European phase, together with a debit order, according to which the filing fee, the designation fee, the examination fee and the renewal fee for the third year are to be debited from the applicant's deposit account. It is specified that the debit order is to be executed on 18 October 2024. On the evening of 10 October 2024, the applicant notices that the renewal fee is not yet due and should not be debited from the deposit account. What is the latest point in time for revoking the order to debit the renewal fee in Central Fee Payment (CFP)?\",\n",
      "        \"options\": [\n",
      "            \"A. 10 October 2024\",\n",
      "            \"B. 17 October 2024\",\n",
      "            \"C. 18 October 2024\",\n",
      "            \"D. A debit order cannot be revoked in part\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 53: {'question': 'EP-A1 was filed on March 1, 2023. The applicant failed to appoint a representative within the three-month period after the beginning of the proceedings, leading to an interruption. If no new representative is appointed and communicated by the European Patent Office within two months from the communication, what will happen to EP-A1?', 'options': ['A. The application will be withdrawn.', 'B. The application will automatically proceed without a representative.', 'C. The applicant will have the option to request re-establishment of rights for appointing a representative.', 'D. The European Patent Office will extend the period for appointing a representative.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Applicants may request processing of their international application under PCT Direct by filing a letter (\\\"PCT Direct letter\\\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing\",\n",
      "            \"B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0\",\n",
      "            \"C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0\",\n",
      "            \"D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"EP-1 is a regular European patent application (Euro -direct application) .  Which one of the following missed time limits can be remedied for EP -1 before the EPO by requesting re- establishment of rights ?\",\n",
      "        \"options\": [\n",
      "            \"A. T ime limit for pay ing the designation fee\",\n",
      "            \"B. T ime limit for requesting examination\",\n",
      "            \"C. T ime limit for filing the application within the priority period\",\n",
      "            \"D. T ime limit for paying the fee for re- establishment of rights\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 54: {'question': 'An applicant is filing an international application under PCT, with the priority document filed in Japanese and requested to be searched in Japanese. The International Searching Authority (ISA) cannot conduct a search in Japanese but can handle documents in Chinese. Which of the following statements is correct?', 'options': ['A. The applicant does not need to provide any additional translation as Japanese is accepted by the ISA.', 'B. The applicant must file a Chinese translation of the priority document with the International Bureau (IB) for processing.', 'C. The applicant can request PCT Direct, and if approved, the application will proceed without a translation.', 'D. The applicant should file an English translation as it is widely accepted by patent offices.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 20  June 2023, applicant P validly filed an international patent application PCT-P, claiming priority from European patent application EP -I filed on 7 July 2022. Today, 12 October 2023, he discovers that he should also have claimed priority from EP -II filed on 3 July 2022. Can the missing priority claim still be validly added?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, the time  limit for adding the priority claim expires on 3  November 2023.\",\n",
      "            \"B. Yes, the time limit for adding the priority claim expires on 7  November 2023.\",\n",
      "            \"C. Yes, the time  limit for adding the priority claim expires on 20 October 2023.\",\n",
      "            \"D. No, the time  limit for adding the priority claim expired on 3 July 2023.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"After receipt of a negative written opinion issued by the EPO acting as ISA, amendments under Art icle 19 PCT were filed during the international phase. No request for international preliminary examination was filed. Form  1200 was used,  and no further amendments were filed with the EPO upon entry into the regional phase.   What communication under Rules  161/162 EPC will be received in the regional phase?\",\n",
      "        \"options\": [\n",
      "            \"A. Form 1226AA ;  if you do not reply to it in time, the application will be deemed to be withdrawn\",\n",
      "            \"B. Form 1226BB offering the opportunity to comment and file amendments\",\n",
      "            \"C. Form 1226CC offering the opportunity to file amendments before the supplementary European search report is drawn up\",\n",
      "            \"D. Form 1226AC stating that the examination has started\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 55: {'question': 'On 15 March 2023, applicant Q validly filed an international patent application PCT-Q with a priority claim from European patent application EP-I filed on 1 April 2022. Today, 15 October 2023, the Receiving Section informs that due to administrative issues, the priority date should be corrected to 5 April 2022. Can this correction still be made?', 'options': ['A. Yes, the time limit for correcting the earliest priority date expires on 4 November 2023.', 'B. Yes, the time limit for correcting the earliest priority date expires on 8 November 2023.', 'C. Yes, the time limit for correcting the earliest priority date expires on 15 October 2023.', 'D. No, the time limit for correcting the earliest priority date expired on 1 April 2023.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Company M, which has  its principal place of business in Tijuana, Mexico, validly filed an international patent application PCT -M with the Mexican Institute of Industrial Property. The application was filed in Spanish. A few days later, the applicant files an English translati on of the application.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant can choose the EPO as ISA and the USPTO as IPEA.\",\n",
      "            \"B. The applicant can choose the USPTO as ISA and the EPO as IPEA.\",\n",
      "            \"C. The applicant can choose the Austrian Patent Offic e as ISA and the\",\n",
      "            \"EPO as IPEA.\",\n",
      "            \"D. The applicant can choose the EPO as ISA and the Intellectual Property\",\n",
      "            \"Office of Singapore as IPEA.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You filed an international patent application on 6 June 2024, claiming the priority of a European patent application filed on 7  July 2023. You received a communication dated 25 September 2024 from the EPO acting as International Searching Authority (ISA), stating that the requirement of unity of invention has not been complied with. The ISA identifies three inventions. You are invited to pay two additional search fees. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. You must pay two additional search fees by 25 October 2024\",\n",
      "            \"B. You do not need to file a response to the provisional opinion accompanying the partial search results\",\n",
      "            \"C. If you pay two additional search fees under protest, you must pay two protest fees within the time limit\",\n",
      "            \"D. If you do not pay any additional search fees within the time limit, the international patent application will be deemed to be withdrawn\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 56: {'question': 'You filed a European patent application on 10 March 2023, claiming priority from an earlier French application with a filing date of 9 February 2022. The application entered the national phase in France on 5 September 2023. Which of the following statements is correct?', 'options': ['A. The third-year renewal fee can be validly paid without any additional fee until 10 March 2024, and the fourth-year renewal fee must be paid centrally to the EPO by 31 August 2024.', 'B. The third-year renewal fee can be validly paid without any additional fee until 5 September 2024, and the fourth-year renewal fee must be paid centrally to the EPO by 31 August 2025.', 'C. The third-year renewal fee can be validly paid without any additional fee until 9 February 2026, and the fourth-year renewal fee must be paid separately in France by 31 July 2026.', 'D. The third-year renewal fee can be validly paid without any additional fee until 10 March 2025, and the fourth-year renewal fee must be paid centrally to the EPO by 31 August 2025.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .\",\n",
      "            \"B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .\",\n",
      "            \"C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .\",\n",
      "            \"D. Ms Smith can only be deleted as inventor with her consent .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 57: {'question': 'A European patent was granted to Firm X. After the grant, Firm Y filed an opposition against the patent claiming lack of inventive step over document D1. During the opposition proceedings, Firm Z joined as third party and filed observations under Art. 115 EPC, arguing that the claims lacked sufficiency of disclosure in view of document D2. Following a thorough examination, the opposition division decided to maintain the patent as granted without considering any amendments. Firm Y then withdrew its opposition before the appeal proceedings. Which of the following statements is correct?', 'options': ['A. The patent proprietor (Firm X) can file an appeal against the decision to maintain the patent.', 'B. Since Firm Y has withdrawn its opposition, no further action can be taken and the decision stands.', 'C. A third party with observations (Firm Z) cannot file an appeal as it did not participate in the opposition proceedings.', 'D. The opponents withdrawal of opposition is a procedural issue and does not affect the substantive decisions made by the opposition division.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"In which of the following cases is the applicant entitled to a reduction of the filing fee  under Rule  6 EPC ? A declaration of such entitlement has  been made by crossing the relevant box on Form  1001.\",\n",
      "        \"options\": [\n",
      "            \"A. A Spanish European patent attorney files a European patent application in Spanish for a natural person who is resident in Andorra and of Andorra n nationality .\",\n",
      "            \"B. A firm whose principal place of business is in Germany and a natural person who is resident in Germany  and of Dutch nationality  jointly file a European patent application in Dutch. The German firm employs 200 people with an annual turnover of EUR 60 million.\",\n",
      "            \"C. A natural person resident in the USA and of Belgian nationality files a European patent application in French.\",\n",
      "            \"D. A natural person resident in the USA and of Swiss nationality files a European patent application in Italian.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Which of the following statements about filing third- party observations is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The person that filed third- party observations will be a party to the proceedings before the EPO, and the applicant is obliged to respond to third- party observations\",\n",
      "            \"B. Third -party observations must be filed in writing and may not be filed anonymously\",\n",
      "            \"C. Third -party observations are considered by the examining division only if they include a statement of the grounds on which they are based, and an official fee is paid\",\n",
      "            \"D. Third -party observations can be filed after the publication of a European patent application and must be filed in an official language of the EPO\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?\",\n",
      "        \"options\": [\n",
      "            \"A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.\",\n",
      "            \"B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.\",\n",
      "            \"C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.\",\n",
      "            \"D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 58: {'question': 'Under which circumstance may a third party other than the applicant prosecute an application for a patent?', 'options': ['A. If a national court decides that the third party, rather than the applicant, is entitled to the grant of the patent before it is granted.', 'B. If a national court rules that the third party has a legitimate interest in prosecuting the application after the patent has been granted.', 'C. If the third party files an appeal against the decision to refuse the patent application.', 'D. If the original applicant decides to abandon the application without any legal proceedings.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Which functionalities or services can be accessed directly from MyEPO Portfolio?\",\n",
      "        \"options\": [\n",
      "            \"A. A shared area with examiners, European Patent Register, filing via the EPO's online filing software eOLF\",\n",
      "            \"B. Mailbox, a shared area with examiners, replying to a communication under Article  94(3) EPC\",\n",
      "            \"C. Mailbox, patent search via publication server, a shared area with examiners\",\n",
      "            \"D. Filing via the EPO's Online Filing 2.0, patent search via publication server, Mailbox\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In which of the following cases is the applicant entitled to a reduction of the filing fee  under Rule  6 EPC ? A declaration of such entitlement has  been made by crossing the relevant box on Form  1001.\",\n",
      "        \"options\": [\n",
      "            \"A. A Spanish European patent attorney files a European patent application in Spanish for a natural person who is resident in Andorra and of Andorra n nationality .\",\n",
      "            \"B. A firm whose principal place of business is in Germany and a natural person who is resident in Germany  and of Dutch nationality  jointly file a European patent application in Dutch. The German firm employs 200 people with an annual turnover of EUR 60 million.\",\n",
      "            \"C. A natural person resident in the USA and of Belgian nationality files a European patent application in French.\",\n",
      "            \"D. A natural person resident in the USA and of Swiss nationality files a European patent application in Italian.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 59: {'question': 'Under Rule 17, within how many months of the date mentioned in the European Patent Bulletin for the publication of the search report must the designation fee be paid?', 'options': ['A. One month', 'B. Six months', 'C. Twelve months', 'D. There is no time limit specified']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicant Korhonen is a Finnish national resident in Finland. He filed a European patent application in Finnish and provided an English translation in time. In response to the extended European search report (EESR), Korhonen wishes to file amended claims t ogether with a request for examination. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Korhonen must file the amended claims in Finnish and must then  provide a translation into English, in time\",\n",
      "            \"B. Korhonen is allowed to file the amended claims in Finnish if he then provides a\",\n",
      "            \"translation into any official language of the EPO, in time C. Korhonen is allowed to file the amended claims in Finnish if he then provides a translation into English, in time\",\n",
      "            \"D. Korhonen is not allowed to file the amended claims in Finnish\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?\",\n",
      "        \"options\": [\n",
      "            \"A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.\",\n",
      "            \"B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.\",\n",
      "            \"C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.\",\n",
      "            \"D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 60: {'question': 'If an applicant files corrected application documents under Rule 52, which of the following steps must be taken according to EPC Rule 57?', 'options': ['A. The application must immediately proceed to substantive examination.', 'B. The requirement laid down in Rule 52 concerning the claim to priority has been satisfied and no further action is needed.', 'C. An abstract in accordance with Article 78, paragraph 1(e) must be provided within three months of filing the corrected documents.', 'D. The designation fee needs to be paid again as the document was not initially compliant.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?\",\n",
      "        \"options\": [\n",
      "            \"A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.\",\n",
      "            \"B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.\",\n",
      "            \"C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.\",\n",
      "            \"D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 10 October 2024, an applicant files a request for entry into the European phase, together with a debit order, according to which the filing fee, the designation fee, the examination fee and the renewal fee for the third year are to be debited from the applicant's deposit account. It is specified that the debit order is to be executed on 18 October 2024. On the evening of 10 October 2024, the applicant notices that the renewal fee is not yet due and should not be debited from the deposit account. What is the latest point in time for revoking the order to debit the renewal fee in Central Fee Payment (CFP)?\",\n",
      "        \"options\": [\n",
      "            \"A. 10 October 2024\",\n",
      "            \"B. 17 October 2024\",\n",
      "            \"C. 18 October 2024\",\n",
      "            \"D. A debit order cannot be revoked in part\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 61: {'question': 'In oral opposition proceedings, the interlocutory decision was based on a document that did not comply with Rule 50(1). What actions are required of the patent proprietor?', 'options': ['A. Pay the fee for publishing a new specification and file translations of any amended claims in both official languages.', 'B. File a formally compliant version of the document and pay the fee for publishing a new specification.', 'C. No action is necessary as long as no appeal is filed.', 'D. Only pay the fee for publishing a new specification.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?\",\n",
      "        \"options\": [\n",
      "            \"A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.\",\n",
      "            \"B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.\",\n",
      "            \"C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.\",\n",
      "            \"D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .\",\n",
      "            \"B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .\",\n",
      "            \"C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .\",\n",
      "            \"D. Ms Smith can only be deleted as inventor with her consent .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Linguist filed a European patent application in Dutch and used English as language of the proceedings. When requesting unitary effect on 10 October 2024, Mr Linguist must provide a translation of the specification. Mr Linguist would like to obtain immediate registration of the unitary effect. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Mr Linguist must provide a translation of the specification into Dutch\",\n",
      "            \"B. Mr Linguist must provide a translation of the specification into an official language of any of the 18 states to which the unitary effect extends\",\n",
      "            \"C. Mr Linguist must provide a translation of the specification into an official language of any of the 24 states that have signed the UPCA\",\n",
      "            \"D. Mr Linguist may provide a translation of the specification into Spanish\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 62: {'question': 'During oral proceedings, the opposition division decided to maintain the European patent as amended on the basis of a request containing handwritten amendments to the claims. Which of the following statements is correct?', 'options': ['A. The patent proprietor must file translations of the claims in the official languages of the European Patent Office within three months.', 'B. If no appeal is filed, the patent proprietor will not be invited to provide a formally compliant version of the amended claims while the decision is still pending.', 'C. Together with the interlocutory decision, the patent proprietor will receive an invitation to file translations of the claims and provide a formally compliant version of the amended claims within four months.', 'D. The patent proprietor must file translations of the claims in the official languages of the European Patent Office within two months.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"After receipt of a negative written opinion issued by the EPO acting as ISA, amendments under Art icle 19 PCT were filed during the international phase. No request for international preliminary examination was filed. Form  1200 was used,  and no further amendments were filed with the EPO upon entry into the regional phase.   What communication under Rules  161/162 EPC will be received in the regional phase?\",\n",
      "        \"options\": [\n",
      "            \"A. Form 1226AA ;  if you do not reply to it in time, the application will be deemed to be withdrawn\",\n",
      "            \"B. Form 1226BB offering the opportunity to comment and file amendments\",\n",
      "            \"C. Form 1226CC offering the opportunity to file amendments before the supplementary European search report is drawn up\",\n",
      "            \"D. Form 1226AC stating that the examination has started\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Linguist filed a European patent application in Dutch and used English as language of the proceedings. When requesting unitary effect on 10 October 2024, Mr Linguist must provide a translation of the specification. Mr Linguist would like to obtain immediate registration of the unitary effect. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Mr Linguist must provide a translation of the specification into Dutch\",\n",
      "            \"B. Mr Linguist must provide a translation of the specification into an official language of any of the 18 states to which the unitary effect extends\",\n",
      "            \"C. Mr Linguist must provide a translation of the specification into an official language of any of the 24 states that have signed the UPCA\",\n",
      "            \"D. Mr Linguist may provide a translation of the specification into Spanish\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 63: {'question': 'Firm X owns a European patent, EP 123456789. Firm Y filed an opposition against EP 123456789, requesting its revocation. During the opposition proceedings, Firm Z joined the opposition as a third party and requested that the claims be amended to include additional features from document D3 to overcome the novelty objection raised by Firm Y. At the end of the opposition proceedings, the opposition division decided to maintain the patent in amended form. Which of the following statements is correct?', 'options': [\"A. Firm Z can file an appeal against the opposition division's decision because it requested amendments.\", \"B. Firm Y can file an appeal against the opposition division's decision if it disagrees with the maintenance of the patent in amended form.\", 'C. Firm X cannot file an appeal as it agreed to maintain the patent as granted.', 'D. None of the parties can file an appeal because all requested amendments were accepted by the opposition division.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Last week Greta validly filed the international patent application PCT -G with the German Patent and Trade mark Office ( DPMA ) and appointed Hassan to represent her. Hassan is entitled to act before the DPMA  but he is not a European patent attorney. Greta and Hassan are resident in Germany.  Which of the following statements is not correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Hassan can represent Greta before the EPO acting as the International Searching Authority for PCT -G.\",\n",
      "            \"B. In order for Hassan to be able to act before the EPO acting as the International Searching Authority , he needs to submit a power of attorney signed by Greta.\",\n",
      "            \"C. According to the provisions of the PCT, it is mandatory that the d emand for international preliminary examination is signed by Greta or Hassan.\",\n",
      "            \"D. According to the provisions of the PCT, an international application can only be withdrawn by the applicant or an agent appointed by a power of attorney.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 64: {'question': 'EP-A1XYZ', 'options': ['A. Y', 'B. Z', 'C. X', 'D. YZ']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Last week Greta validly filed the international patent application PCT -G with the German Patent and Trade mark Office ( DPMA ) and appointed Hassan to represent her. Hassan is entitled to act before the DPMA  but he is not a European patent attorney. Greta and Hassan are resident in Germany.  Which of the following statements is not correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Hassan can represent Greta before the EPO acting as the International Searching Authority for PCT -G.\",\n",
      "            \"B. In order for Hassan to be able to act before the EPO acting as the International Searching Authority , he needs to submit a power of attorney signed by Greta.\",\n",
      "            \"C. According to the provisions of the PCT, it is mandatory that the d emand for international preliminary examination is signed by Greta or Hassan.\",\n",
      "            \"D. According to the provisions of the PCT, an international application can only be withdrawn by the applicant or an agent appointed by a power of attorney.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 10 October 2024, an applicant files a request for entry into the European phase, together with a debit order, according to which the filing fee, the designation fee, the examination fee and the renewal fee for the third year are to be debited from the applicant's deposit account. It is specified that the debit order is to be executed on 18 October 2024. On the evening of 10 October 2024, the applicant notices that the renewal fee is not yet due and should not be debited from the deposit account. What is the latest point in time for revoking the order to debit the renewal fee in Central Fee Payment (CFP)?\",\n",
      "        \"options\": [\n",
      "            \"A. 10 October 2024\",\n",
      "            \"B. 17 October 2024\",\n",
      "            \"C. 18 October 2024\",\n",
      "            \"D. A debit order cannot be revoked in part\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 20  June 2023, applicant P validly filed an international patent application PCT-P, claiming priority from European patent application EP -I filed on 7 July 2022. Today, 12 October 2023, he discovers that he should also have claimed priority from EP -II filed on 3 July 2022. Can the missing priority claim still be validly added?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, the time  limit for adding the priority claim expires on 3  November 2023.\",\n",
      "            \"B. Yes, the time limit for adding the priority claim expires on 7  November 2023.\",\n",
      "            \"C. Yes, the time  limit for adding the priority claim expires on 20 October 2023.\",\n",
      "            \"D. No, the time  limit for adding the priority claim expired on 3 July 2023.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 65: {'question': 'On 15 March 2024, an applicant filed a demand for international preliminary examination with the European Patent Office (EPO) as the International Preliminary Examining Authority (IPEA). In the demand, the applicant elected the EPO but did not indicate whether it was for a regional patent or a European patent. Later, during the international phase, the EPO interpreted this demand differently from how the IPEA had done. According to the case law provided, which of the following statements is correct?', 'options': [\"A. The interpretation by the EPO is invalid because it differs from the IPEA's initial interpretation.\", 'B. The validity of the election was determined during the international phase, and the EPOs interpretation takes precedence.', 'C. The applicant must re-elect the EPO for both regional and European patents within 2 months to avoid any ambiguity.', 'D. The IPEAs interpretation is binding, and the EPO should not reinterpret it.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?\",\n",
      "        \"options\": [\n",
      "            \"A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO\",\n",
      "            \"B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application\",\n",
      "            \"C. File an electronic certified copy of the Luxembourg patent application with the EPO\",\n",
      "            \"D. File a certified copy of the Luxembourg patent application with the International Bureau\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 10 October 2024, an applicant files a request for entry into the European phase, together with a debit order, according to which the filing fee, the designation fee, the examination fee and the renewal fee for the third year are to be debited from the applicant's deposit account. It is specified that the debit order is to be executed on 18 October 2024. On the evening of 10 October 2024, the applicant notices that the renewal fee is not yet due and should not be debited from the deposit account. What is the latest point in time for revoking the order to debit the renewal fee in Central Fee Payment (CFP)?\",\n",
      "        \"options\": [\n",
      "            \"A. 10 October 2024\",\n",
      "            \"B. 17 October 2024\",\n",
      "            \"C. 18 October 2024\",\n",
      "            \"D. A debit order cannot be revoked in part\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 66: {'question': 'An inventor filed an application for a European patent with the EPO on 15 June 2023, which claims priority from a French national application filed on 16 July 2022. The French application was not included in the file of the European patent application. By when must the applicant submit a certified copy of the French application to preserve the right of priority under Article 54(3) EPC?', 'options': ['A. Within four months from 15 June 2023', 'B. Within twelve months from 16 July 2022', 'C. Within two months from the date of filing the European patent application, which is 15 June 2023', 'D. No certified copy is required as long as a declaration that the French application is a complete translation of the European application is filed']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. As no renewal fees have been paid, the application is deemed to be withdrawn .\",\n",
      "            \"B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .\",\n",
      "            \"C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .\",\n",
      "            \"D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A communication under Article 94(3) EPC, setting a four -month time limit for reply is dated 12 September 2024. The applicant receives the letter on 21 September 2024, as evidenced by the postal receipt signed by him.  What is the last day for replying to the communication?\",\n",
      "        \"options\": [\n",
      "            \"A. 13 January 2025\",\n",
      "            \"B. 12 January 2025\",\n",
      "            \"C. 22 January 2025\",\n",
      "            \"D. 14 January 2025\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Last week Greta validly filed the international patent application PCT -G with the German Patent and Trade mark Office ( DPMA ) and appointed Hassan to represent her. Hassan is entitled to act before the DPMA  but he is not a European patent attorney. Greta and Hassan are resident in Germany.  Which of the following statements is not correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Hassan can represent Greta before the EPO acting as the International Searching Authority for PCT -G.\",\n",
      "            \"B. In order for Hassan to be able to act before the EPO acting as the International Searching Authority , he needs to submit a power of attorney signed by Greta.\",\n",
      "            \"C. According to the provisions of the PCT, it is mandatory that the d emand for international preliminary examination is signed by Greta or Hassan.\",\n",
      "            \"D. According to the provisions of the PCT, an international application can only be withdrawn by the applicant or an agent appointed by a power of attorney.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 67: {'question': 'An European patent application was filed on 15 May 2017. According to Rule 51, which of the following statements is correct regarding the payment of the third-year renewal fee?', 'options': ['A. The third-year renewal fee can be paid any time before 31 August 2018 without incurring an additional fee.', 'B. The third-year renewal fee must be paid by 30 November 2018 to avoid any additional fees.', 'C. The third-year renewal fee can only be validly paid between 15 May 2018 and 30 August 2018.', 'D. The third-year renewal fee can be validly paid without an additional fee by 31 May 2018.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .\",\n",
      "            \"B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .\",\n",
      "            \"C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .\",\n",
      "            \"D. Ms Smith can only be deleted as inventor with her consent .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Linguist filed a European patent application in Dutch and used English as language of the proceedings. When requesting unitary effect on 10 October 2024, Mr Linguist must provide a translation of the specification. Mr Linguist would like to obtain immediate registration of the unitary effect. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Mr Linguist must provide a translation of the specification into Dutch\",\n",
      "            \"B. Mr Linguist must provide a translation of the specification into an official language of any of the 18 states to which the unitary effect extends\",\n",
      "            \"C. Mr Linguist must provide a translation of the specification into an official language of any of the 24 states that have signed the UPCA\",\n",
      "            \"D. Mr Linguist may provide a translation of the specification into Spanish\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 68: {'question': 'Firm X owns a European patent, EP 1234567. Firm Y filed an opposition against EP 1234567. During the proceedings, Firm Z joined as opponent and argued that the claims were not inventive in view of document D3. The opposition division issued a decision to revoke the patent based on this argument. Firm X is dissatisfied with this decision. Which of the following statements is correct?', 'options': [\"A. Firm X can file an appeal against the opposition division's decision, as it is dissatisfied with the revocation of its patent.\", \"B. Only Firm Y can file an appeal against the opposition division's decision, since it was the original opponent and the grounds for opposition were based on its arguments.\", 'C. Neither Firm X nor Firm Z can file an appeal because the decision has already been made by the opposition division.', 'D. Firm Z cannot file an appeal as it did not originally oppose the patent but joined later with new arguments.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .\",\n",
      "            \"B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .\",\n",
      "            \"C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .\",\n",
      "            \"D. Ms Smith can only be deleted as inventor with her consent .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 69: {'question': 'If the European Patent Office begins technical preparations for publication of an application, but the filing date and content of the application are not finally determined at that time, what action will be initiated?', 'options': ['A. The application will be automatically withdrawn.', 'B. A correction of the publication will be initiated as soon as the filing date and content are finally determined.', 'C. No action will be taken until the application is fully examined.', 'D. The application will be published with tentative information until finalization.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The applicant received a communication pursuant to Article 90(3) EPC and Rule  60 EPC, requesting them to file a designation of inventor but missed the time limit for filing a response. After expiry of the time limit, the Receiving Section issued a decision to refuse the European patent application, dated 10  October 2024. What can the applicant do to remedy the situation?\",\n",
      "        \"options\": [\n",
      "            \"A. File a notice of appeal against the decision within four months of notification of the decision\",\n",
      "            \"B. File a request for further processing within two months of notification of the decision\",\n",
      "            \"C. File, within two months of notification of the decision, a request for re-establishment of rights in respect of the time limit for filing the designation of inventor\",\n",
      "            \"D. A, B and C are correct\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Last week Greta validly filed the international patent application PCT -G with the German Patent and Trade mark Office ( DPMA ) and appointed Hassan to represent her. Hassan is entitled to act before the DPMA  but he is not a European patent attorney. Greta and Hassan are resident in Germany.  Which of the following statements is not correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Hassan can represent Greta before the EPO acting as the International Searching Authority for PCT -G.\",\n",
      "            \"B. In order for Hassan to be able to act before the EPO acting as the International Searching Authority , he needs to submit a power of attorney signed by Greta.\",\n",
      "            \"C. According to the provisions of the PCT, it is mandatory that the d emand for international preliminary examination is signed by Greta or Hassan.\",\n",
      "            \"D. According to the provisions of the PCT, an international application can only be withdrawn by the applicant or an agent appointed by a power of attorney.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 70: {'question': 'On 25 October 2023, you filed a European patent application with the EPO. On 16 November 2024, you receive a communication from the Examining Division stating that your request for amendment under Rule 86(3) EPC 1973 was disregarded as it was submitted after completion of the proceedings up to grant. What can be done to address this situation?', 'options': ['A Submit a new request for amendment under Rule 86(3) EPC 1973, even though it will not be considered as the proceedings have already concluded.', 'B File an appeal against the decision within two months of receiving the communication from the Examining Division.', 'C Request re-establishment of rights in respect of the missed opportunity to amend the application, but this is not possible as the proceedings have concluded.', 'D Contact the EPO and request a review of the decision, as it may be reconsidered due to recent case law changes.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 10 October 2024, an applicant files a request for entry into the European phase, together with a debit order, according to which the filing fee, the designation fee, the examination fee and the renewal fee for the third year are to be debited from the applicant's deposit account. It is specified that the debit order is to be executed on 18 October 2024. On the evening of 10 October 2024, the applicant notices that the renewal fee is not yet due and should not be debited from the deposit account. What is the latest point in time for revoking the order to debit the renewal fee in Central Fee Payment (CFP)?\",\n",
      "        \"options\": [\n",
      "            \"A. 10 October 2024\",\n",
      "            \"B. 17 October 2024\",\n",
      "            \"C. 18 October 2024\",\n",
      "            \"D. A debit order cannot be revoked in part\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 71: {'question': \"On 15 March 2018, you filed a European patent application (EP-A). Today, 31 October 2023, you receive a communication from the EPO entitled 'Decision to grant a European patent pursuant to Article 97(1) EPC'. This communication states that the mention of the grant is valid for all contracting states. What is the latest date by which you must pay the renewal fee for the fourth year without incurring an additional fee?\", 'options': ['A. 30 November 2023', 'B. 31 December 2023', 'C. 31 January 2024', 'D. 31 March 2024']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In which of the following situations does the EPO recommend using the EPO Contingency Upload Service?\",\n",
      "        \"options\": [\n",
      "            \"A. When you submit documents after business hours\",\n",
      "            \"B. When the EPO filing systems are functioning correctly, but you encounter a technical issue at your end\",\n",
      "            \"C. When there is a system outage at the EPO that prevents document submission via the standard filing systems\",\n",
      "            \"D. When the EPO is closed due to an official holiday\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?\",\n",
      "        \"options\": [\n",
      "            \"A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO\",\n",
      "            \"B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application\",\n",
      "            \"C. File an electronic certified copy of the Luxembourg patent application with the EPO\",\n",
      "            \"D. File a certified copy of the Luxembourg patent application with the International Bureau\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 72: {'question': \"On 15 March 2023, you filed a European patent application EP-A, which did not claim priority. Today, 30 November 2024, you receive a communication from the EPO entitled 'Decision to grant a European patent pursuant to Article 97(1) EPC'. This communication states that the mention of the grant is valid for all contracting states. Which of the following statements is correct?\", 'options': ['A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 15 March 2026.', 'B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2026.', 'C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The earliest valid payment can be made on 1 January 2025, and the latest by 30 November 2026.', 'D. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 31 March 2027.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Which functionalities or services can be accessed directly from MyEPO Portfolio?\",\n",
      "        \"options\": [\n",
      "            \"A. A shared area with examiners, European Patent Register, filing via the EPO's online filing software eOLF\",\n",
      "            \"B. Mailbox, a shared area with examiners, replying to a communication under Article  94(3) EPC\",\n",
      "            \"C. Mailbox, patent search via publication server, a shared area with examiners\",\n",
      "            \"D. Filing via the EPO's Online Filing 2.0, patent search via publication server, Mailbox\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 20  June 2023, applicant P validly filed an international patent application PCT-P, claiming priority from European patent application EP -I filed on 7 July 2022. Today, 12 October 2023, he discovers that he should also have claimed priority from EP -II filed on 3 July 2022. Can the missing priority claim still be validly added?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, the time  limit for adding the priority claim expires on 3  November 2023.\",\n",
      "            \"B. Yes, the time limit for adding the priority claim expires on 7  November 2023.\",\n",
      "            \"C. Yes, the time  limit for adding the priority claim expires on 20 October 2023.\",\n",
      "            \"D. No, the time  limit for adding the priority claim expired on 3 July 2023.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"European patent application EP -X was filed on 1  October 2020, claiming the priority of a Belgian application filed on 16 October 2019. The mention of the grant of European patent EP -X was published on 2  October 2024. The proprietor filed a request for unitary effect and was informed by communication dated 10  October 2024, that unitary effect had been registered for EP -X-C0 on the same date. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. A renewal fee still has to be paid by 31 October 2024 in respect of the 5th year for EP -X\",\n",
      "            \"B. A renewal fee is due on 31 October 2024 in respect of the 5th year for EP -X-C0\",\n",
      "            \"C. A renewal fee is due on 31 October 2024 in respect of the 6th year for EP -X-C0\",\n",
      "            \"D. No renewal fee has to be paid on 31 October 2024\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 73: {'question': \"If a priority claim is made for an application that was filed more than twelve months before the European patent application and the date cannot be corrected within the twelve-month period, what must the applicant do to maintain the priority claim's validity?\", 'options': ['A. Request re-establishment of rights in respect of the priority period and file this request within two months of the expiry of the priority period.', 'B. Indicate a corrected date lying within the twelve-month period from the filing of the European patent application.', 'C. File a new application for the same invention without mentioning the previous applications.', 'D. Submit a declaration stating that the priority cannot be maintained.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. As no renewal fees have been paid, the application is deemed to be withdrawn .\",\n",
      "            \"B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .\",\n",
      "            \"C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .\",\n",
      "            \"D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international application is published , together  with the search report drawn up by the CNIPA , 18 m onths + 1 day after the filing date (no priority claimed). The application has no more than 35 pages and 15 claims. Which statement reflects all actions the CN  applicant  needs to take for entry into the EP phase 25 months  after the filing date ? A request for early processing has been filed.\",\n",
      "        \"options\": [\n",
      "            \"A. Complete and file Form 1200 and pay the filing fee and the search fee\",\n",
      "            \"B. Complete and file Form 1200 and pay the filing fee, the search fee and the renewal fee for the third year\",\n",
      "            \"C. Complete and file Form 1200, pay the filing fee and the search fee and appoint a representative\",\n",
      "            \"D. None of the above statements\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 74: {'question': 'A European patent application was filed on 15 June 2020. Proceedings were interrupted under Rule 142 EPC on 15 March 2022 due to the applicants incapacity. The representative appointed by the applicant was unable to act during this period. On 30 November 2023, the proceedings are resumed, and no renewal fees have been paid so far. Which of the following statements is correct?', 'options': ['A. As no renewal fees have been paid, the application is deemed to be withdrawn.', 'B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 30 November 2023 at the latest.', 'C. The renewal fees for the third and fourth years can be validly paid with an additional fee by 31 May 2024 at the latest.', 'D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 30 November 2023 at the latest.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"EP-1 is a regular European patent application (Euro -direct application) .  Which one of the following missed time limits can be remedied for EP -1 before the EPO by requesting re- establishment of rights ?\",\n",
      "        \"options\": [\n",
      "            \"A. T ime limit for pay ing the designation fee\",\n",
      "            \"B. T ime limit for requesting examination\",\n",
      "            \"C. T ime limit for filing the application within the priority period\",\n",
      "            \"D. T ime limit for paying the fee for re- establishment of rights\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 10 October 2021, European patent attorney X filed European patent application EP -A with the EPO on the applicant's behalf. Application EP -A was published on 12 April 2023, together  with the extended European search report. On 6  October 2023, the applicant contacts a new European patent attorney  Y to replace X as representative and issues Y with its instructions to reply to the extended European search report. The applicant did not inform X that he would be replaced.  What are the steps necessary to validly appoint representative Y and to avoid any loss of rights for European patent application EP -A?\",\n",
      "        \"options\": [\n",
      "            \"A. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 12 October 2023 at the latest and files in good time an authorisation signed by the applicant .\",\n",
      "            \"B. New representative Y requests a change of representative and files a response to the extended European search report with  the EPO by 12 October 2023 at the latest .\",\n",
      "            \"C. New representative Y requests a change of representative and files a response to the extended European search report with the EPO by 23 October 2023 at the latest.\",\n",
      "            \"D. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 23 October 2023 at the latest and files in good time an authorisation signed by the applicant .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The opposition division revoked European patent EP -B1. The patent proprietor filed an appeal  in time . The b oard of appeal forwarded a copy of the appeal to the o pponent/ respondent with a communication dated 1 June 2023 giving it an opportunity to file comments within a period of four  months.  The opponent/respondent files comments today, 12 October 2023. What further action has to be taken ?\",\n",
      "        \"options\": [\n",
      "            \"A. The opponent/ respondent needs  to request an extension of the period for comment.\",\n",
      "            \"B. The opponent/respondent needs to pay a fee for further processing.\",\n",
      "            \"C. The opponent/respondent needs to file a substantiated request for reestablishment of rights and pay the associated fee.\",\n",
      "            \"D. None of the above.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 75: {'question': 'In what situation can the time limit for requesting examination be remedied under Article R. 70 EPC, given that the applicant has missed the deadline to request examination within six months of the publication date of the European search report?', 'options': ['A. By filing a request for re-establishment of rights with the fee and justification within three months from the expiry of the time limit.', 'B. The time limit can never be remedied under R. 70 EPC, it is an absolute deadline.', 'C. By filing a formal amendment to extend the period after six months but before the examination process starts.', 'D. By directly appealing the decision not to consider the application for examination.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Which functionalities or services can be accessed directly from MyEPO Portfolio?\",\n",
      "        \"options\": [\n",
      "            \"A. A shared area with examiners, European Patent Register, filing via the EPO's online filing software eOLF\",\n",
      "            \"B. Mailbox, a shared area with examiners, replying to a communication under Article  94(3) EPC\",\n",
      "            \"C. Mailbox, patent search via publication server, a shared area with examiners\",\n",
      "            \"D. Filing via the EPO's Online Filing 2.0, patent search via publication server, Mailbox\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You filed an international patent application on 6 June 2024, claiming the priority of a European patent application filed on 7  July 2023. You received a communication dated 25 September 2024 from the EPO acting as International Searching Authority (ISA), stating that the requirement of unity of invention has not been complied with. The ISA identifies three inventions. You are invited to pay two additional search fees. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. You must pay two additional search fees by 25 October 2024\",\n",
      "            \"B. You do not need to file a response to the provisional opinion accompanying the partial search results\",\n",
      "            \"C. If you pay two additional search fees under protest, you must pay two protest fees within the time limit\",\n",
      "            \"D. If you do not pay any additional search fees within the time limit, the international patent application will be deemed to be withdrawn\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A communication under Article 94(3) EPC, setting a four -month time limit for reply is dated 12 September 2024. The applicant receives the letter on 21 September 2024, as evidenced by the postal receipt signed by him.  What is the last day for replying to the communication?\",\n",
      "        \"options\": [\n",
      "            \"A. 13 January 2025\",\n",
      "            \"B. 12 January 2025\",\n",
      "            \"C. 22 January 2025\",\n",
      "            \"D. 14 January 2025\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 76: {'question': 'For an international application filed before July 1, 2005, which office can act as the International Searching Authority (ISA) for which no supplementary European search report will be drawn up by the EPO?', 'options': ['A. Swedish Intellectual Property Office', 'B. Austrian Patent Office', 'C. Spanish Patent and Trademark Office', 'D. German Patent and Trade Mark Office']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A communication under Article 94(3) EPC, setting a four -month time limit for reply is dated 12 September 2024. The applicant receives the letter on 21 September 2024, as evidenced by the postal receipt signed by him.  What is the last day for replying to the communication?\",\n",
      "        \"options\": [\n",
      "            \"A. 13 January 2025\",\n",
      "            \"B. 12 January 2025\",\n",
      "            \"C. 22 January 2025\",\n",
      "            \"D. 14 January 2025\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Which functionalities or services can be accessed directly from MyEPO Portfolio?\",\n",
      "        \"options\": [\n",
      "            \"A. A shared area with examiners, European Patent Register, filing via the EPO's online filing software eOLF\",\n",
      "            \"B. Mailbox, a shared area with examiners, replying to a communication under Article  94(3) EPC\",\n",
      "            \"C. Mailbox, patent search via publication server, a shared area with examiners\",\n",
      "            \"D. Filing via the EPO's Online Filing 2.0, patent search via publication server, Mailbox\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 77: {'question': 'An applicant files a European patent application in Spanish, which is an admissible non-EPO language under Article 14(2) EPC 1973, with a translation into an official EPO language. If the applicant fails to file the required translation within two months as per Rule 6 of the EPC, what will be the consequence?', 'options': ['A. The application will automatically become abandoned.', 'B. The applicant can remedy the deficiency by filing the translation within six months from the date of filing and paying a late fee.', 'C. The applicant must file the translation to avoid loss of rights, but cannot request further processing at this stage.', \"D. The applicant's application will be considered as if it were filed in an official EPO language without any further action required.\"]}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Applicants may request processing of their international application under PCT Direct by filing a letter (\\\"PCT Direct letter\\\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing\",\n",
      "            \"B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0\",\n",
      "            \"C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0\",\n",
      "            \"D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international application is published , together  with the search report drawn up by the CNIPA , 18 m onths + 1 day after the filing date (no priority claimed). The application has no more than 35 pages and 15 claims. Which statement reflects all actions the CN  applicant  needs to take for entry into the EP phase 25 months  after the filing date ? A request for early processing has been filed.\",\n",
      "        \"options\": [\n",
      "            \"A. Complete and file Form 1200 and pay the filing fee and the search fee\",\n",
      "            \"B. Complete and file Form 1200 and pay the filing fee, the search fee and the renewal fee for the third year\",\n",
      "            \"C. Complete and file Form 1200, pay the filing fee and the search fee and appoint a representative\",\n",
      "            \"D. None of the above statements\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. As no renewal fees have been paid, the application is deemed to be withdrawn .\",\n",
      "            \"B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .\",\n",
      "            \"C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .\",\n",
      "            \"D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Attempt 1 failed. Retrying...\n",
      "Question 78: {'question': 'In an international application filed under PCT, which of the following actions must be taken if the applicant wishes to enter the European phase with amended claims after receiving the international search report but before filing the European patent application?', 'options': ['A. File a request for early processing under Rule 145(2)(b) PCT without amending the claims.', 'B. Amend the claims in the international application and submit a copy of the amended claims to the International Bureau within two months from the date of receiving the international search report, but not file them with the European Patent Office (EPO).', 'C. File a letter containing informal comments on the search opinion with the EPO and simultaneously amend the claims in the application as filed.', 'D. File an amendment to the claims directly with the EPO during the European phase, without considering amendments made in the international phase.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"EP-1 is a regular European patent application (Euro -direct application) .  Which one of the following missed time limits can be remedied for EP -1 before the EPO by requesting re- establishment of rights ?\",\n",
      "        \"options\": [\n",
      "            \"A. T ime limit for pay ing the designation fee\",\n",
      "            \"B. T ime limit for requesting examination\",\n",
      "            \"C. T ime limit for filing the application within the priority period\",\n",
      "            \"D. T ime limit for paying the fee for re- establishment of rights\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicant Korhonen is a Finnish national resident in Finland. He filed a European patent application in Finnish and provided an English translation in time. In response to the extended European search report (EESR), Korhonen wishes to file amended claims t ogether with a request for examination. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Korhonen must file the amended claims in Finnish and must then  provide a translation into English, in time\",\n",
      "            \"B. Korhonen is allowed to file the amended claims in Finnish if he then provides a\",\n",
      "            \"translation into any official language of the EPO, in time C. Korhonen is allowed to file the amended claims in Finnish if he then provides a translation into English, in time\",\n",
      "            \"D. Korhonen is not allowed to file the amended claims in Finnish\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?\",\n",
      "        \"options\": [\n",
      "            \"A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO\",\n",
      "            \"B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application\",\n",
      "            \"C. File an electronic certified copy of the Luxembourg patent application with the EPO\",\n",
      "            \"D. File a certified copy of the Luxembourg patent application with the International Bureau\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 79: {'question': 'According to the guidelines, if an applicant files a European patent application in Finnish and amends claims after receiving an examination report, which of the following statements is correct regarding the filing of amended claims?', 'options': ['A. The amended claims must be filed in English only.', 'B. The amended claims can be filed in Finnish with a translation into English to be submitted within one month.', 'C. The applicant is not allowed to file the amended claims in any language other than English.', 'D. The amended claims should be filed in German as it is an official EPO language.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"EP-1 is a regular European patent application (Euro -direct application) .  Which one of the following missed time limits can be remedied for EP -1 before the EPO by requesting re- establishment of rights ?\",\n",
      "        \"options\": [\n",
      "            \"A. T ime limit for pay ing the designation fee\",\n",
      "            \"B. T ime limit for requesting examination\",\n",
      "            \"C. T ime limit for filing the application within the priority period\",\n",
      "            \"D. T ime limit for paying the fee for re- establishment of rights\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 10 October 2021, European patent attorney X filed European patent application EP -A with the EPO on the applicant's behalf. Application EP -A was published on 12 April 2023, together  with the extended European search report. On 6  October 2023, the applicant contacts a new European patent attorney  Y to replace X as representative and issues Y with its instructions to reply to the extended European search report. The applicant did not inform X that he would be replaced.  What are the steps necessary to validly appoint representative Y and to avoid any loss of rights for European patent application EP -A?\",\n",
      "        \"options\": [\n",
      "            \"A. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 12 October 2023 at the latest and files in good time an authorisation signed by the applicant .\",\n",
      "            \"B. New representative Y requests a change of representative and files a response to the extended European search report with  the EPO by 12 October 2023 at the latest .\",\n",
      "            \"C. New representative Y requests a change of representative and files a response to the extended European search report with the EPO by 23 October 2023 at the latest.\",\n",
      "            \"D. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 23 October 2023 at the latest and files in good time an authorisation signed by the applicant .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 80: {'context': 'EP-1 is a regular European patent application (Euro-direct application). The applicant has filed this application in English, which is one of the languages of the EPO. However, the requirement for translations into other official languages of the EPO must be met by the relevant deadlines.', 'question': 'EP-1 was filed on 5 May 2023 and specifies that it claims a priority from a U.S. application filed on 6 June 2022. If an English translation is required to be submitted for EP-1 into one of the other official languages, within which timeframe must this translation be provided to avoid loss of rights?', 'options': ['A. By 5 July 2023', 'B. By 6 August 2023', 'C. By 5 November 2023', 'D. By 5 January 2024']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You filed an international patent application on 6 June 2024, claiming the priority of a European patent application filed on 7  July 2023. You received a communication dated 25 September 2024 from the EPO acting as International Searching Authority (ISA), stating that the requirement of unity of invention has not been complied with. The ISA identifies three inventions. You are invited to pay two additional search fees. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. You must pay two additional search fees by 25 October 2024\",\n",
      "            \"B. You do not need to file a response to the provisional opinion accompanying the partial search results\",\n",
      "            \"C. If you pay two additional search fees under protest, you must pay two protest fees within the time limit\",\n",
      "            \"D. If you do not pay any additional search fees within the time limit, the international patent application will be deemed to be withdrawn\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"EP-1 is a regular European patent application (Euro -direct application) .  Which one of the following missed time limits can be remedied for EP -1 before the EPO by requesting re- establishment of rights ?\",\n",
      "        \"options\": [\n",
      "            \"A. T ime limit for pay ing the designation fee\",\n",
      "            \"B. T ime limit for requesting examination\",\n",
      "            \"C. T ime limit for filing the application within the priority period\",\n",
      "            \"D. T ime limit for paying the fee for re- establishment of rights\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 81: {'question': 'An applicant filed a European patent application on 15 March 2023, requesting examination under Rule 70(1). The applicant disagrees with the search opinion issued by the EPO and wishes to request an appeal. By which date should the appeal fee be paid?', 'options': ['A. Within one month of receiving the search opinion', 'B. Within two months of receiving the search opinion', 'C. The appeal fee can be paid at any time after receiving the search opinion', 'D. Within three months of receiving the search opinion']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"An international application is published , together  with the search report drawn up by the CNIPA , 18 m onths + 1 day after the filing date (no priority claimed). The application has no more than 35 pages and 15 claims. Which statement reflects all actions the CN  applicant  needs to take for entry into the EP phase 25 months  after the filing date ? A request for early processing has been filed.\",\n",
      "        \"options\": [\n",
      "            \"A. Complete and file Form 1200 and pay the filing fee and the search fee\",\n",
      "            \"B. Complete and file Form 1200 and pay the filing fee, the search fee and the renewal fee for the third year\",\n",
      "            \"C. Complete and file Form 1200, pay the filing fee and the search fee and appoint a representative\",\n",
      "            \"D. None of the above statements\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A communication under Article 94(3) EPC, setting a four -month time limit for reply is dated 12 September 2024. The applicant receives the letter on 21 September 2024, as evidenced by the postal receipt signed by him.  What is the last day for replying to the communication?\",\n",
      "        \"options\": [\n",
      "            \"A. 13 January 2025\",\n",
      "            \"B. 12 January 2025\",\n",
      "            \"C. 22 January 2025\",\n",
      "            \"D. 14 January 2025\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Which functionalities or services can be accessed directly from MyEPO Portfolio?\",\n",
      "        \"options\": [\n",
      "            \"A. A shared area with examiners, European Patent Register, filing via the EPO's online filing software eOLF\",\n",
      "            \"B. Mailbox, a shared area with examiners, replying to a communication under Article  94(3) EPC\",\n",
      "            \"C. Mailbox, patent search via publication server, a shared area with examiners\",\n",
      "            \"D. Filing via the EPO's Online Filing 2.0, patent search via publication server, Mailbox\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 82: {'question': 'If an applicant fails to indicate claims for searching within the required time frame, what will be included in the search report?', 'options': ['A. Only the abstract of the application', 'B. A partial search report based on the first claim in each category', 'C. Full details of all claims as stated in the application', 'D. The rejection of the application']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Which of the following statements about filing third- party observations is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The person that filed third- party observations will be a party to the proceedings before the EPO, and the applicant is obliged to respond to third- party observations\",\n",
      "            \"B. Third -party observations must be filed in writing and may not be filed anonymously\",\n",
      "            \"C. Third -party observations are considered by the examining division only if they include a statement of the grounds on which they are based, and an official fee is paid\",\n",
      "            \"D. Third -party observations can be filed after the publication of a European patent application and must be filed in an official language of the EPO\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. As no renewal fees have been paid, the application is deemed to be withdrawn .\",\n",
      "            \"B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .\",\n",
      "            \"C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .\",\n",
      "            \"D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In which of the following situations does the EPO recommend using the EPO Contingency Upload Service?\",\n",
      "        \"options\": [\n",
      "            \"A. When you submit documents after business hours\",\n",
      "            \"B. When the EPO filing systems are functioning correctly, but you encounter a technical issue at your end\",\n",
      "            \"C. When there is a system outage at the EPO that prevents document submission via the standard filing systems\",\n",
      "            \"D. When the EPO is closed due to an official holiday\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 83: {'question': 'According to Article 115 EPC, which of the following statements about third-party observations is correct?', 'options': ['A. The third party filing such observations will be considered as a party to the proceedings before the EPO and the applicant must respond to these observations.', 'B. Third-party observations can be filed anonymously without any official fee required.', 'C. Third-party observations may not be considered by the examining division unless they include a statement of grounds, are filed in an official language of the EPO, and an official fee is paid.', \"D. There is no obligation for the applicant to respond to third-party observations, and such observations do not constitute a party's participation in the proceedings.\"]}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 20  June 2023, applicant P validly filed an international patent application PCT-P, claiming priority from European patent application EP -I filed on 7 July 2022. Today, 12 October 2023, he discovers that he should also have claimed priority from EP -II filed on 3 July 2022. Can the missing priority claim still be validly added?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, the time  limit for adding the priority claim expires on 3  November 2023.\",\n",
      "            \"B. Yes, the time limit for adding the priority claim expires on 7  November 2023.\",\n",
      "            \"C. Yes, the time  limit for adding the priority claim expires on 20 October 2023.\",\n",
      "            \"D. No, the time  limit for adding the priority claim expired on 3 July 2023.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicants may request processing of their international application under PCT Direct by filing a letter (\\\"PCT Direct letter\\\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing\",\n",
      "            \"B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0\",\n",
      "            \"C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0\",\n",
      "            \"D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 84: {'question': 'An applicant filed an European patent application EP-A on 15 March 2023, which claimed priority from a previous application filed on 15 April 2022 with the same filing date. Today is 12 October 2023. According to the given context, can this missing claim still be added?', 'options': ['A. Yes, the time limit for adding the priority claim expires on 14 November 2023.', 'B. No, the time limit for adding the priority claim expired on 15 April 2023.', 'C. Yes, the time limit for adding the priority claim expires on 15 October 2023.', 'D. No, the time limit for adding the priority claim expired on 14 March 2023.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 20  June 2023, applicant P validly filed an international patent application PCT-P, claiming priority from European patent application EP -I filed on 7 July 2022. Today, 12 October 2023, he discovers that he should also have claimed priority from EP -II filed on 3 July 2022. Can the missing priority claim still be validly added?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, the time  limit for adding the priority claim expires on 3  November 2023.\",\n",
      "            \"B. Yes, the time limit for adding the priority claim expires on 7  November 2023.\",\n",
      "            \"C. Yes, the time  limit for adding the priority claim expires on 20 October 2023.\",\n",
      "            \"D. No, the time  limit for adding the priority claim expired on 3 July 2023.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In which of the following cases is the applicant entitled to a reduction of the filing fee  under Rule  6 EPC ? A declaration of such entitlement has  been made by crossing the relevant box on Form  1001.\",\n",
      "        \"options\": [\n",
      "            \"A. A Spanish European patent attorney files a European patent application in Spanish for a natural person who is resident in Andorra and of Andorra n nationality .\",\n",
      "            \"B. A firm whose principal place of business is in Germany and a natural person who is resident in Germany  and of Dutch nationality  jointly file a European patent application in Dutch. The German firm employs 200 people with an annual turnover of EUR 60 million.\",\n",
      "            \"C. A natural person resident in the USA and of Belgian nationality files a European patent application in French.\",\n",
      "            \"D. A natural person resident in the USA and of Swiss nationality files a European patent application in Italian.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 10 October 2021, European patent attorney X filed European patent application EP -A with the EPO on the applicant's behalf. Application EP -A was published on 12 April 2023, together  with the extended European search report. On 6  October 2023, the applicant contacts a new European patent attorney  Y to replace X as representative and issues Y with its instructions to reply to the extended European search report. The applicant did not inform X that he would be replaced.  What are the steps necessary to validly appoint representative Y and to avoid any loss of rights for European patent application EP -A?\",\n",
      "        \"options\": [\n",
      "            \"A. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 12 October 2023 at the latest and files in good time an authorisation signed by the applicant .\",\n",
      "            \"B. New representative Y requests a change of representative and files a response to the extended European search report with  the EPO by 12 October 2023 at the latest .\",\n",
      "            \"C. New representative Y requests a change of representative and files a response to the extended European search report with the EPO by 23 October 2023 at the latest.\",\n",
      "            \"D. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 23 October 2023 at the latest and files in good time an authorisation signed by the applicant .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 85: {'question': 'If an applicant claims priority from an application filed on 15 January 2023, but later discovers that the actual priority date should be 18 January 2023, and this correction is made within six months of filing the European patent application on 7 July 2023, can the corrected priority date still be validly claimed?', 'options': ['A. Yes, as long as the correction is made within six months of filing the European patent application.', 'B. No, because the corrected priority date exceeds the original filing date by three days.', 'C. Yes, but only if the applicant successfully requests re-establishment of rights in respect of the priority claim.', 'D. No, because the time limit for adding a priority claim expires 12 months after the filing date of the first application.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?\",\n",
      "        \"options\": [\n",
      "            \"A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO\",\n",
      "            \"B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application\",\n",
      "            \"C. File an electronic certified copy of the Luxembourg patent application with the EPO\",\n",
      "            \"D. File a certified copy of the Luxembourg patent application with the International Bureau\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicant Korhonen is a Finnish national resident in Finland. He filed a European patent application in Finnish and provided an English translation in time. In response to the extended European search report (EESR), Korhonen wishes to file amended claims t ogether with a request for examination. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Korhonen must file the amended claims in Finnish and must then  provide a translation into English, in time\",\n",
      "            \"B. Korhonen is allowed to file the amended claims in Finnish if he then provides a\",\n",
      "            \"translation into any official language of the EPO, in time C. Korhonen is allowed to file the amended claims in Finnish if he then provides a translation into English, in time\",\n",
      "            \"D. Korhonen is not allowed to file the amended claims in Finnish\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 86: {'question': 'An applicant from Germany filed a European patent application using German, with no claims included initially. The description was in German and accompanied by a French translation. After receiving an examination readiness notification, the applicant wishes to file amended claims. Which of the following statements is correct?', 'options': ['A. The application cannot be processed because it lacks claims.', 'B. The applicant can file the amended claims in German and must provide a translation into any official EPO language, in time.', 'C. The applicant can file the amended claims in French and must provide a translation into any official EPO language, in time.', 'D. The applicant can file the amended claims in English but cannot provide a translation.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Company M, which has  its principal place of business in Tijuana, Mexico, validly filed an international patent application PCT -M with the Mexican Institute of Industrial Property. The application was filed in Spanish. A few days later, the applicant files an English translati on of the application.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant can choose the EPO as ISA and the USPTO as IPEA.\",\n",
      "            \"B. The applicant can choose the USPTO as ISA and the EPO as IPEA.\",\n",
      "            \"C. The applicant can choose the Austrian Patent Offic e as ISA and the\",\n",
      "            \"EPO as IPEA.\",\n",
      "            \"D. The applicant can choose the EPO as ISA and the Intellectual Property\",\n",
      "            \"Office of Singapore as IPEA.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international application is published , together  with the search report drawn up by the CNIPA , 18 m onths + 1 day after the filing date (no priority claimed). The application has no more than 35 pages and 15 claims. Which statement reflects all actions the CN  applicant  needs to take for entry into the EP phase 25 months  after the filing date ? A request for early processing has been filed.\",\n",
      "        \"options\": [\n",
      "            \"A. Complete and file Form 1200 and pay the filing fee and the search fee\",\n",
      "            \"B. Complete and file Form 1200 and pay the filing fee, the search fee and the renewal fee for the third year\",\n",
      "            \"C. Complete and file Form 1200, pay the filing fee and the search fee and appoint a representative\",\n",
      "            \"D. None of the above statements\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 87: {'question': 'An international PCT application with an Austrian filing date, filed in German, was processed by the Austrian Patent Office (Austrian ISA) and now the applicant wishes to enter the European phase via the EPO as IPEA. Which of the following statements is correct?', 'options': ['A. The translation of the application into one of the official languages of the EPO must be submitted within 31 months from the filing date.', 'B. The provisional protection is only effective upon publication by the EPO, which occurs at the same time as the international publication.', 'C. No additional documents are required for entering the European phase since the application was initially processed by the Austrian ISA.', \"D. The applicant can choose any of the contracting states' patent offices as IPEA instead of the EPO.\"]}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 20  June 2023, applicant P validly filed an international patent application PCT-P, claiming priority from European patent application EP -I filed on 7 July 2022. Today, 12 October 2023, he discovers that he should also have claimed priority from EP -II filed on 3 July 2022. Can the missing priority claim still be validly added?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, the time  limit for adding the priority claim expires on 3  November 2023.\",\n",
      "            \"B. Yes, the time limit for adding the priority claim expires on 7  November 2023.\",\n",
      "            \"C. Yes, the time  limit for adding the priority claim expires on 20 October 2023.\",\n",
      "            \"D. No, the time  limit for adding the priority claim expired on 3 July 2023.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Which functionalities or services can be accessed directly from MyEPO Portfolio?\",\n",
      "        \"options\": [\n",
      "            \"A. A shared area with examiners, European Patent Register, filing via the EPO's online filing software eOLF\",\n",
      "            \"B. Mailbox, a shared area with examiners, replying to a communication under Article  94(3) EPC\",\n",
      "            \"C. Mailbox, patent search via publication server, a shared area with examiners\",\n",
      "            \"D. Filing via the EPO's Online Filing 2.0, patent search via publication server, Mailbox\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A communication under Article 94(3) EPC, setting a four -month time limit for reply is dated 12 September 2024. The applicant receives the letter on 21 September 2024, as evidenced by the postal receipt signed by him.  What is the last day for replying to the communication?\",\n",
      "        \"options\": [\n",
      "            \"A. 13 January 2025\",\n",
      "            \"B. 12 January 2025\",\n",
      "            \"C. 22 January 2025\",\n",
      "            \"D. 14 January 2025\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 88: {'question': 'If an applicant claims priority from an application having the same filing date as the European patent application, what must be done to establish a valid priority claim according to the Guidelines for Examination in the EPO?', 'options': ['A. The applicant must indicate a corrected date lying within the twelve-month period preceding the filing date.', 'B. The applicant must request re-establishment of rights in respect of the priority period and do so within two months of the expiry of the priority period, and this request is subsequently granted.', 'C. The applicant must file a new application within the same two-month period as the original application.', 'D. Priority cannot be claimed from an application having the same filing date; it must be corrected or re-established under Rule 52(3) or Art. 122.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"After receipt of a negative written opinion issued by the EPO acting as ISA, amendments under Art icle 19 PCT were filed during the international phase. No request for international preliminary examination was filed. Form  1200 was used,  and no further amendments were filed with the EPO upon entry into the regional phase.   What communication under Rules  161/162 EPC will be received in the regional phase?\",\n",
      "        \"options\": [\n",
      "            \"A. Form 1226AA ;  if you do not reply to it in time, the application will be deemed to be withdrawn\",\n",
      "            \"B. Form 1226BB offering the opportunity to comment and file amendments\",\n",
      "            \"C. Form 1226CC offering the opportunity to file amendments before the supplementary European search report is drawn up\",\n",
      "            \"D. Form 1226AC stating that the examination has started\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?\",\n",
      "        \"options\": [\n",
      "            \"A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.\",\n",
      "            \"B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.\",\n",
      "            \"C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.\",\n",
      "            \"D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 89: {'question': 'If the Opposition Division decides to maintain the European patent as amended, what must the patent proprietor do after receiving the communication informing them of the text in which the patent will be maintained?', 'options': ['A. Pay the fee for publishing a new specification and file translations of any amended claims within three months.', 'B. File observations only if they disagree with the text communicated by the Opposition Division.', 'C. Request an extension to review the decision of the Opposition Division before taking any action.', 'D. Wait for the appeal procedure to start automatically.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Applicant Korhonen is a Finnish national resident in Finland. He filed a European patent application in Finnish and provided an English translation in time. In response to the extended European search report (EESR), Korhonen wishes to file amended claims t ogether with a request for examination. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Korhonen must file the amended claims in Finnish and must then  provide a translation into English, in time\",\n",
      "            \"B. Korhonen is allowed to file the amended claims in Finnish if he then provides a\",\n",
      "            \"translation into any official language of the EPO, in time C. Korhonen is allowed to file the amended claims in Finnish if he then provides a translation into English, in time\",\n",
      "            \"D. Korhonen is not allowed to file the amended claims in Finnish\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Company M, which has  its principal place of business in Tijuana, Mexico, validly filed an international patent application PCT -M with the Mexican Institute of Industrial Property. The application was filed in Spanish. A few days later, the applicant files an English translati on of the application.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant can choose the EPO as ISA and the USPTO as IPEA.\",\n",
      "            \"B. The applicant can choose the USPTO as ISA and the EPO as IPEA.\",\n",
      "            \"C. The applicant can choose the Austrian Patent Offic e as ISA and the\",\n",
      "            \"EPO as IPEA.\",\n",
      "            \"D. The applicant can choose the EPO as ISA and the Intellectual Property\",\n",
      "            \"Office of Singapore as IPEA.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 10 October 2021, European patent attorney X filed European patent application EP -A with the EPO on the applicant's behalf. Application EP -A was published on 12 April 2023, together  with the extended European search report. On 6  October 2023, the applicant contacts a new European patent attorney  Y to replace X as representative and issues Y with its instructions to reply to the extended European search report. The applicant did not inform X that he would be replaced.  What are the steps necessary to validly appoint representative Y and to avoid any loss of rights for European patent application EP -A?\",\n",
      "        \"options\": [\n",
      "            \"A. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 12 October 2023 at the latest and files in good time an authorisation signed by the applicant .\",\n",
      "            \"B. New representative Y requests a change of representative and files a response to the extended European search report with  the EPO by 12 October 2023 at the latest .\",\n",
      "            \"C. New representative Y requests a change of representative and files a response to the extended European search report with the EPO by 23 October 2023 at the latest.\",\n",
      "            \"D. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 23 October 2023 at the latest and files in good time an authorisation signed by the applicant .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 90: {'question': 'Company X filed a European patent application in Swedish, which was subsequently translated into English within two months as required by Rule 6(1) EPC. The applicant now wishes to amend the claims and provide a new translation. Which of the following statements is correct?', 'options': ['A. Company X must file the amended claims in English and must then provide a new translation into Swedish, in time.', 'B. Company X can file the amended claims in Swedish and must then provide a new translation into any official language of the EPO, in time.', 'C. Company X is allowed to file the amended claims in Swedish if it provides a new translation into English, in time.', 'D. Company X is not allowed to file the amended claims in Swedish']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The opposition division revoked European patent EP -B1. The patent proprietor filed an appeal  in time . The b oard of appeal forwarded a copy of the appeal to the o pponent/ respondent with a communication dated 1 June 2023 giving it an opportunity to file comments within a period of four  months.  The opponent/respondent files comments today, 12 October 2023. What further action has to be taken ?\",\n",
      "        \"options\": [\n",
      "            \"A. The opponent/ respondent needs  to request an extension of the period for comment.\",\n",
      "            \"B. The opponent/respondent needs to pay a fee for further processing.\",\n",
      "            \"C. The opponent/respondent needs to file a substantiated request for reestablishment of rights and pay the associated fee.\",\n",
      "            \"D. None of the above.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 20  June 2023, applicant P validly filed an international patent application PCT-P, claiming priority from European patent application EP -I filed on 7 July 2022. Today, 12 October 2023, he discovers that he should also have claimed priority from EP -II filed on 3 July 2022. Can the missing priority claim still be validly added?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, the time  limit for adding the priority claim expires on 3  November 2023.\",\n",
      "            \"B. Yes, the time limit for adding the priority claim expires on 7  November 2023.\",\n",
      "            \"C. Yes, the time  limit for adding the priority claim expires on 20 October 2023.\",\n",
      "            \"D. No, the time  limit for adding the priority claim expired on 3 July 2023.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 91: {'question': 'In T 1152/05, why was the notice of appeal deemed not to have been filed?', 'options': ['A. The notice was filed after the deadline.', 'B. A translation into French was not submitted simultaneously.', 'C. The company did not have its principal place of business in the European Union.', 'D. It was filed in Dutch, but the appellant could not benefit from Art. 14(4) EPC.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"After receipt of a negative written opinion issued by the EPO acting as ISA, amendments under Art icle 19 PCT were filed during the international phase. No request for international preliminary examination was filed. Form  1200 was used,  and no further amendments were filed with the EPO upon entry into the regional phase.   What communication under Rules  161/162 EPC will be received in the regional phase?\",\n",
      "        \"options\": [\n",
      "            \"A. Form 1226AA ;  if you do not reply to it in time, the application will be deemed to be withdrawn\",\n",
      "            \"B. Form 1226BB offering the opportunity to comment and file amendments\",\n",
      "            \"C. Form 1226CC offering the opportunity to file amendments before the supplementary European search report is drawn up\",\n",
      "            \"D. Form 1226AC stating that the examination has started\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 92: {'question': \"During the opposition proceedings of Firm A's European patent EP against Firm B's opposition claim that the subject-matter was not new in view of document D1, Firm C filed observations under Article 115 EPC arguing the subject-matter was not novel due to document D2. If Firm B withdraws its opposition at the end of these proceedings, which statement is correct according to the context provided?\", 'options': ['A. The opposition division must maintain the patent as granted since Firm B withdrew its opposition.', 'B. The opposition division can still continue with the opposition proceedings if it deems there are sufficient grounds for doing so, even after Firm B withdraws its opposition.', \"C. Firm C is entitled to file an appeal against the opposition division's decision regardless of Firm B's withdrawal of its opposition.\", 'D. If the opposition division decides to maintain the patent as granted due to lack of new evidence, Firm A cannot object.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"European patent application EP -X was filed on 1  October 2020, claiming the priority of a Belgian application filed on 16 October 2019. The mention of the grant of European patent EP -X was published on 2  October 2024. The proprietor filed a request for unitary effect and was informed by communication dated 10  October 2024, that unitary effect had been registered for EP -X-C0 on the same date. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. A renewal fee still has to be paid by 31 October 2024 in respect of the 5th year for EP -X\",\n",
      "            \"B. A renewal fee is due on 31 October 2024 in respect of the 5th year for EP -X-C0\",\n",
      "            \"C. A renewal fee is due on 31 October 2024 in respect of the 6th year for EP -X-C0\",\n",
      "            \"D. No renewal fee has to be paid on 31 October 2024\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The applicant received a communication pursuant to Article 90(3) EPC and Rule  60 EPC, requesting them to file a designation of inventor but missed the time limit for filing a response. After expiry of the time limit, the Receiving Section issued a decision to refuse the European patent application, dated 10  October 2024. What can the applicant do to remedy the situation?\",\n",
      "        \"options\": [\n",
      "            \"A. File a notice of appeal against the decision within four months of notification of the decision\",\n",
      "            \"B. File a request for further processing within two months of notification of the decision\",\n",
      "            \"C. File, within two months of notification of the decision, a request for re-establishment of rights in respect of the time limit for filing the designation of inventor\",\n",
      "            \"D. A, B and C are correct\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 93: {'question': 'After filing a European patent application EP-X on 1 October 2023, the applicant received a communication from the Examining Division under Article 94 EPC on 15 May 2025, requesting information regarding the unitary effect. If no response is provided within the prescribed time limit, what will happen?', 'options': ['A. The application for unitary effect will be deemed withdrawn.', 'B. The application will automatically receive unitary effect on 1 October 2028.', 'C. The Examining Division will issue a decision to refuse the application.', 'D. The applicant will have to file a notice of appeal within two months.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"You filed an international patent application on 6 June 2024, claiming the priority of a European patent application filed on 7  July 2023. You received a communication dated 25 September 2024 from the EPO acting as International Searching Authority (ISA), stating that the requirement of unity of invention has not been complied with. The ISA identifies three inventions. You are invited to pay two additional search fees. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. You must pay two additional search fees by 25 October 2024\",\n",
      "            \"B. You do not need to file a response to the provisional opinion accompanying the partial search results\",\n",
      "            \"C. If you pay two additional search fees under protest, you must pay two protest fees within the time limit\",\n",
      "            \"D. If you do not pay any additional search fees within the time limit, the international patent application will be deemed to be withdrawn\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .\",\n",
      "            \"B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .\",\n",
      "            \"C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .\",\n",
      "            \"D. Ms Smith can only be deleted as inventor with her consent .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 94: {'question': 'You submitted an international patent application to the EPO acting as International Searching Authority (ISA) on 15 March 2024, claiming priority from a national application filed in France on 16 April 2023. You are informed that a search will be performed for one invention but not another due to non-payment of an additional search fee within the two-month period. If you decide to pay the additional fee after this period, which of the following actions is required?', 'options': ['A. No further action is necessary as the ISA will perform a supplementary search.', 'B. You must file a request for a supplementary international search and pay the corresponding fee within four months from the application date.', 'C. The additional search can be requested only by filing a new international application with both inventions claimed.', 'D. You are required to withdraw one of the inventions before requesting an additional search.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Company M, which has  its principal place of business in Tijuana, Mexico, validly filed an international patent application PCT -M with the Mexican Institute of Industrial Property. The application was filed in Spanish. A few days later, the applicant files an English translati on of the application.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant can choose the EPO as ISA and the USPTO as IPEA.\",\n",
      "            \"B. The applicant can choose the USPTO as ISA and the EPO as IPEA.\",\n",
      "            \"C. The applicant can choose the Austrian Patent Offic e as ISA and the\",\n",
      "            \"EPO as IPEA.\",\n",
      "            \"D. The applicant can choose the EPO as ISA and the Intellectual Property\",\n",
      "            \"Office of Singapore as IPEA.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 95: {'question': 'A European patent application was filed on 15 March 2020, and the filing date was confirmed. Considering Rule 51(1) as amended, which of the following statements is correct regarding the payment of the third-year renewal fee?', 'options': ['A The earliest date for valid payment of the third-year renewal fee under Rule 51(1) is 30 June 2022.', 'B The due date for the third-year renewal fee under Rule 51(1) is 30 September 2022.', 'C The earliest date for valid payment of the fourth-year renewal fee under Rule 51(1) is 30 December 2022.', 'D The due date for the third-year renewal fee under Rule 51(1) is 31 March 2023.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?\",\n",
      "        \"options\": [\n",
      "            \"A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO\",\n",
      "            \"B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application\",\n",
      "            \"C. File an electronic certified copy of the Luxembourg patent application with the EPO\",\n",
      "            \"D. File a certified copy of the Luxembourg patent application with the International Bureau\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The applicant received a communication pursuant to Article 90(3) EPC and Rule  60 EPC, requesting them to file a designation of inventor but missed the time limit for filing a response. After expiry of the time limit, the Receiving Section issued a decision to refuse the European patent application, dated 10  October 2024. What can the applicant do to remedy the situation?\",\n",
      "        \"options\": [\n",
      "            \"A. File a notice of appeal against the decision within four months of notification of the decision\",\n",
      "            \"B. File a request for further processing within two months of notification of the decision\",\n",
      "            \"C. File, within two months of notification of the decision, a request for re-establishment of rights in respect of the time limit for filing the designation of inventor\",\n",
      "            \"D. A, B and C are correct\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicant Korhonen is a Finnish national resident in Finland. He filed a European patent application in Finnish and provided an English translation in time. In response to the extended European search report (EESR), Korhonen wishes to file amended claims t ogether with a request for examination. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Korhonen must file the amended claims in Finnish and must then  provide a translation into English, in time\",\n",
      "            \"B. Korhonen is allowed to file the amended claims in Finnish if he then provides a\",\n",
      "            \"translation into any official language of the EPO, in time C. Korhonen is allowed to file the amended claims in Finnish if he then provides a translation into English, in time\",\n",
      "            \"D. Korhonen is not allowed to file the amended claims in Finnish\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 96: {'question': 'An applicant has filed a European patent application claiming priority from an earlier U.S. application, but did not submit the certified copy of the U.S. application within sixteen months of the earliest priority date as required by Rule 53(1). Which of the following actions can be taken to comply with this requirement?', 'options': ['A. Request the U.S. Patent and Trademark Office (USPTO) to prepare and send a certified copy of the U.S. application to the EPO', 'B. Submit a valid DAS code to obtain an electronic copy of the U.S. application from the International Bureau, which can be used as a substitute for the certified copy', 'C. File a request with the Receiving Section at the EPO to extend the time limit for filing the certified copy due to exceptional circumstances', 'D. Provide a sworn statement explaining why the certified copy was not filed in time and hope that it will be accepted']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 10 October 2021, European patent attorney X filed European patent application EP -A with the EPO on the applicant's behalf. Application EP -A was published on 12 April 2023, together  with the extended European search report. On 6  October 2023, the applicant contacts a new European patent attorney  Y to replace X as representative and issues Y with its instructions to reply to the extended European search report. The applicant did not inform X that he would be replaced.  What are the steps necessary to validly appoint representative Y and to avoid any loss of rights for European patent application EP -A?\",\n",
      "        \"options\": [\n",
      "            \"A. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 12 October 2023 at the latest and files in good time an authorisation signed by the applicant .\",\n",
      "            \"B. New representative Y requests a change of representative and files a response to the extended European search report with  the EPO by 12 October 2023 at the latest .\",\n",
      "            \"C. New representative Y requests a change of representative and files a response to the extended European search report with the EPO by 23 October 2023 at the latest.\",\n",
      "            \"D. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 23 October 2023 at the latest and files in good time an authorisation signed by the applicant .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?\",\n",
      "        \"options\": [\n",
      "            \"A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.\",\n",
      "            \"B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.\",\n",
      "            \"C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.\",\n",
      "            \"D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. As no renewal fees have been paid, the application is deemed to be withdrawn .\",\n",
      "            \"B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .\",\n",
      "            \"C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .\",\n",
      "            \"D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 97: {'question': 'If European Patent Attorney Y is appointed as the new representative for European patent application EP -A, which of the following actions must be taken to ensure that there is no loss of rights and that the change is validly recorded with the EPO?', 'options': ['A. The applicant should notify the EPO of the change in representation, file a response to the extended European search report by 12 October 2023 at the latest, and ensure an authorisation signed by the applicant is submitted.', 'B. Attorney Y must file a request for a change of representative with the EPO, reply to the extended European search report within 6 months from the date of filing the request, and obtain an authorisation signed by the applicant.', 'C. The new representative should only notify the EPO of the change in representation and reply to the extended European search report within 30 days after receiving instructions from the applicant.', 'D. Attorney Y needs to inform X that he is no longer representing EP -A, file a response to the extended European search report by 12 October 2023 at the latest, and submit an authorisation signed by the applicant.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Company M, which has  its principal place of business in Tijuana, Mexico, validly filed an international patent application PCT -M with the Mexican Institute of Industrial Property. The application was filed in Spanish. A few days later, the applicant files an English translati on of the application.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant can choose the EPO as ISA and the USPTO as IPEA.\",\n",
      "            \"B. The applicant can choose the USPTO as ISA and the EPO as IPEA.\",\n",
      "            \"C. The applicant can choose the Austrian Patent Offic e as ISA and the\",\n",
      "            \"EPO as IPEA.\",\n",
      "            \"D. The applicant can choose the EPO as ISA and the Intellectual Property\",\n",
      "            \"Office of Singapore as IPEA.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?\",\n",
      "        \"options\": [\n",
      "            \"A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO\",\n",
      "            \"B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application\",\n",
      "            \"C. File an electronic certified copy of the Luxembourg patent application with the EPO\",\n",
      "            \"D. File a certified copy of the Luxembourg patent application with the International Bureau\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 98: {'question': 'A company, XYZ, has its principal place of business in Paris, France, and filed an international patent application PCT-FR with the French National Institute for Industrial Property (INPI). The application was originally written in French. After filing, the applicant realizes that a translation into English is necessary. Which of the following actions should the applicant take to ensure compliance with EPO requirements for translations of the application?', 'options': ['A. File the English translation directly with the EPO as the receiving Office.', 'B. Request the INPI to prepare and send an English translation to the EPO.', 'C. Submit a valid DAS code (Digital Access Service) to the International Bureau to obtain an English translation of the application.', 'D. File a request for examination with the EPO, specifying that an English translation is required.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 10 October 2024, an applicant files a request for entry into the European phase, together with a debit order, according to which the filing fee, the designation fee, the examination fee and the renewal fee for the third year are to be debited from the applicant's deposit account. It is specified that the debit order is to be executed on 18 October 2024. On the evening of 10 October 2024, the applicant notices that the renewal fee is not yet due and should not be debited from the deposit account. What is the latest point in time for revoking the order to debit the renewal fee in Central Fee Payment (CFP)?\",\n",
      "        \"options\": [\n",
      "            \"A. 10 October 2024\",\n",
      "            \"B. 17 October 2024\",\n",
      "            \"C. 18 October 2024\",\n",
      "            \"D. A debit order cannot be revoked in part\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In which of the following situations does the EPO recommend using the EPO Contingency Upload Service?\",\n",
      "        \"options\": [\n",
      "            \"A. When you submit documents after business hours\",\n",
      "            \"B. When the EPO filing systems are functioning correctly, but you encounter a technical issue at your end\",\n",
      "            \"C. When there is a system outage at the EPO that prevents document submission via the standard filing systems\",\n",
      "            \"D. When the EPO is closed due to an official holiday\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?\",\n",
      "        \"options\": [\n",
      "            \"A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.\",\n",
      "            \"B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.\",\n",
      "            \"C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.\",\n",
      "            \"D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 99: {'question': 'On 15 July 2023, an applicant wishes to pay the renewal fee for a European patent application using a debit order under Rule 51(1). If they receive a validation rejection due to payment being too early, what is their latest option to validly pay the renewal fee without incurring additional charges?', 'options': ['A. Pay the renewal fee on 30 June 2024', 'B. Pay the renewal fee between 1 August 2023 and 30 September 2023', 'C. Pay the renewal fee by 31 July 2023', 'D. No additional options are available if the initial payment was rejected']}\n"
     ]
    }
   ],
   "source": [
    "# evaluate_generate_mcq_question(save_dir='../outputs/evaluation2/', data_dir='../outputs/',\n",
    "#                             test_name=f'evaluate_mcq_questions_generation', model=model,\n",
    "#                             knowledge_vector_db=knowledge_vector_db, n=100)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Pour vrifier que les nouveaux embeddings font pas de btises"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "embedding load\n",
      "[\n",
      "    {\n",
      "        \"question\": \"During the examination proceedings the applicant notes that claim 1 contains a typographical error. What is the last point in time for requesting correction of the error under Rule 139 EPC?\",\n",
      "        \"options\": [\n",
      "            \"A. One day before the decision to grant a European patent is handed over to the EPO postal service\",\n",
      "            \"B. Date  of publication of the mention of the grant of the European patent\",\n",
      "            \"C. Date of notification of the decision to grant\",\n",
      "            \"D. Date of the communication under Rule 71(3) EPC\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A British company buys a French firm with an IP portfolio which includes an international application that claims priority of a British national application. The international application is in French. The British company wants to pursue the invention as a European patent application. However, they would prefer that the language of the European proceedings be English.   Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A.  Upon entry into the European phase before the EPO, the applicant can file a translation into English and English will become the language of the proceedings\",\n",
      "            \"B.  The applicant can enter the European phase with the application in French and then validly file a European divisional application in English\",\n",
      "            \"C.  The applicant can select English as the language of the proceedings in the request form for entry into the European phase (EPO Form 1200) and English will become the language of the proceedings\",\n",
      "            \"D.  None of  the above\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"European patent application EP-1 is filed on 10 December 2020, but the inventor is not designated. The designation of the inventor is filed on 25 February 2022. Will the application be refused?\",\n",
      "        \"options\": [\n",
      "            \"A. No. The designation of the inventor was filed in due time.\",\n",
      "            \"B. Yes. The designation of the inventor was not filed in due time.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 0: {'question': 'If a European patent application is filed in a language other than English, French, or German, what must be provided within two months of filing according to the EPC?', 'options': ['A. A translation into any non-official EPO language', 'B. A translation into one of the official languages of the EPO (English, French, or German)', 'C. An additional fee for using a non-official language', \"D. A declaration stating the applicant's preference for the language used\"]}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"International application PCT-1 enters the European regional phase as EP-1 today. Independent claims 1 and 10 of the international application were considered to lack unity in the international phase and a partial search report was drawn up by the EPO as ISA in respect of the invention of claim 1. The applicant wishes to have the opportunity to protect the invention of claim 10 during the EPO regional phase, but wants to keep costs to a minimum, at least at the beginning. What can the applicant do?\",\n",
      "        \"options\": [\n",
      "            \"A. File a divisional application to the invention of independent claim 10 after entry into the EPO regional phase.\",\n",
      "            \"B. Pay an additional search fee in respect of the invention of independent claim 10 within two months of entry into the EPO regional phase.\",\n",
      "            \"C. Pay an additional search fee in respect of the invention of independent claim 10 within two months of notification by the EPO.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Entry into the European phase of an international application can be effected early provided an express request for early processing is made at the time the requirements of Rule 159(1) EPC are complied with. International application PCT-1 was filed 28 months ago with no claim to priority. The application consists of 20 pages, including 16 claims. The international search was carried out by the EPO acting as ISA and the international search report was published with the international application. Which of the following fees must be paid in order to effect early entry into the European phase?\",\n",
      "        \"options\": [\n",
      "            \"A. The filing fee.\",\n",
      "            \"B. The filing fee, the examination fee and the designation fee.\",\n",
      "            \"C. The filing fee, the examination fee, the designation fee and the renewal fee.\",\n",
      "            \"D. The filing fee, the claims fee, the examination fee, the designation fee and the renewal fee.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Your Client, A Inc, is a sub-licensee under European patent application EP-1. Can the sub-licence be recorded in the European Patent Register?\",\n",
      "        \"options\": [\n",
      "            \"A. No, it is not possible to record sub-licences in the European Patent Register.\",\n",
      "            \"B. Yes, any sub-licence can be recorded in the European Patent Register.\",\n",
      "            \"C. Yes, provided the licensee granting the sub-licence has recorded its licence in the European Patent Register.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 1: {'question': 'An international application PCT-2 enters the European regional phase as EP-2, and the applicant wishes to obtain a search report for an additional invention claimed in the application that was not searched by the EPO in the international phase. According to the guidelines, what is the correct course of action?', 'options': ['A. File a request for supplementary European search without any additional fees.', 'B. Pay an additional search fee within 31 months from the filing date or the earliest priority claim to obtain a supplementary European search report.', 'C. Wait for the EPO to conduct a full search automatically.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On receipt of the decision to grant its European patent application EP-1 under Rule 71a(1) EPC the applicant realizes that they have made a significant typographical error in claim 1. \\nWhat action can they take before the EPO to correct the error?\",\n",
      "        \"options\": [\n",
      "            \"A. None\",\n",
      "            \"B. Seek correction under Rule 140 EPC\",\n",
      "            \"C. Seek correction under Rule 139 EPC\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicant Korhonen is a Finnish national resident in Finland. He filed a European patent application in Finnish and provided an English translation in time. In response to the extended European search report (EESR), Korhonen wishes to file amended claims t ogether with a request for examination. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Korhonen must file the amended claims in Finnish and must then  provide a translation into English, in time\",\n",
      "            \"B. Korhonen is allowed to file the amended claims in Finnish if he then provides a\",\n",
      "            \"translation into any official language of the EPO, in time C. Korhonen is allowed to file the amended claims in Finnish if he then provides a translation into English, in time\",\n",
      "            \"D. Korhonen is not allowed to file the amended claims in Finnish\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?\",\n",
      "        \"options\": [\n",
      "            \"A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.\",\n",
      "            \"B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.\",\n",
      "            \"C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.\",\n",
      "            \"D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 2: {'question': 'If a patent proprietor receives an interlocutory decision to maintain their European patent in amended form, which of the following actions must they take within three months?', 'options': ['A. File translations of any amended claims in all official languages of the EPO other than the language of the proceedings.', 'B. Pay the fee for publishing a new specification of the European patent.', 'C. Provide a formally compliant version of amended text passages if based on documents not complying with Rule 50(1).', 'D. None of the above.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On receipt of the decision to grant its European patent application EP-1 under Rule 71a(1) EPC the applicant realizes that they have made a significant typographical error in claim 1. \\nWhat action can they take before the EPO to correct the error?\",\n",
      "        \"options\": [\n",
      "            \"A. None\",\n",
      "            \"B. Seek correction under Rule 140 EPC\",\n",
      "            \"C. Seek correction under Rule 139 EPC\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"It is permitted to file observations under Article 115 EPC in respect of a patent undergoing limitation proceedings. However, there is no provision under Article 105b EPC or Rule 95 EPC for examination as to patentability, \\nand Article 115 EPC specifically refers to observations concerning patentability. \\nIs there any reason why a third party might nevertheless file observations under Article 115 EPC in respect of a patent undergoing limitation proceedings?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, the examining division may be persuaded to consider patentability as part of the limitation proceedings.\",\n",
      "            \"B. Yes, patentability can be considered in the broader sense as including issues relating to Articles 84 and 123(2) EPC.\",\n",
      "            \"C. No, there is no point in filing observations on patentability because they will not be taken into consideration.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application EP-A is refused in a decision dated 1 June 2023. Today is 15 July 2023. Is it still possible to file a divisional application from EP-A?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes.\",\n",
      "            \"B. No.\",\n",
      "            \"C. Only if the decision to refuse the application is appealed.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 3: {'question': 'According to Article 115 EPC, which of the following statements about third-party observations is true?', 'options': ['A. Third parties must pay a fee to present their observations.', 'B. Third parties can present observations in any language they choose.', 'C. Third parties are considered as parties to the proceedings when presenting observations.', \"D. Third parties' observations must be filed in an official language of the EPO.\"]}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 10 October 2021, European patent attorney X filed European patent application EP -A with the EPO on the applicant's behalf. Application EP -A was published on 12 April 2023, together  with the extended European search report. On 6  October 2023, the applicant contacts a new European patent attorney  Y to replace X as representative and issues Y with its instructions to reply to the extended European search report. The applicant did not inform X that he would be replaced.  What are the steps necessary to validly appoint representative Y and to avoid any loss of rights for European patent application EP -A?\",\n",
      "        \"options\": [\n",
      "            \"A. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 12 October 2023 at the latest and files in good time an authorisation signed by the applicant .\",\n",
      "            \"B. New representative Y requests a change of representative and files a response to the extended European search report with  the EPO by 12 October 2023 at the latest .\",\n",
      "            \"C. New representative Y requests a change of representative and files a response to the extended European search report with the EPO by 23 October 2023 at the latest.\",\n",
      "            \"D. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 23 October 2023 at the latest and files in good time an authorisation signed by the applicant .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"International patent application PCT-1 is filed on 16 June 2019 without any claim to priority. Steps are taken to enter the EPO regional phase on 26 December 2021. When should the renewal fee in respect of the third year be paid (without surcharge)?\",\n",
      "        \"options\": [\n",
      "            \"A. 30 June 2021\",\n",
      "            \"B. 26 December 2021\",\n",
      "            \"C. 2 January 2022\",\n",
      "            \"D. 17 January 2022\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Most fees for European patent applications cannot be paid before their due date. One exception is renewal fees, which can always be paid up to:\",\n",
      "        \"options\": [\n",
      "            \"A. Three months before the due date.\",\n",
      "            \"B. Six months before the due date.\",\n",
      "            \"C. One year before the due date.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 4: {'question': 'For a European patent application EP-1, which was filed on 5 February 2023, what are the deadlines for paying the filing and search fees if the application falls under type (i) or (ii)?', 'options': ['A. Filing fee within one month of filing, no specific deadline for the search fee.', 'B. Both filing and search fees within one month of filing EP-1.', 'C. Filing fee within one month of filing, search fee within 31 months of filing EP-1.', 'D. Both filing and search fees within 31 months of filing EP-1.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"What is the last point in time for an effective withdrawal of a European patent application?\",\n",
      "        \"options\": [\n",
      "            \"4 A.  Date of receipt of the communication under Rule 71(3) EPC\",\n",
      "            \"B.  The latest of the date of payment of the fee for grant and publishing and the date of filing of the translations of the claims in the two other official languages of the EPO\",\n",
      "            \"C.  Date of publication of the mention of the grant in the European Patent Bulletin\",\n",
      "            \"D.  One day before the date of publication of the mention of the grant in the European Patent Bulletin\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A French patent application FP2, including claim 1 related to subject-matter A and claim 2 related to A+B, is filed validly claiming priority from an earlier French patent application FP1 related to subject-matter A and filed ten months earlier.\\nFP1 is still pending. No relevant prior art has been discovered regarding subject-matter A or A+B. Ten months after the filing of FP2, the applicant instructs you to file a European patent application EP1 identical to and claiming priority from FP2 and if possible from FP1. They also ask about the likely outcome of the EP1. What do you tell them, based on our current knowledge of the situation?\",\n",
      "        \"options\": [\n",
      "            \"A. Both priority claims are valid and EP1 may be granted with both claims 1 and 2.\",\n",
      "            \"B. EP1 cannot validly claim priority from FP1 but the priority from FP2 is valid and EP1 may be granted with both claims 1 and 2.\",\n",
      "            \"C. EP1 cannot validly claim priority from FP1, which becomes prior art for subject-matter A. Claim 1 will not be granted in EP1.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"European patent EP-B is granted with a claim directed to a method of operating a heart pacemaker in dependence upon the required cardiac output while a person is exercising, the pacemaker including a pressure sensing means mounted on a pacing lead and adapted to be implanted in a heart and used to sense the right ventricular systolic pressure, which pressure is used to control the pacer rate. Is it permissible in opposition or opposition appeal proceedings to amend the claim to be directed to a heart pacemaker in order to address problems relating to Article 53(c) EPC?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, a change in claim category is permitted.\",\n",
      "            \"B. No, a change in claim category would contravene Article 123(3) EPC.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 5: {'question': 'Given the European patent application EP1, which claims priority from FP2 for subject-matter A+B but not from FP1, and considering that FP1 has been published 18 months after its filing, what is the status of claim 1 in EP1 related to subject-matter A, assuming no other relevant prior art?', 'options': ['A. Claim 1 will be granted as it benefits from a valid priority claim.', 'B. Claim 1 will not be granted due to lack of a valid priority claim and FP1 being prior art for subject-matter A.', 'C. The status of claim 1 cannot be determined without further information.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"European patent application EP -X was filed on 1  October 2020, claiming the priority of a Belgian application filed on 16 October 2019. The mention of the grant of European patent EP -X was published on 2  October 2024. The proprietor filed a request for unitary effect and was informed by communication dated 10  October 2024, that unitary effect had been registered for EP -X-C0 on the same date. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. A renewal fee still has to be paid by 31 October 2024 in respect of the 5th year for EP -X\",\n",
      "            \"B. A renewal fee is due on 31 October 2024 in respect of the 5th year for EP -X-C0\",\n",
      "            \"C. A renewal fee is due on 31 October 2024 in respect of the 6th year for EP -X-C0\",\n",
      "            \"D. No renewal fee has to be paid on 31 October 2024\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You are monitoring the progress of an international application and on reviewing the details of the international search report you realize that you know of relevant prior art that has not been cited in the search report, but which is likely to be novelty-destroying in respect of at least some of the claims. \\nYou believe that the international application will enter the national or regional phase in a significant number of countries or regions and it would therefore be time-consuming and costly to file separate observations in respect of each of \\nthe national or regional applications. What can you do?\",\n",
      "        \"options\": [\n",
      "            \"A. File observations online using ePCT.\",\n",
      "            \"B. Send a letter with your observations to the receiving office or the International Bureau.\",\n",
      "            \"C. File observations by letter.\",\n",
      "            \"D. It is not possible to file observations on international applications.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 6: {'question': 'If a divisional application of second or subsequent generations is filed, what additional fee must be paid according to the guidelines?', 'options': ['A. The filing fee and search fee for the divisional application must be paid within one month of filing the European patent application.', 'B. The additional fee due for any pages in excess of 35 should be paid as specified under A-III, 13.2.', 'C. No additional fees are required for divisional applications beyond the initial filing and search fees.', 'D. The designation fee(s) must be paid within six months of the date on which the European Patent Bulletin mentions the publication of the European search report.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The applicant for European patent application EP-1 has granted an exclusive license under the application. The exclusive licensee wishes to make its rights known by recording the license in the European Patent Register. \\nIs it possible to record the exclusive license?\",\n",
      "        \"options\": [\n",
      "            \"A. No, exclusive licenses cannot be recorded in the European Patent Register.\",\n",
      "            \"B. Yes, exclusive licenses can be recorded in the European Patent Register at the joint request of both the applicant and the licensee.\",\n",
      "            \"C. Yes, exclusive licenses can be recorded in the European Patent Register, but only by the applicant.\",\n",
      "            \"D. Yes, exclusive licences can be recorded in the European Patent Register by either the applicant or the licensee.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application EP-A is refused in a decision dated 1 June 2023. Today is 15 July 2023. Is it still possible to file a divisional application from EP-A?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes.\",\n",
      "            \"B. No.\",\n",
      "            \"C. Only if the decision to refuse the application is appealed.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 7: {'question': 'If a licensee wishes to record an exclusive license under a European patent application in the European Patent Register, which of the following conditions must be met according to EPC Rule 24(a)?', 'options': [\"A. Only the licensee's request is necessary.\", \"B. The applicant's and the licensee's joint request is required.\", \"C. Only the applicant's request is necessary.\", 'D. No request is needed as long as the license is exclusive.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Where an assumed infringer intervenes in opposition appeal proceedings, which of the following fees are payable?\",\n",
      "        \"options\": [\n",
      "            \"A. The opposition fee.\",\n",
      "            \"B. The appeal fee.\",\n",
      "            \"C. The opposition fee and the appeal fee.\",\n",
      "            \"D. The assumed infringer must pay the opposition fee and may choose whether to pay the appeal fee.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In response to an opposition, the patentee introduces the features of claim 12 as granted into claim 1. Claim 12 was dependent on claim 1 and is phrased as a result to be achieved. The opponent argues that the amendment introduces a lack of clarity. Will the opposition division agree with the opponent?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes. A claim feature may not be phrased as a result to be achieved.\",\n",
      "            \"B. Perhaps. It depends on whether or not the feature phrased as a result to be achieved is considered to be clear.\",\n",
      "            \"C. No. Since the feature was already in the claims set the amendment does not introduce a lack of clarity.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .\",\n",
      "            \"B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .\",\n",
      "            \"C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .\",\n",
      "            \"D. Ms Smith can only be deleted as inventor with her consent .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 8: {'question': 'According to the guidelines, which of the following amendments is admissible during opposition proceedings without invoking actual grounds for opposition?', 'options': ['A. Adding new claims that improve the disclosure in the patent specification.', 'B. Deleting an independent claim with its dependent claims but not amending other parts of the patent.', 'C. Replacing one independent claim as granted by multiple independent claims each directed to a specific embodiment covered by the independent claim as granted, if such replacement is occasioned by a ground for opposition.', 'D. Simply tidying up and improving the disclosure in the patent specification.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A communication pursuant to Article 94(3) EPC is dated 7 December 2022. In the communication a time limit of four months is set for replying to objections raised by the examining division.  Which of the following statements is not  correct?\",\n",
      "        \"options\": [\n",
      "            \"A.  The communication is deemed to be delivered on 17 December 2022\",\n",
      "            \"B. The time limit for replying to the communication expires on 17 April 2023\",\n",
      "            \"C.  Further processing for replying to the communication can be validly requested on 19 June 2023 at the latest\",\n",
      "            \"D.  An extension of the time limit for filing the reply can be validly requested on 14 April 2023\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You filed a European patent application which discloses a new amino acid sequence. This sequence is however only used in a single example and is not part of the claims. No sequence listing was filed.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. If you are invited by the EPO to file a sequence listing, you need to file it and pay a late furnishing fee to the EPO\",\n",
      "            \"B. If you are invited by the EPO to file a sequence listing and do not react to this invitation in due time, the application is deemed to be withdrawn\",\n",
      "            \"C. If you are invited by the EPO to file a sequence listing, you need to file it in PDF format\",\n",
      "            \"D. You do not need to file any sequence listing because the amino acid sequence is not claimed\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicants may request processing of their international application under PCT Direct by filing a letter (\\\"PCT Direct letter\\\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing\",\n",
      "            \"B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0\",\n",
      "            \"C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0\",\n",
      "            \"D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 9: {'question': 'An applicant files a European patent application disclosing nucleotide sequences without providing a sequence listing as required by Rule 30(1) EPC. According to Case Law II, C.7.5 and the Guidelines for Examination in the EPO, what must the applicant do after receiving an invitation from the EPO?', 'options': ['A. The application is automatically withdrawn if no response is given within the time limit', 'B. File a sequence listing and pay any applicable late furnishing fee within the set time limit', 'C. Only provide a written explanation why a sequence listing is not necessary', 'D. Wait for the EPO to incorporate the sequences into the application']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"You are monitoring the progress of an international application and on reviewing the details of the international search report you realize that you know of relevant prior art that has not been cited in the search report, but which is likely to be novelty-destroying in respect of at least some of the claims. \\nYou believe that the international application will enter the national or regional phase in a significant number of countries or regions and it would therefore be time-consuming and costly to file separate observations in respect of each of \\nthe national or regional applications. What can you do?\",\n",
      "        \"options\": [\n",
      "            \"A. File observations online using ePCT.\",\n",
      "            \"B. Send a letter with your observations to the receiving office or the International Bureau.\",\n",
      "            \"C. File observations by letter.\",\n",
      "            \"D. It is not possible to file observations on international applications.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Is the following statement true or false?\\n\\nWhen proceedings for grant of a European patent application are stayed following the institution of entitlement proceedings, renewal fees which fall due during the period of stay can be paid up to the date of resumption of the proceedings for grant.\",\n",
      "        \"options\": [\n",
      "            \"A. True\",\n",
      "            \"B. False\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicants may request processing of their international application under PCT Direct by filing a letter (\\\"PCT Direct letter\\\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing\",\n",
      "            \"B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0\",\n",
      "            \"C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0\",\n",
      "            \"D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 10: {'question': 'If an applicant wishes to enter their Euro-PCT application into the European phase, which of the following steps must they take within two months from the international filing date or the date of designation/election as receiving Office?', 'options': ['A. Request the International Bureau to send copies of documents in the files promptly to the EPO and pay the filing fee under Rule 159(1)(c) PCT.', 'B. File a letter with informal comments aimed at overcoming objections raised in the search opinion established by the EPO for the priority application using PCT Direct.', 'C. Send a letter with your observations to the receiving office or the International Bureau regarding relevant prior art not cited in the international search report.', 'D. Pay the renewal fees which fall due during the period of stay following the institution of entitlement proceedings.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Company X wishes to file an opposition to European patent EP-B, which was recently granted to its main competitor, company Y. To avoid retaliation, company X would prefer not to file the opposition in its own name. It therefore asks a European patent attorney to file the opposition in her name. Will the EPO accept this?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\",\n",
      "            \"C. Only if the patentee does not object\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application EP-A is refused in a decision dated 1 June 2023. Today is 15 July 2023. Is it still possible to file a divisional application from EP-A?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes.\",\n",
      "            \"B. No.\",\n",
      "            \"C. Only if the decision to refuse the application is appealed.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 11: {'question': 'A European patent application EP-A was filed on 5 May 2023, and a divisional application from this parent application was filed on 15 November 2023. The search report for the divisional application was published in the European Patent Bulletin on 1 February 2024. By when must the designation fee(s) be paid to avoid losing rights according to Rule 36(3) and Rule 36(4) of the EPC?', 'options': ['A. Within six months from 5 May 2023.', 'B. Within six months from 15 November 2023.', 'C. Within six months from 1 February 2024.', 'D. The designation fee is not applicable for divisional applications.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Your client filed an international patent application in 2021. In which of the following countries can they (directly) enter the national phase?\",\n",
      "        \"options\": [\n",
      "            \"A. Lithuania\",\n",
      "            \"B. France\",\n",
      "            \"C. Italy\",\n",
      "            \"D. None of the above\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Company X wishes to file an opposition to European patent EP-B, which was recently granted to its main competitor, company Y. To avoid retaliation, company X would prefer not to file the opposition in its own name. It therefore asks a European patent attorney to file the opposition in her name. Will the EPO accept this?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\",\n",
      "            \"C. Only if the patentee does not object\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 12: {'question': 'According to Article 26 PCT, how long after entry into the regional phase must the applicant be given the opportunity to correct an international application before the EPO can reject it?', 'options': ['A. Before the application is entered into the regional phase', 'B. Within 16 months from the priority date', 'C. After the application has been rejected for non-compliance with PCT requirements', 'D. At any time during the international phase']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The applicant for European patent application EP-1 has granted an exclusive license under the application. The exclusive licensee wishes to make its rights known by recording the license in the European Patent Register. \\nIs it possible to record the exclusive license?\",\n",
      "        \"options\": [\n",
      "            \"A. No, exclusive licenses cannot be recorded in the European Patent Register.\",\n",
      "            \"B. Yes, exclusive licenses can be recorded in the European Patent Register at the joint request of both the applicant and the licensee.\",\n",
      "            \"C. Yes, exclusive licenses can be recorded in the European Patent Register, but only by the applicant.\",\n",
      "            \"D. Yes, exclusive licences can be recorded in the European Patent Register by either the applicant or the licensee.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"European patent application EP -X was filed on 1  October 2020, claiming the priority of a Belgian application filed on 16 October 2019. The mention of the grant of European patent EP -X was published on 2  October 2024. The proprietor filed a request for unitary effect and was informed by communication dated 10  October 2024, that unitary effect had been registered for EP -X-C0 on the same date. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. A renewal fee still has to be paid by 31 October 2024 in respect of the 5th year for EP -X\",\n",
      "            \"B. A renewal fee is due on 31 October 2024 in respect of the 5th year for EP -X-C0\",\n",
      "            \"C. A renewal fee is due on 31 October 2024 in respect of the 6th year for EP -X-C0\",\n",
      "            \"D. No renewal fee has to be paid on 31 October 2024\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 27 October 2022 you filed European patent application EP -A claiming priority from FR -A filed on 29 October 2021. Your intention was that both applications would have the same content. On 3 November 2022, however, you noticed that page 3 of the description and claims 7 -12 are missing in EP -A. The fees have not been paid yet.  Which statement is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. If the EPO notes that page 3 of the description and claims 7 -12 are missing, it will invite you to file these missing parts within a time limit of two months\",\n",
      "            \"B. You may of your own volition file page 3 of the description at any time up to 2 January 2023 without the application being re -dated\",\n",
      "            \"C. If the subject -matter of claims 7 -12 is also present in the description, you may add claims 7 -12 at any time\",\n",
      "            \"D. The best solution is to withdraw EP -A and refile it, claiming priority from FR -A\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 13: {'question': 'If an exclusive license has been granted under a European patent application, can it be recorded in the European Patent Register?', 'options': ['A. No, because exclusive licenses cannot be registered once the patent is granted.', 'B. Yes, but only if both the applicant and the licensee request it before the grant of the patent.', 'C. Yes, but only after the patent has been granted by a request to the national offices.', 'D. Yes, as long as both the applicant and the licensee so request.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"European patent application EP-1 is filed on 10 December 2020, but the inventor is not designated. The designation of the inventor is filed on 25 February 2022. Will the application be refused?\",\n",
      "        \"options\": [\n",
      "            \"A. No. The designation of the inventor was filed in due time.\",\n",
      "            \"B. Yes. The designation of the inventor was not filed in due time.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You receive an email on 30 October 2023 from a United States patent attorney asking you to enter the regional phase before the EPO in respect of international application PCT-1. The international application was filed at the United States Patent and Trademark Office on 14 March 2022 claiming priority from United States patent application US-1 filed 14 March 2021. Can you effect entry into the EPO regional phase?\",\n",
      "        \"options\": [\n",
      "            \"A. No, the 31-month period has expired.\",\n",
      "            \"B. Yes, provided the priority of US-1 is withdrawn.\",\n",
      "            \"C. Yes, provided use is made of the provisions for further processing.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Antonia, an applicant living in Argentina and having Argentinian nationality, intends to file a European patent application EP -A and an international patent application PCT- A.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Antonia can validly file PCT- A with the International Bureau of WIPO\",\n",
      "            \"B. Antonia can validly file PCT -A with the EPO\",\n",
      "            \"C. Antonia can validly file EP -A with the EPO\",\n",
      "            \"D. None of the above\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 14: {'question': \"If an inventor has not been named in the international application by the 31-month time limit from the filing date, what action must the applicant take within two months to comply with the EPO's requirements?\", 'options': ['A. Pay the designation fee.', 'B. File a notice correcting the priority claim.', 'C. Submit a declaration of inventorship.', 'D. Request further processing according to Rule 135.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Which of the following statements about filing third- party observations is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The person that filed third- party observations will be a party to the proceedings before the EPO, and the applicant is obliged to respond to third- party observations\",\n",
      "            \"B. Third -party observations must be filed in writing and may not be filed anonymously\",\n",
      "            \"C. Third -party observations are considered by the examining division only if they include a statement of the grounds on which they are based, and an official fee is paid\",\n",
      "            \"D. Third -party observations can be filed after the publication of a European patent application and must be filed in an official language of the EPO\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Today is 28 March 2023. Following national proceedings for entitlement of European patent application EP-1, the successful party has elected to file a new application under Article 61(1)(b) EPC. EP-1 was filed on 12 April 2019 and the new application, EP-2, was filed on 10 January 2023.  What is the last day for paying the first renewal fee that is payable for the new application, without surcharge (i.e. not including the fees for past renewals)?\",\n",
      "        \"options\": [\n",
      "            \"A. 31 January 2023.\",\n",
      "            \"B. 2 May 2023.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You receive an email on 30 October 2023 from a United States patent attorney asking you to enter the regional phase before the EPO in respect of international application PCT-1. The international application was filed at the United States Patent and Trademark Office on 14 March 2022 claiming priority from United States patent application US-1 filed 14 March 2021. Can you effect entry into the EPO regional phase?\",\n",
      "        \"options\": [\n",
      "            \"A. No, the 31-month period has expired.\",\n",
      "            \"B. Yes, provided the priority of US-1 is withdrawn.\",\n",
      "            \"C. Yes, provided use is made of the provisions for further processing.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 15: {'question': 'According to the guidelines, which of the following statements about third-party observations is correct?', 'options': ['A. Third-party observations must be filed by an official language of the EPO and can only be made available for file inspection if proceedings become pending again.', 'B. Any third party may present, in written form, observations concerning the patentability of the invention to which the application or patent relates without any fees or deadlines.', 'C. The examining division will make every effort to issue a next office action within three months of receipt of all third-party observations regardless of their content and mode of filing.', 'D. Third-party observations are not considered by the EPO unless they have been filed non-anonymously, substantiated, and the applicant has replied.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Mr Linguist filed a European patent application in Dutch and used English as language of the proceedings. When requesting unitary effect on 10 October 2024, Mr Linguist must provide a translation of the specification. Mr Linguist would like to obtain immediate registration of the unitary effect. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Mr Linguist must provide a translation of the specification into Dutch\",\n",
      "            \"B. Mr Linguist must provide a translation of the specification into an official language of any of the 18 states to which the unitary effect extends\",\n",
      "            \"C. Mr Linguist must provide a translation of the specification into an official language of any of the 24 states that have signed the UPCA\",\n",
      "            \"D. Mr Linguist may provide a translation of the specification into Spanish\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The applicant received a communication pursuant to Article 90(3) EPC and Rule  60 EPC, requesting them to file a designation of inventor but missed the time limit for filing a response. After expiry of the time limit, the Receiving Section issued a decision to refuse the European patent application, dated 10  October 2024. What can the applicant do to remedy the situation?\",\n",
      "        \"options\": [\n",
      "            \"A. File a notice of appeal against the decision within four months of notification of the decision\",\n",
      "            \"B. File a request for further processing within two months of notification of the decision\",\n",
      "            \"C. File, within two months of notification of the decision, a request for re-establishment of rights in respect of the time limit for filing the designation of inventor\",\n",
      "            \"D. A, B and C are correct\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You are monitoring the progress of an international application and on reviewing the details of the international search report you realize that you know of relevant prior art that has not been cited in the search report, but which is likely to be novelty-destroying in respect of at least some of the claims. \\nYou believe that the international application will enter the national or regional phase in a significant number of countries or regions and it would therefore be time-consuming and costly to file separate observations in respect of each of \\nthe national or regional applications. What can you do?\",\n",
      "        \"options\": [\n",
      "            \"A. File observations online using ePCT.\",\n",
      "            \"B. Send a letter with your observations to the receiving office or the International Bureau.\",\n",
      "            \"C. File observations by letter.\",\n",
      "            \"D. It is not possible to file observations on international applications.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 16: {'question': 'A European patent application was filed in 2015 with documents in both English and Spanish, but only the English version of the description was provided initially. The applicant has now submitted a Spanish translation of the description to comply with Rule 6(1). According to the Guidelines for Examination in the EPO, what is the next step regarding the Spanish translation?', 'options': ['A. No further action is required as Rule 6(1) only applies to documents filed within one month of filing.', 'B. The Spanish translation must be filed simultaneously with the request for examination and will be deemed to have been part of the application from the date of filing.', 'C. The Spanish translation should be submitted along with a declaration stating that it is an accurate translation of the English version, but no specific time requirement is mentioned in Rule 6(1).', 'D. The Receiving Section must approve the simultaneous filing of the Spanish translation before it can be accepted.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"International application PCT-1 claims priority from Korean utility model \\napplication KR-U1. Is a translation of the priority document required on \\nentry into the European regional phase?\",\n",
      "        \"options\": [\n",
      "            \"A. A translation into the language of the proceedings is required within two months of the end of the 31-month period for entering \\nthe EPO regional phase.\",\n",
      "            \"B. A translation into one of the official EPO languages is required within two months of the end of the 31-month period for entering the EPO regional phase.\",\n",
      "            \"C. No translation is required unless the validity of the priority claim is relevant to patentability.\",\n",
      "            \"D. No translation is required if a declaration is submitted that the European patent application is a complete translation of the priority application.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"What is the last point in time for an effective withdrawal of a European patent application?\",\n",
      "        \"options\": [\n",
      "            \"4 A.  Date of receipt of the communication under Rule 71(3) EPC\",\n",
      "            \"B.  The latest of the date of payment of the fee for grant and publishing and the date of filing of the translations of the claims in the two other official languages of the EPO\",\n",
      "            \"C.  Date of publication of the mention of the grant in the European Patent Bulletin\",\n",
      "            \"D.  One day before the date of publication of the mention of the grant in the European Patent Bulletin\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You are informed that one of the inventors named in an international application is incorrect. The application names Mr Y, but the correct inventor is Mrs Z. What should you do?\",\n",
      "        \"options\": [\n",
      "            \"A. Obtain the consent of Mr Y to rectification of the inventor before filing a request at the International Bureau with details of the correct inventor.\",\n",
      "            \"B. File a request for rectification at the International Bureau with details of the correct inventor.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 17: {'question': 'If an international PCT application under Euro-PCT rules enters the European phase, what must be done if the initial international publication was not in an official language of the EPO?', 'options': [\"A. A translation into one of the EPO's official languages must be filed within 31 months of the priority date.\", 'B. No action is required as long as a translation is eventually provided by the applicant.', 'C. The application will automatically be published in an official language upon entering the European phase.', 'D. A declaration that the European patent application is a complete translation can replace the need for a translation.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Is the following statement true or false?\\n\\nWhen proceedings for grant of a European patent application are stayed following the institution of entitlement proceedings, renewal fees which fall due during the period of stay can be paid up to the date of resumption of the proceedings for grant.\",\n",
      "        \"options\": [\n",
      "            \"A. True\",\n",
      "            \"B. False\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The opposition division revoked European patent EP -B1. The patent proprietor filed an appeal  in time . The b oard of appeal forwarded a copy of the appeal to the o pponent/ respondent with a communication dated 1 June 2023 giving it an opportunity to file comments within a period of four  months.  The opponent/respondent files comments today, 12 October 2023. What further action has to be taken ?\",\n",
      "        \"options\": [\n",
      "            \"A. The opponent/ respondent needs  to request an extension of the period for comment.\",\n",
      "            \"B. The opponent/respondent needs to pay a fee for further processing.\",\n",
      "            \"C. The opponent/respondent needs to file a substantiated request for reestablishment of rights and pay the associated fee.\",\n",
      "            \"D. None of the above.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. As no renewal fees have been paid, the application is deemed to be withdrawn .\",\n",
      "            \"B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .\",\n",
      "            \"C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .\",\n",
      "            \"D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 18: {'question': 'If the Enlarged Board of Appeal reopens proceedings before the Board of Appeal, which statement regarding renewal fees for an application already pending is true?', 'options': ['A. A renewal fee that would have fallen due during the period from when the original decision was taken until the reopening date must be paid by the same deadline as if no reopening occurred.', 'B. If a renewal fee was due but not yet past its payment period on the day of the original decision, it can still be paid within six months after the reopening notification without any additional fees.', 'C. Renewal fees for an application that were already due when the original decision was taken can only be paid immediately upon notification of the reopening.', 'D. No renewal fees are required if the application is reopened by the Enlarged Board of Appeal.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"International application PCT-1 was filed by applicant A on 5 January 2020 and the requirements for entry into the European regional phase were completed on 19 July 2022. European patent application EP-1 was filed by applicant B on 19 June 2022 validly claiming priority from Italian patent application IT-1 filed on 20 June 2021. PCT-1, EP-1 and IT-1 all relate to the same invention. What is the prior art effect of PCT-1 on EP-1?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT-1 has no prior art effect on EP-1.\",\n",
      "            \"B. PCT-1 will be part of the state of the art according to Article 54(3) EPC.\",\n",
      "            \"C. PCT-1 will be part of the state of the art according to Article 54(2) EPC.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In response to a Rule 71(3) communication you have filed, on the 2 April 2023, the required translations of the claims and paid the grant fee. Today, the 3 May 2023, you receive the decision to grant, dated 28 April 2023. The decision states that the mention of the grant will be published on the 24 May 2023. What is/was the last day a divisional application may be filed?\",\n",
      "        \"options\": [\n",
      "            \"A. 2 April 2023\",\n",
      "            \"B. 28 April 2023\",\n",
      "            \"C. 8 May 2023\",\n",
      "            \"D. 23 May 2023\",\n",
      "            \"E. 24 May 2023\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Your client filed an international patent application in 2021. In which of the following countries can they (directly) enter the national phase?\",\n",
      "        \"options\": [\n",
      "            \"A. Lithuania\",\n",
      "            \"B. France\",\n",
      "            \"C. Italy\",\n",
      "            \"D. None of the above\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 19: {'question': 'Under Article 153(5) EPC, which condition must be fulfilled for a PCT application to be considered part of the state of the art with respect to a European divisional application?', 'options': ['A. The PCT application must have mentioned all EPC contracting states as being designated.', 'B. The PCT application must have been filed before the European phase entry date.', 'C. The PCT application must be validly claiming priority from an earlier patent application.', 'D. The PCT application must have entered the European phase and met any requirements under Rule 159(1).']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Why might an opposition be filed even if the European patent has been surrendered, or has lapsed, in all the designated contracting states (Rule 75 EPC)?\",\n",
      "        \"options\": [\n",
      "            \"A. In the case of surrender or lapse the rights acquired with the patent remain in existence in the period up to surrender or lapse and claims arising from those rights may subsist after the date of grant.\",\n",
      "            \"B. There is no reason to oppose a patent that has been surrendered or has lapsed.\",\n",
      "            \"C. The effect of surrender or lapse is ex nunc, while the effect of revocation is ex tunc.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The first communication from the examining division concerning a European patent application is unexpectedly negative. The applicant decides not to proceed further with the application. Can the applicant get a refund of fees in this situation?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Today is 28 March 2023. Following national proceedings for entitlement of European patent application EP-1, the successful party has elected to file a new application under Article 61(1)(b) EPC. EP-1 was filed on 12 April 2019 and the new application, EP-2, was filed on 10 January 2023.  What is the last day for paying the first renewal fee that is payable for the new application, without surcharge (i.e. not including the fees for past renewals)?\",\n",
      "        \"options\": [\n",
      "            \"A. 31 January 2023.\",\n",
      "            \"B. 2 May 2023.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 20: {'question': 'Under what circumstances can an opposition be filed even if the European patent has been surrendered or has lapsed for all designated states?', 'options': ['A. If the opposition is filed within two months of receiving notification from the EPO about the surrender or lapse (Rule 84(1) EPC).', 'B. Only if the patent had already lapsed prior to the filing of the opposition, according to Rule 75 EPC.', 'C. An opposition can always be filed regardless of whether the patent has been surrendered or lapsed.', 'D. If the patent proprietor has renounced all rights conferred by the patent with ab initio and universal effect.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A professional representative acts as agent for the following actions:  I.  Withdrawing an international patent application at the European Patent Office as receiving Office  II.  Filing a demand for international preliminary examination for an international patent application at the European Patent Office as International Preliminary Examining Authority   Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A.  For both I and II a power of attorney signed by each applicant is always required\",\n",
      "            \"B.  For I a power of attorney signed by each applicant is always required\",\n",
      "            \"C.  For II a power of attorney signed by each applicant is always required\",\n",
      "            \"D.  For both I and II the requirement to submit a power of attorney signed by each applicant may be waived   3\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A communication pursuant to Rule 71(3) EPC was issued for a European patent application. The applicant fulfilled all the necessary requirements . The related decision to grant a European patent was dispatched based on the text intended for grant transmitted to the applicant with the communication under Rule 71(3) EPC. The mention of the grant of the European patent was published in the European Patent Bulletin. During the preparation of the publication of the patent specification an error occurred in that page 2 of the description was omitted from the published specification of this European patent. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. This error in the published specification of this European patent may never be corrected\",\n",
      "            \"B. This error in the published specification of this European patent may be corrected at any time\",\n",
      "            \"C. This error in the published specification of this  European patent may not be corrected during the opposition period or if opposition proceedings are pending\",\n",
      "            \"D. The error may only be corrected if opposition proceedings are pending\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Why might an opposition be filed even if the European patent has been surrendered, or has lapsed, in all the designated contracting states (Rule 75 EPC)?\",\n",
      "        \"options\": [\n",
      "            \"A. In the case of surrender or lapse the rights acquired with the patent remain in existence in the period up to surrender or lapse and claims arising from those rights may subsist after the date of grant.\",\n",
      "            \"B. There is no reason to oppose a patent that has been surrendered or has lapsed.\",\n",
      "            \"C. The effect of surrender or lapse is ex nunc, while the effect of revocation is ex tunc.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 21: {'question': 'According to the guidelines provided, under which circumstance would a signed authorization from a professional representative not be required?', 'options': ['A. If the employee is acting as an employee of the patent proprietor and identifies themselves as such', \"B. When there has been a change in representation without prior notice that the previous representative's authorisation has terminated\", 'C. If the EPO has doubts about the representatives entitlement to act, regardless of their status', 'D. Whenever a new professional representative files an appeal to the European Patent Office']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The EPO as receiving office issues an invitation to the applicant to remedy certain defects in an international application within a time limit of two months from the date of invitation. The invitation is dated as being mailed on 22 September 2023 and is received by the applicant on 2 October 2023. What is the final date for responding to the invitation?\",\n",
      "        \"options\": [\n",
      "            \"A. 22 November 2023\",\n",
      "            \"B. 27 November 2023\",\n",
      "            \"C. 3 December 2023\",\n",
      "            \"D. 4 December 2023\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Entry into the European phase of an international application can be effected early provided an express request for early processing is made at the time the requirements of Rule 159(1) EPC are complied with. International application PCT-1 was filed 28 months ago with no claim to priority. The application consists of 20 pages, including 16 claims. The international search was carried out by the EPO acting as ISA and the international search report was published with the international application. Which of the following fees must be paid in order to effect early entry into the European phase?\",\n",
      "        \"options\": [\n",
      "            \"A. The filing fee.\",\n",
      "            \"B. The filing fee, the examination fee and the designation fee.\",\n",
      "            \"C. The filing fee, the examination fee, the designation fee and the renewal fee.\",\n",
      "            \"D. The filing fee, the claims fee, the examination fee, the designation fee and the renewal fee.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"International application PCT-1 enters the European regional phase as EP-1 today. Independent claims 1 and 10 of the international application were considered to lack unity in the international phase and a partial search report was drawn up by the EPO as ISA in respect of the invention of claim 1. The applicant wishes to have the opportunity to protect the invention of claim 10 during the EPO regional phase, but wants to keep costs to a minimum, at least at the beginning. What can the applicant do?\",\n",
      "        \"options\": [\n",
      "            \"A. File a divisional application to the invention of independent claim 10 after entry into the EPO regional phase.\",\n",
      "            \"B. Pay an additional search fee in respect of the invention of independent claim 10 within two months of entry into the EPO regional phase.\",\n",
      "            \"C. Pay an additional search fee in respect of the invention of independent claim 10 within two months of notification by the EPO.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 22: {'question': 'Which of the following actions must be taken upon entry into the European phase for an international application filed 30 months ago, where no claim to priority was made, and the application consists of 25 pages including 20 claims, with only a partial search report provided by the EPO as ISA in the international phase?', 'options': ['A. Pay only the filing fee.', 'B. Pay the filing fee, the examination fee, and the designation fee.', 'C. Pay the filing fee, the claims fee, the examination fee, the designation fee, and the partial search report fee.', 'D. Pay the filing fee, the claims fee, the examination fee, the designation fee, and no additional fees.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"In response to a Rule 71(3) communication you have filed, on the 2 April 2023, the required translations of the claims and paid the grant fee. Today, the 3 May 2023, you receive the decision to grant, dated 28 April 2023. The decision states that the mention of the grant will be published on the 24 May 2023. What is/was the last day a divisional application may be filed?\",\n",
      "        \"options\": [\n",
      "            \"A. 2 April 2023\",\n",
      "            \"B. 28 April 2023\",\n",
      "            \"C. 8 May 2023\",\n",
      "            \"D. 23 May 2023\",\n",
      "            \"E. 24 May 2023\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Company C files a European patent application for an invention which has been displayed at an officially recognised international exhibition. The exhibition closes two weeks after the invention was first displayed. Rule 25(d) EPC states that a suitable certificate must be filed within four months of the filing of the European patent application. Three months after filing the application, the applicant approaches the authority responsible for the protection of industrial property at the exhibition and obtains a certificate stating the information required according to Rule 25 EPC. The certificate is filed within the four-month period together with the authenticated identification of the invention. Will the certificate be accepted by the EPO?\",\n",
      "        \"options\": [\n",
      "            \"A. No, the certificate was not issued at the exhibition.\",\n",
      "            \"B. Yes, the certificate was filed within the specified four-month period.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Claim 1 of European patent application EP-1 originally defines a polymer blend XY containing, as a filler, graphite, talc, asbestos or silica. \\nThe European search report identifies prior art disclosing a polymer blend XY containing asbestos. Is it permissible under Article 123(2) EPC to restrict the list of fillers by simply omitting asbestos, i.e., to claim a polymer blend XY containing, as a filler, graphite, talc or silica?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 23: {'question': 'According to Rule 25 EPC, which of the following statements must be true for an applicant who has displayed their invention at an official or officially recognised international exhibition?', 'options': ['A. The certificate must be issued by any authority after four months from the exhibition.', 'B. The certificate should state that the invention was not exhibited and can be filed at any time.', 'C. The certificate needs to be accompanied by an identification of the invention, duly authenticated by the authority responsible for the protection of industrial property at the exhibition.', 'D. The certificate is only required if the invention has been displayed in a national exhibition.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The EPO as receiving office issues an invitation to the applicant to remedy certain defects in an international application within a time limit of two months from the date of invitation. The invitation is dated as being mailed on 22 September 2023 and is received by the applicant on 2 October 2023. What is the final date for responding to the invitation?\",\n",
      "        \"options\": [\n",
      "            \"A. 22 November 2023\",\n",
      "            \"B. 27 November 2023\",\n",
      "            \"C. 3 December 2023\",\n",
      "            \"D. 4 December 2023\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In the case of applicants entitled to a fee reduction under Rule 6(3) EPC, does the fee reduction include the additional fee for pages in excess of 35?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A British company buys a French firm with an IP portfolio which includes an international application that claims priority of a British national application. The international application is in French. The British company wants to pursue the invention as a European patent application. However, they would prefer that the language of the European proceedings be English.   Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A.  Upon entry into the European phase before the EPO, the applicant can file a translation into English and English will become the language of the proceedings\",\n",
      "            \"B.  The applicant can enter the European phase with the application in French and then validly file a European divisional application in English\",\n",
      "            \"C.  The applicant can select English as the language of the proceedings in the request form for entry into the European phase (EPO Form 1200) and English will become the language of the proceedings\",\n",
      "            \"D.  None of  the above\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 24: {'question': 'If an applicant files a European patent application in Japanese, what must be done according to the Guidelines for Examination in the EPO?', 'options': ['A. The application can remain in Japanese without any further action.', 'B. A translation into English, French or German must be filed within two months of filing.', 'C. The applicant must file a request form in Japanese with no translation required.', 'D. No action is needed as long as the application includes claims.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The applicant received a communication pursuant to Article 90(3) EPC and Rule  60 EPC, requesting them to file a designation of inventor but missed the time limit for filing a response. After expiry of the time limit, the Receiving Section issued a decision to refuse the European patent application, dated 10  October 2024. What can the applicant do to remedy the situation?\",\n",
      "        \"options\": [\n",
      "            \"A. File a notice of appeal against the decision within four months of notification of the decision\",\n",
      "            \"B. File a request for further processing within two months of notification of the decision\",\n",
      "            \"C. File, within two months of notification of the decision, a request for re-establishment of rights in respect of the time limit for filing the designation of inventor\",\n",
      "            \"D. A, B and C are correct\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Your Client, A Inc, is a sub-licensee under European patent application EP-1. Can the sub-licence be recorded in the European Patent Register?\",\n",
      "        \"options\": [\n",
      "            \"A. No, it is not possible to record sub-licences in the European Patent Register.\",\n",
      "            \"B. Yes, any sub-licence can be recorded in the European Patent Register.\",\n",
      "            \"C. Yes, provided the licensee granting the sub-licence has recorded its licence in the European Patent Register.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 25: {'question': \"If an inventor's name, country of residence, or applicant's signature is missing from the European patent application, within what time frame must the deficiency be remedied to avoid refusal of the application?\", 'options': ['A. Within 2 months from the issue of the communication under Rule 163', 'B. Within 6 months from the filing date of the application', 'C. Within 18 months from the earliest priority date', 'D. No time limit, as long as the deficiency is corrected before grant']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"During proceedings before the opposition division there is a valid intervention under Article 105 EPC. At the conclusion of the proceedings the patent is maintained in amended form. Is the assumed infringer permitted to appeal?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?\",\n",
      "        \"options\": [\n",
      "            \"A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO\",\n",
      "            \"B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application\",\n",
      "            \"C. File an electronic certified copy of the Luxembourg patent application with the EPO\",\n",
      "            \"D. File a certified copy of the Luxembourg patent application with the International Bureau\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 26: {'question': 'If an applicant realizes they have filed incorrect application documents on the filing date, under which rule can they file corrected documents without changing the filing date?', 'options': ['A. Rule 56a(2)', 'B. Rule 40', 'C. Rule 53(1)', 'D. Rule 55']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Last week Greta validly filed the international patent application PCT -G with the German Patent and Trade mark Office ( DPMA ) and appointed Hassan to represent her. Hassan is entitled to act before the DPMA  but he is not a European patent attorney. Greta and Hassan are resident in Germany.  Which of the following statements is not correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Hassan can represent Greta before the EPO acting as the International Searching Authority for PCT -G.\",\n",
      "            \"B. In order for Hassan to be able to act before the EPO acting as the International Searching Authority , he needs to submit a power of attorney signed by Greta.\",\n",
      "            \"C. According to the provisions of the PCT, it is mandatory that the d emand for international preliminary examination is signed by Greta or Hassan.\",\n",
      "            \"D. According to the provisions of the PCT, an international application can only be withdrawn by the applicant or an agent appointed by a power of attorney.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"European patent EP-B is granted with a claim directed to a method of operating a heart pacemaker in dependence upon the required cardiac output while a person is exercising, the pacemaker including a pressure sensing means mounted on a pacing lead and adapted to be implanted in a heart and used to sense the right ventricular systolic pressure, which pressure is used to control the pacer rate. Is it permissible in opposition or opposition appeal proceedings to amend the claim to be directed to a heart pacemaker in order to address problems relating to Article 53(c) EPC?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, a change in claim category is permitted.\",\n",
      "            \"B. No, a change in claim category would contravene Article 123(3) EPC.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 27: {'question': 'During opposition proceedings against European patent EP, Firm A requested maintenance of the patent as granted. Firm B argued that claims 1-5 were invalid under Article 52(1) EPC due to being directed to a computer program. At the end of the opposition proceedings, which of the following is true if the opposition division upholds the patent?', 'options': ['A. Firm A can file an appeal against the decision only within two months from the date of the decision.', 'B. Firm B can file an appeal against the decision only within three months from the date of the decision.', 'C. Neither Firm A nor Firm B is entitled to file an appeal since the opposition division upheld the patent as granted.', 'D. Both Firm A and Firm B are entitled to file an appeal against the decision, but only within one month from the date of the decision.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"What is the last point in time for an effective withdrawal of a European patent application?\",\n",
      "        \"options\": [\n",
      "            \"4 A.  Date of receipt of the communication under Rule 71(3) EPC\",\n",
      "            \"B.  The latest of the date of payment of the fee for grant and publishing and the date of filing of the translations of the claims in the two other official languages of the EPO\",\n",
      "            \"C.  Date of publication of the mention of the grant in the European Patent Bulletin\",\n",
      "            \"D.  One day before the date of publication of the mention of the grant in the European Patent Bulletin\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Your Client, A Inc, is a sub-licensee under European patent application EP-1. Can the sub-licence be recorded in the European Patent Register?\",\n",
      "        \"options\": [\n",
      "            \"A. No, it is not possible to record sub-licences in the European Patent Register.\",\n",
      "            \"B. Yes, any sub-licence can be recorded in the European Patent Register.\",\n",
      "            \"C. Yes, provided the licensee granting the sub-licence has recorded its licence in the European Patent Register.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Company M, which has  its principal place of business in Tijuana, Mexico, validly filed an international patent application PCT -M with the Mexican Institute of Industrial Property. The application was filed in Spanish. A few days later, the applicant files an English translati on of the application.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant can choose the EPO as ISA and the USPTO as IPEA.\",\n",
      "            \"B. The applicant can choose the USPTO as ISA and the EPO as IPEA.\",\n",
      "            \"C. The applicant can choose the Austrian Patent Offic e as ISA and the\",\n",
      "            \"EPO as IPEA.\",\n",
      "            \"D. The applicant can choose the EPO as ISA and the Intellectual Property\",\n",
      "            \"Office of Singapore as IPEA.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 28: {'question': 'If Company X holds a licence recorded in the European Patent Register, which of the following actions can it take with respect to granting sub-licences?', 'options': ['A. It can grant sub-licences without any conditions.', 'B. It cannot grant sub-licences as only the original licensee can do so.', 'C. It can grant sub-licences, but such grants must be recorded in the European Patent Register if they are granted by a licensee whose licence is already recorded there.', 'D. It can grant sub-licences, and these will automatically be recorded in the European Patent Register regardless of the original licence.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The applicant received a communication pursuant to Article 90(3) EPC and Rule  60 EPC, requesting them to file a designation of inventor but missed the time limit for filing a response. After expiry of the time limit, the Receiving Section issued a decision to refuse the European patent application, dated 10  October 2024. What can the applicant do to remedy the situation?\",\n",
      "        \"options\": [\n",
      "            \"A. File a notice of appeal against the decision within four months of notification of the decision\",\n",
      "            \"B. File a request for further processing within two months of notification of the decision\",\n",
      "            \"C. File, within two months of notification of the decision, a request for re-establishment of rights in respect of the time limit for filing the designation of inventor\",\n",
      "            \"D. A, B and C are correct\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Two applicants resident in Germany jointly file an international application with the EPO as receiving office. No agent or common representative is appointed. Following receipt of the international search report, the applicants both agree that the international application should be withdrawn, so the first-named applicant on Form PCT/RO/101 sends a letter, signed by him, to the EPO as receiving office specifically withdrawing the international application. Will the application be withdrawn?\",\n",
      "        \"options\": [\n",
      "            \"A. No\",\n",
      "            \"B. Yes\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 27 October 2022 you filed European patent application EP -A claiming priority from FR -A filed on 29 October 2021. Your intention was that both applications would have the same content. On 3 November 2022, however, you noticed that page 3 of the description and claims 7 -12 are missing in EP -A. The fees have not been paid yet.  Which statement is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. If the EPO notes that page 3 of the description and claims 7 -12 are missing, it will invite you to file these missing parts within a time limit of two months\",\n",
      "            \"B. You may of your own volition file page 3 of the description at any time up to 2 January 2023 without the application being re -dated\",\n",
      "            \"C. If the subject -matter of claims 7 -12 is also present in the description, you may add claims 7 -12 at any time\",\n",
      "            \"D. The best solution is to withdraw EP -A and refile it, claiming priority from FR -A\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 29: {'question': \"An international application was filed with the EPO as receiving office on 15 March 2023, claiming priority from an earlier filing dated 16 March 2022. The inventor's name and details were not included in the PCT request. After 31 months from the priority date, the applicant realizes this error and wants to correct it. What action should the applicant take?\", 'options': ['A. File a notice of appeal against the potential refusal decision', 'B. Submit a request for further processing within two months of realizing the omission', \"C. Immediately file the missing inventor's details directly with the EPO without any formal request\", 'D. B and C are correct']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Applicants may request processing of their international application under PCT Direct by filing a letter (\\\"PCT Direct letter\\\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing\",\n",
      "            \"B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0\",\n",
      "            \"C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0\",\n",
      "            \"D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"European patent application EP-1 is filed on 10 December 2020, but the inventor is not designated. The designation of the inventor is filed on 25 February 2022. Will the application be refused?\",\n",
      "        \"options\": [\n",
      "            \"A. No. The designation of the inventor was filed in due time.\",\n",
      "            \"B. Yes. The designation of the inventor was not filed in due time.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You file an international application for an applicant on 6 November 2023, but do not pay the fees because the applicant wishes to delay paying them as long as possible. The fees are due by 6 December 2023, but are not paid until 11 December 2023. What is the most likely outcome?\",\n",
      "        \"options\": [\n",
      "            \"A. The international application will be considered to be withdrawn.\",\n",
      "            \"B. The fees will be accepted as if they had been paid within the one-month period.\",\n",
      "            \"C. The applicant will be sent an invitation to pay a late payment fee of 50% of the fees due.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 30: {'question': 'According to Rule 160, if the European Patent Office notes that a Euro-PCT application has been deemed withdrawn due to a missing translation or request for examination, what must be communicated to the applicant?', 'options': ['A. No communication is required.', 'B. A notice of withdrawal will be sent via registered mail.', 'C. The European Patent Office will communicate this to the applicant according to Rule 112, paragraph 2.', 'D. An invitation to pay a late payment fee will be issued.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Errors and mistakes in any document filed with the European Patent Office may be corrected on request under Rule 139 EPC. What is the last date in written proceedings prior to grant that such a request can be made?\",\n",
      "        \"options\": [\n",
      "            \"A. Up to the time the decision to grant has been received by the applicant or their representative.\",\n",
      "            \"B. Up to the time the decision to grant has been handed over to the EPO internal postal service.\",\n",
      "            \"C. Up to the expiry of the time limit for replying to the communication under Rule 71(3) EPC.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Why might an opposition be filed even if the European patent has been surrendered, or has lapsed, in all the designated contracting states (Rule 75 EPC)?\",\n",
      "        \"options\": [\n",
      "            \"A. In the case of surrender or lapse the rights acquired with the patent remain in existence in the period up to surrender or lapse and claims arising from those rights may subsist after the date of grant.\",\n",
      "            \"B. There is no reason to oppose a patent that has been surrendered or has lapsed.\",\n",
      "            \"C. The effect of surrender or lapse is ex nunc, while the effect of revocation is ex tunc.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You represent an individual applicant from Spain who has filed a European patent application in Spanish and satisfied all the requirements for filing. Examination was requested in Spanish at the time of filing the application. The examination and designation fees are due by 7 November 2023 and the applicant has asked you whether he is entitled to a reduction of 20% in the examination fee. What is the correct answer?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant is entitled to a reduction of 20% in the examination fee under Rule 6(3) EPC and Article 14(1) RFees.\",\n",
      "            \"B. The applicant is entitled to a reduction in the examination fee under Rule 6(3)EPC and Article 14(1) RFees, but the reduction is not 20%.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 31: {'question': 'If an amended text of a European patent has been drawn up during opposition appeal proceedings, what must be filed within three months according to the Guidelines for Examination in the EPO, D-VI, 7.2.3?', 'options': ['A. The fee for publishing a new specification of the European patent; translations of any amended claims in the two official languages other than the language of the proceedings; and a formally compliant verbatim version of amended text passages.', 'B. The fee for publishing a new specification of the European patent; translations into all official languages other than the language of the proceedings; and a formally compliant verbatim version of amended text passages.', 'C. The fee for publishing a new specification of the European patent; translations of any amended claims in the two official languages of the EPO; and no additional documents are required.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Applicants may request processing of their international application under PCT Direct by filing a letter (\\\"PCT Direct letter\\\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing\",\n",
      "            \"B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0\",\n",
      "            \"C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0\",\n",
      "            \"D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"European patent EP-B is granted with a claim directed to a method of operating a heart pacemaker in dependence upon the required cardiac output while a person is exercising, the pacemaker including a pressure sensing means mounted on a pacing lead and adapted to be implanted in a heart and used to sense the right ventricular systolic pressure, which pressure is used to control the pacer rate. Is it permissible in opposition or opposition appeal proceedings to amend the claim to be directed to a heart pacemaker in order to address problems relating to Article 53(c) EPC?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, a change in claim category is permitted.\",\n",
      "            \"B. No, a change in claim category would contravene Article 123(3) EPC.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 32: {'question': 'If an applicant wishes to review their European patent application under Article 25 PCT, which of the following steps must be taken within the two-month time limit after receiving notice from the International Bureau (IB)?', 'options': ['A. Submit a formal request for early processing directly to the EPO.', 'B. Pay the filing fee and furnish a translation of the application documents if not already provided, without notifying the IB or the receiving Office.', 'C. Notify the receiving Office or International Bureau of their intention to review the application under Article 25 PCT and pay any required fees.', 'D. Amend the claims in the application and submit them to the EPO for re-evaluation.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Two applicants resident in Germany jointly file an international application with the EPO as receiving office. No agent or common representative is appointed. Following receipt of the international search report, the applicants both agree that the international application should be withdrawn, so the first-named applicant on Form PCT/RO/101 sends a letter, signed by him, to the EPO as receiving office specifically withdrawing the international application. Will the application be withdrawn?\",\n",
      "        \"options\": [\n",
      "            \"A. No\",\n",
      "            \"B. Yes\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The European Patent Office as receiving Office for an international patent application invites the applicant to provide a missing abstract within a period of two months. The invitation is dated 2 December 2022 and is received by the applicant on 12 December 2022. The date of receipt stamped on the communication by the mail service provides evidence of the receipt date. What is the final date for responding to the invitation?\",\n",
      "        \"options\": [\n",
      "            \"A. 2 February 2023\",\n",
      "            \"B. 13 February 2023\",\n",
      "            \"C. 5 February 2023\",\n",
      "            \"D. 6 February 2023\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The applicants for international application PCT-1 are based in Japan. Having regard to the provisions of the EPC and the PCT, can the applicants themselves comply with the requirements of Rule 159(1) EPC?\",\n",
      "        \"options\": [\n",
      "            \"A. No, a professional representative must be appointed.\",\n",
      "            \"B. No, a professional representative or appropriate legal representative must be appointed.\",\n",
      "            \"C. Yes, the applicants can themselves comply with the requirements of Rule 159(1) EPC.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 33: {'question': 'If an international application is filed with an authority of a Contracting State for transmittal to the European Patent Office as the receiving Office, how many weeks does the Contracting State have to ensure that the application reaches the European Patent Office?', 'options': ['A. Within 2 weeks', 'B. Not later than two weeks before the end of the thirteenth month from filing or, if priority is claimed, from the date of priority', 'C. Within one week', 'D. Within four weeks']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"You are informed that one of the inventors named in an international application is incorrect. The application names Mr Y, but the correct inventor is Mrs Z. What should you do?\",\n",
      "        \"options\": [\n",
      "            \"A. Obtain the consent of Mr Y to rectification of the inventor before filing a request at the International Bureau with details of the correct inventor.\",\n",
      "            \"B. File a request for rectification at the International Bureau with details of the correct inventor.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Your client filed an international patent application in 2021. In which of the following countries can they (directly) enter the national phase?\",\n",
      "        \"options\": [\n",
      "            \"A. Lithuania\",\n",
      "            \"B. France\",\n",
      "            \"C. Italy\",\n",
      "            \"D. None of the above\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The time limit for paying the examination fee for a European patent application ends on 18 August 2023. The applicant wishes to pay by bank transfer and wants to make absolutely sure that no additional fees have to be paid even if the payment is delayed due to unforeseen circumstances. What can he do?\",\n",
      "        \"options\": [\n",
      "            \"A. Nothing. If the payment is received too late by the EPO it will be considered not to have been made.\",\n",
      "            \"B. Effect the payment no later than 13 August 2023.\",\n",
      "            \"C. Effect the payment no later than 8 August 2023.\",\n",
      "            \"D. It is sufficient to effect the payment on the last day for payment, that is on 18 August 2023.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 34: {'question': 'For a European patent application, if the designation fee has not been paid by the deadline, what action can an applicant take to still pay the fee while avoiding immediate withdrawal of the request for extension or validation?', 'options': ['A. Pay the fee and surcharge within two months after notification of loss of rights concerning the designation fee.', 'B. Directly withdraw the application without paying any additional fees.', 'C. Request re-establishment of rights according to Article 122 and Rule 136 for non-payment of the extension or validation fee.', 'D. Pay the fee immediately within the basic period regardless of the grace period.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Most fees for European patent applications cannot be paid before their due date. One exception is renewal fees, which can always be paid up to:\",\n",
      "        \"options\": [\n",
      "            \"A. Three months before the due date.\",\n",
      "            \"B. Six months before the due date.\",\n",
      "            \"C. One year before the due date.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Which functionalities or services can be accessed directly from MyEPO Portfolio?\",\n",
      "        \"options\": [\n",
      "            \"A. A shared area with examiners, European Patent Register, filing via the EPO's online filing software eOLF\",\n",
      "            \"B. Mailbox, a shared area with examiners, replying to a communication under Article  94(3) EPC\",\n",
      "            \"C. Mailbox, patent search via publication server, a shared area with examiners\",\n",
      "            \"D. Filing via the EPO's Online Filing 2.0, patent search via publication server, Mailbox\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Errors and mistakes in any document filed with the European Patent Office may be corrected on request under Rule 139 EPC. What is the last date in written proceedings prior to grant that such a request can be made?\",\n",
      "        \"options\": [\n",
      "            \"A. Up to the time the decision to grant has been received by the applicant or their representative.\",\n",
      "            \"B. Up to the time the decision to grant has been handed over to the EPO internal postal service.\",\n",
      "            \"C. Up to the expiry of the time limit for replying to the communication under Rule 71(3) EPC.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 35: {'question': \"For European patent applications, the filing fee and search fee must be paid within how many months of the application's filing date?\", 'options': ['A. One month', 'B. Six months', 'C. Twelve months', 'D. Thirty-one months for Euro-PCT applications']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A British company buys a French firm with an IP portfolio which includes an international application that claims priority of a British national application. The international application is in French. The British company wants to pursue the invention as a European patent application. However, they would prefer that the language of the European proceedings be English.   Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A.  Upon entry into the European phase before the EPO, the applicant can file a translation into English and English will become the language of the proceedings\",\n",
      "            \"B.  The applicant can enter the European phase with the application in French and then validly file a European divisional application in English\",\n",
      "            \"C.  The applicant can select English as the language of the proceedings in the request form for entry into the European phase (EPO Form 1200) and English will become the language of the proceedings\",\n",
      "            \"D.  None of  the above\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Last week Greta validly filed the international patent application PCT -G with the German Patent and Trade mark Office ( DPMA ) and appointed Hassan to represent her. Hassan is entitled to act before the DPMA  but he is not a European patent attorney. Greta and Hassan are resident in Germany.  Which of the following statements is not correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Hassan can represent Greta before the EPO acting as the International Searching Authority for PCT -G.\",\n",
      "            \"B. In order for Hassan to be able to act before the EPO acting as the International Searching Authority , he needs to submit a power of attorney signed by Greta.\",\n",
      "            \"C. According to the provisions of the PCT, it is mandatory that the d emand for international preliminary examination is signed by Greta or Hassan.\",\n",
      "            \"D. According to the provisions of the PCT, an international application can only be withdrawn by the applicant or an agent appointed by a power of attorney.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The first communication from the examining division concerning a European patent application is unexpectedly negative. The applicant decides not to proceed further with the application. Can the applicant get a refund of fees in this situation?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 36: {'question': 'If an applicant files a European patent application in Japanese, which of the following statements is true according to the Guidelines for Examination in the EPO?', 'options': ['A. The applicant must simultaneously file a translation into one of the official EPO languages (English, French or German) within two months of filing.', 'B. The application can be filed in Japanese only if the applicant is a national of a contracting state that has Japanese as an official language.', 'C. A 30% reduction in fees is automatically granted for applications filed in non-official EPO languages like Japanese.', 'D. The language of the proceedings will always remain Japanese unless explicitly changed by the applicant.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .\",\n",
      "            \"B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .\",\n",
      "            \"C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .\",\n",
      "            \"D. Ms Smith can only be deleted as inventor with her consent .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicant X filed European patent application EP -X on 23 August 2019 as a first filing. The applicant filed application EP -Y as a divisional application of EP- X on 26 September 2022. Please consider the following statements:   2 I. The renewal fee for the fourth year for EP -X was due on 31 August 2022; the renewal fees for the third and fourth years for EP -Y were due on 26 September 2022 II. The renewal fee for the fourth year for EP -X can be validly paid on 28 February 2023 together with the necessary additional fee; the renewal fees for the third and fourth years for EP -Y can be validly paid without additional fee up to 31 January 2023  Which of the following items applies?\",\n",
      "        \"options\": [\n",
      "            \"A. Only statement I is correct\",\n",
      "            \"B. Only statement II is correct\",\n",
      "            \"C. Both statements I and II are correct\",\n",
      "            \"D. Both statements I and II are incorrect\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The applicant for European patent application EP-1 has granted an exclusive license under the application. The exclusive licensee wishes to make its rights known by recording the license in the European Patent Register. \\nIs it possible to record the exclusive license?\",\n",
      "        \"options\": [\n",
      "            \"A. No, exclusive licenses cannot be recorded in the European Patent Register.\",\n",
      "            \"B. Yes, exclusive licenses can be recorded in the European Patent Register at the joint request of both the applicant and the licensee.\",\n",
      "            \"C. Yes, exclusive licenses can be recorded in the European Patent Register, but only by the applicant.\",\n",
      "            \"D. Yes, exclusive licences can be recorded in the European Patent Register by either the applicant or the licensee.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 37: {'question': 'If a European patent application was filed on 15 March 2023, which of the following statements regarding the designation of the inventor is correct according to EPC Rule 19 and Art. 81 EPC?', 'options': ['A. The applicant can designate anyone as the inventor regardless of whether they are the actual inventor.', 'B. If the applicant is not the sole inventor, a statement indicating the origin of the right must be included in the designation.', 'C. The designation of the inventor is optional and does not need to be made until after the patent grant.', 'D. The designation can only include the actual inventors and no other parties.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A professional representative acts as agent for the following actions:  I.  Withdrawing an international patent application at the European Patent Office as receiving Office  II.  Filing a demand for international preliminary examination for an international patent application at the European Patent Office as International Preliminary Examining Authority   Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A.  For both I and II a power of attorney signed by each applicant is always required\",\n",
      "            \"B.  For I a power of attorney signed by each applicant is always required\",\n",
      "            \"C.  For II a power of attorney signed by each applicant is always required\",\n",
      "            \"D.  For both I and II the requirement to submit a power of attorney signed by each applicant may be waived   3\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The time limit for paying the examination fee for a European patent application ends on 18 August 2023. The applicant wishes to pay by bank transfer and wants to make absolutely sure that no additional fees have to be paid even if the payment is delayed due to unforeseen circumstances. What can he do?\",\n",
      "        \"options\": [\n",
      "            \"A. Nothing. If the payment is received too late by the EPO it will be considered not to have been made.\",\n",
      "            \"B. Effect the payment no later than 13 August 2023.\",\n",
      "            \"C. Effect the payment no later than 8 August 2023.\",\n",
      "            \"D. It is sufficient to effect the payment on the last day for payment, that is on 18 August 2023.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Generally speaking, oral proceedings must be held if any party to proceedings so requests. This does not apply to requests for further oral proceedings \\nbefore the same department where the parties and the subject of the proceedings are the same. Are there any other situations in which the EPO may refuse a request for oral proceedings?\",\n",
      "        \"options\": [\n",
      "            \"A. There are no further exceptions.\",\n",
      "            \"B. The receiving section may refuse a request for oral proceedings.\",\n",
      "            \"C. The opposition division may refuse a request for oral proceedings.\",\n",
      "            \"D. The Legal Division may refuse a request for oral proceedings.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 38: {'question': 'If an application fails to meet the filing fee payment deadline, by which date must the application be deemed withdrawn according to the provided context?', 'options': ['A. 30 days after the initial due date', 'B. The same day as the missed payment deadline', 'C. One month from the original due date for paying the filing fee', 'D. On the third business day following the missed payment deadline']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Entry into the European phase of an international application can be effected early provided an express request for early processing is made at the time the requirements of Rule 159(1) EPC are complied with. International application PCT-1 was filed 28 months ago with no claim to priority. The application consists of 20 pages, including 16 claims. The international search was carried out by the EPO acting as ISA and the international search report was published with the international application. Which of the following fees must be paid in order to effect early entry into the European phase?\",\n",
      "        \"options\": [\n",
      "            \"A. The filing fee.\",\n",
      "            \"B. The filing fee, the examination fee and the designation fee.\",\n",
      "            \"C. The filing fee, the examination fee, the designation fee and the renewal fee.\",\n",
      "            \"D. The filing fee, the claims fee, the examination fee, the designation fee and the renewal fee.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A professional representative acts as agent for the following actions:  I.  Withdrawing an international patent application at the European Patent Office as receiving Office  II.  Filing a demand for international preliminary examination for an international patent application at the European Patent Office as International Preliminary Examining Authority   Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A.  For both I and II a power of attorney signed by each applicant is always required\",\n",
      "            \"B.  For I a power of attorney signed by each applicant is always required\",\n",
      "            \"C.  For II a power of attorney signed by each applicant is always required\",\n",
      "            \"D.  For both I and II the requirement to submit a power of attorney signed by each applicant may be waived   3\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Following entry into the EPO regional phase, a translation of the international \\napplication is not filed at the EPO in due time. How can this be remedied?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant can request reinstatement of rights under Rule 49.6 PCT.\",\n",
      "            \"B. The applicant can file the translation, request further processing and pay the further processing fee under Rule 135 EPC within two months \\nof notification by the EPO.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 39: {'question': \"According to Rule 159(1) of the European Patent Convention, which of the following acts must be performed within 31 months from the filing date or, if priority is claimed, from the earliest priority date to initiate the European phase for an international application PCT-2 that was not published in one of the EPO's official languages and consists of more than 35 pages?\", 'options': ['A. Supplying the translation and paying the filing fee.', 'B. Supplying the translation, specifying the application documents, and paying the filing fee.', 'C. Specifying the application documents, paying the designation fee, and the search fee.', 'D. Filing a demand for international preliminary examination.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The European Patent Office as receiving Office for an international patent application invites the applicant to provide a missing abstract within a period of two months. The invitation is dated 2 December 2022 and is received by the applicant on 12 December 2022. The date of receipt stamped on the communication by the mail service provides evidence of the receipt date. What is the final date for responding to the invitation?\",\n",
      "        \"options\": [\n",
      "            \"A. 2 February 2023\",\n",
      "            \"B. 13 February 2023\",\n",
      "            \"C. 5 February 2023\",\n",
      "            \"D. 6 February 2023\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international application is published , together  with the search report drawn up by the CNIPA , 18 m onths + 1 day after the filing date (no priority claimed). The application has no more than 35 pages and 15 claims. Which statement reflects all actions the CN  applicant  needs to take for entry into the EP phase 25 months  after the filing date ? A request for early processing has been filed.\",\n",
      "        \"options\": [\n",
      "            \"A. Complete and file Form 1200 and pay the filing fee and the search fee\",\n",
      "            \"B. Complete and file Form 1200 and pay the filing fee, the search fee and the renewal fee for the third year\",\n",
      "            \"C. Complete and file Form 1200, pay the filing fee and the search fee and appoint a representative\",\n",
      "            \"D. None of the above statements\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 10 October 2021, European patent attorney X filed European patent application EP -A with the EPO on the applicant's behalf. Application EP -A was published on 12 April 2023, together  with the extended European search report. On 6  October 2023, the applicant contacts a new European patent attorney  Y to replace X as representative and issues Y with its instructions to reply to the extended European search report. The applicant did not inform X that he would be replaced.  What are the steps necessary to validly appoint representative Y and to avoid any loss of rights for European patent application EP -A?\",\n",
      "        \"options\": [\n",
      "            \"A. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 12 October 2023 at the latest and files in good time an authorisation signed by the applicant .\",\n",
      "            \"B. New representative Y requests a change of representative and files a response to the extended European search report with  the EPO by 12 October 2023 at the latest .\",\n",
      "            \"C. New representative Y requests a change of representative and files a response to the extended European search report with the EPO by 23 October 2023 at the latest.\",\n",
      "            \"D. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 23 October 2023 at the latest and files in good time an authorisation signed by the applicant .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 40: {'question': 'If a supplementary European search report is required for an international application, what actions must be taken within six months from the date of notification to avoid losing rights?', 'options': ['A. File the necessary responses and pay any required fees', 'B. Submit a waiver form to opt out of receiving the supplementary search report', 'C. Only file the necessary responses without paying any additional fees', 'D. No action is needed if no objections are raised within six months']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"An international application is published , together  with the search report drawn up by the CNIPA , 18 m onths + 1 day after the filing date (no priority claimed). The application has no more than 35 pages and 15 claims. Which statement reflects all actions the CN  applicant  needs to take for entry into the EP phase 25 months  after the filing date ? A request for early processing has been filed.\",\n",
      "        \"options\": [\n",
      "            \"A. Complete and file Form 1200 and pay the filing fee and the search fee\",\n",
      "            \"B. Complete and file Form 1200 and pay the filing fee, the search fee and the renewal fee for the third year\",\n",
      "            \"C. Complete and file Form 1200, pay the filing fee and the search fee and appoint a representative\",\n",
      "            \"D. None of the above statements\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"After receipt of a negative written opinion issued by the EPO acting as ISA, amendments under Art icle 19 PCT were filed during the international phase. No request for international preliminary examination was filed. Form  1200 was used,  and no further amendments were filed with the EPO upon entry into the regional phase.   What communication under Rules  161/162 EPC will be received in the regional phase?\",\n",
      "        \"options\": [\n",
      "            \"A. Form 1226AA ;  if you do not reply to it in time, the application will be deemed to be withdrawn\",\n",
      "            \"B. Form 1226BB offering the opportunity to comment and file amendments\",\n",
      "            \"C. Form 1226CC offering the opportunity to file amendments before the supplementary European search report is drawn up\",\n",
      "            \"D. Form 1226AC stating that the examination has started\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You are the agent for international application PCT-1. Shortly before the end of the international phase the applicant informs you that they wish to continue only with the regional phase before the EPO and additionally that there was an error in the details of the inventor and that the correct inventor is Ms White and not Mr Black. They ask you whether it would be better to wait until entry \\ninto the EPO regional phase rather than to rush correction of the inventorship details in the international phase. What is your advice?\",\n",
      "        \"options\": [\n",
      "            \"A. Inventorship should be corrected if at all possible in the international phase.\",\n",
      "            \"B. It would be better to wait until after entry into the EPO regional phase.\",\n",
      "            \"C. There is no difference between the two options.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 41: {'question': 'An international application was filed in Chinese under PCT, and after being searched by CNIPA as the International Searching Authority (ISA), it was published 18 months + 1 day after the filing date with no priority claimed. The applicant wishes to enter the regional phase through the EPO. Which of the following actions is required before entry into the European phase if a request for early processing has been filed?', 'options': ['A. Complete and file Form 1200, pay the filing fee and search fee, but no renewal fees are due.', 'B. Complete and file Form 1200, pay the filing fee, search fee, and renewal fees for the first year.', 'C. Complete and file Form 1200, pay the filing fee, search fee, and appoint a representative.', 'D. None of the above statements are correct.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"You filed an international patent application on 6 June 2024, claiming the priority of a European patent application filed on 7  July 2023. You received a communication dated 25 September 2024 from the EPO acting as International Searching Authority (ISA), stating that the requirement of unity of invention has not been complied with. The ISA identifies three inventions. You are invited to pay two additional search fees. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. You must pay two additional search fees by 25 October 2024\",\n",
      "            \"B. You do not need to file a response to the provisional opinion accompanying the partial search results\",\n",
      "            \"C. If you pay two additional search fees under protest, you must pay two protest fees within the time limit\",\n",
      "            \"D. If you do not pay any additional search fees within the time limit, the international patent application will be deemed to be withdrawn\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The applicant for international application PCT-1 wishes to prevent publication of the application. What is the last day for withdrawing the application and \\npreventing publication?\",\n",
      "        \"options\": [\n",
      "            \"A. The 15th day prior to the date of publication.\",\n",
      "            \"B. Any time prior to the date of publication.\",\n",
      "            \"C. The end of the day five weeks before the end of the 18th month from the priority or filing date as appropriate.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In response to a Rule 71(3) communication you have filed, on the 2 April 2023, the required translations of the claims and paid the grant fee. Today, the 3 May 2023, you receive the decision to grant, dated 28 April 2023. The decision states that the mention of the grant will be published on the 24 May 2023. What is/was the last day a divisional application may be filed?\",\n",
      "        \"options\": [\n",
      "            \"A. 2 April 2023\",\n",
      "            \"B. 28 April 2023\",\n",
      "            \"C. 8 May 2023\",\n",
      "            \"D. 23 May 2023\",\n",
      "            \"E. 24 May 2023\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 42: {'question': 'If you filed a European patent application on 15 March 2024, and now need to pay the filing fee and search fee within one month from the filing date, by which date must these fees be paid?', 'options': ['A. 14 April 2024', 'B. 15 April 2024', 'C. 16 April 2024', 'D. 17 April 2024']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Errors and mistakes in any document filed with the European Patent Office may be corrected on request under Rule 139 EPC. What is the last date in written proceedings prior to grant that such a request can be made?\",\n",
      "        \"options\": [\n",
      "            \"A. Up to the time the decision to grant has been received by the applicant or their representative.\",\n",
      "            \"B. Up to the time the decision to grant has been handed over to the EPO internal postal service.\",\n",
      "            \"C. Up to the expiry of the time limit for replying to the communication under Rule 71(3) EPC.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"European patent application EP-1 is filed on 10 December 2020, but the inventor is not designated. The designation of the inventor is filed on 25 February 2022. Will the application be refused?\",\n",
      "        \"options\": [\n",
      "            \"A. No. The designation of the inventor was filed in due time.\",\n",
      "            \"B. Yes. The designation of the inventor was not filed in due time.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The time limit for paying the examination fee for a European patent application ends on 18 August 2023. The applicant wishes to pay by bank transfer and wants to make absolutely sure that no additional fees have to be paid even if the payment is delayed due to unforeseen circumstances. What can he do?\",\n",
      "        \"options\": [\n",
      "            \"A. Nothing. If the payment is received too late by the EPO it will be considered not to have been made.\",\n",
      "            \"B. Effect the payment no later than 13 August 2023.\",\n",
      "            \"C. Effect the payment no later than 8 August 2023.\",\n",
      "            \"D. It is sufficient to effect the payment on the last day for payment, that is on 18 August 2023.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 43: {'question': 'If an applicant files a Euro-PCT application, when must the examination fee be paid according to the guidelines provided?', 'options': [\"A. On the European patent application's filing date.\", 'B. Within six months of the date on which the European Patent Bulletin mentions the publication of the European search report.', 'C. There is no need to pay the examination fee for a Euro-PCT application.', 'D. Immediately upon filing, but not later than one month after filing.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The first communication from the examining division concerning a European patent application is unexpectedly negative. The applicant decides not to proceed further with the application. Can the applicant get a refund of fees in this situation?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A British company buys a French firm with an IP portfolio which includes an international application that claims priority of a British national application. The international application is in French. The British company wants to pursue the invention as a European patent application. However, they would prefer that the language of the European proceedings be English.   Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A.  Upon entry into the European phase before the EPO, the applicant can file a translation into English and English will become the language of the proceedings\",\n",
      "            \"B.  The applicant can enter the European phase with the application in French and then validly file a European divisional application in English\",\n",
      "            \"C.  The applicant can select English as the language of the proceedings in the request form for entry into the European phase (EPO Form 1200) and English will become the language of the proceedings\",\n",
      "            \"D.  None of  the above\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 44: {'question': 'A company filed a European patent application in Spanish, which is not an official EPO language, without providing a translation into one of the official languages (English, French, or German). According to Rule 6(1), within two months of filing, what must the applicant do to avoid losing rights?', 'options': ['A. Request a withdrawal of the application', 'B. File an English, French, or German translation of the application', 'C. Pay a penalty fee and proceed without translation', 'D. Wait for the EPO to provide a mandatory translation']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent application EP-A is refused in a decision dated 1 June 2023. Today is 15 July 2023. Is it still possible to file a divisional application from EP-A?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes.\",\n",
      "            \"B. No.\",\n",
      "            \"C. Only if the decision to refuse the application is appealed.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The applicant received a communication pursuant to Article 90(3) EPC and Rule  60 EPC, requesting them to file a designation of inventor but missed the time limit for filing a response. After expiry of the time limit, the Receiving Section issued a decision to refuse the European patent application, dated 10  October 2024. What can the applicant do to remedy the situation?\",\n",
      "        \"options\": [\n",
      "            \"A. File a notice of appeal against the decision within four months of notification of the decision\",\n",
      "            \"B. File a request for further processing within two months of notification of the decision\",\n",
      "            \"C. File, within two months of notification of the decision, a request for re-establishment of rights in respect of the time limit for filing the designation of inventor\",\n",
      "            \"D. A, B and C are correct\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicant Korhonen is a Finnish national resident in Finland. He filed a European patent application in Finnish and provided an English translation in time. In response to the extended European search report (EESR), Korhonen wishes to file amended claims t ogether with a request for examination. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Korhonen must file the amended claims in Finnish and must then  provide a translation into English, in time\",\n",
      "            \"B. Korhonen is allowed to file the amended claims in Finnish if he then provides a\",\n",
      "            \"translation into any official language of the EPO, in time C. Korhonen is allowed to file the amended claims in Finnish if he then provides a translation into English, in time\",\n",
      "            \"D. Korhonen is not allowed to file the amended claims in Finnish\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 45: {'question': 'A Swedish national, applicant Andersson, files a European patent application in Swedish, which is an admissible non-EPO language according to A-VII, 3.2. According to Rule 6(1) EPC, what must he do within two months of filing?', 'options': ['A. File the entire application in English, French or German.', 'B. Provide a translation into one of the official languages of the EPO.', 'C. No action is required as Swedish is an admissible language without additional translation obligations.', 'D. Pay an increased filing fee for using a non-official language.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"In opposition proceedings a patent proprietor has proposed amendments to claims 1, 3 and 4 of its patent to overcome issues of novelty and inventive step. The proprietor has also noted a problem with the clarity of claim 2 and has additionally proposed an amendment to this claim. Is the amendment of claim 2 permitted?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 27 October 2022 you filed European patent application EP -A claiming priority from FR -A filed on 29 October 2021. Your intention was that both applications would have the same content. On 3 November 2022, however, you noticed that page 3 of the description and claims 7 -12 are missing in EP -A. The fees have not been paid yet.  Which statement is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. If the EPO notes that page 3 of the description and claims 7 -12 are missing, it will invite you to file these missing parts within a time limit of two months\",\n",
      "            \"B. You may of your own volition file page 3 of the description at any time up to 2 January 2023 without the application being re -dated\",\n",
      "            \"C. If the subject -matter of claims 7 -12 is also present in the description, you may add claims 7 -12 at any time\",\n",
      "            \"D. The best solution is to withdraw EP -A and refile it, claiming priority from FR -A\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A British company buys a French firm with an IP portfolio which includes an international application that claims priority of a British national application. The international application is in French. The British company wants to pursue the invention as a European patent application. However, they would prefer that the language of the European proceedings be English.   Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A.  Upon entry into the European phase before the EPO, the applicant can file a translation into English and English will become the language of the proceedings\",\n",
      "            \"B.  The applicant can enter the European phase with the application in French and then validly file a European divisional application in English\",\n",
      "            \"C.  The applicant can select English as the language of the proceedings in the request form for entry into the European phase (EPO Form 1200) and English will become the language of the proceedings\",\n",
      "            \"D.  None of  the above\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 46: {'question': 'In opposition proceedings, if a party fails to enclose or file relevant documents within the prescribed time limit, what is the likely consequence according to the guidelines?', 'options': ['A. The EPO will disregard these documents and they will not be considered in the opposition process.', 'B. The opposition will be automatically dismissed due to lack of documentation.', 'C. The party will receive a warning but the documents will still be included in the file.', 'D. The documents are automatically deemed as filed, and become part of the public record regardless of whether they were properly submitted.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"An international patent application was filed on 17 February 2022 claiming priority from a European patent application filed on 17 February 2021. The international search report together with the written opinion was transmitted to the applicant on 10 June 2022.   What is the last day for filing a demand for international preliminary examination?\",\n",
      "        \"options\": [\n",
      "            \"A. 17 December 2022\",\n",
      "            \"B. 19 December 2022\",\n",
      "            \"C. 10 September 2022\",\n",
      "            \"D. 12 September 2022\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Where an assumed infringer intervenes in opposition appeal proceedings, which of the following fees are payable?\",\n",
      "        \"options\": [\n",
      "            \"A. The opposition fee.\",\n",
      "            \"B. The appeal fee.\",\n",
      "            \"C. The opposition fee and the appeal fee.\",\n",
      "            \"D. The assumed infringer must pay the opposition fee and may choose whether to pay the appeal fee.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Company C files a European patent application for an invention which has been displayed at an officially recognised international exhibition. The exhibition closes two weeks after the invention was first displayed. Rule 25(d) EPC states that a suitable certificate must be filed within four months of the filing of the European patent application. Three months after filing the application, the applicant approaches the authority responsible for the protection of industrial property at the exhibition and obtains a certificate stating the information required according to Rule 25 EPC. The certificate is filed within the four-month period together with the authenticated identification of the invention. Will the certificate be accepted by the EPO?\",\n",
      "        \"options\": [\n",
      "            \"A. No, the certificate was not issued at the exhibition.\",\n",
      "            \"B. Yes, the certificate was filed within the specified four-month period.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 47: {'question': 'According to Rule 25 EPC, what information must be included in the certificate of exhibition filed by the applicant within four months of filing the European patent application?', 'options': ['A. The opening date and closing date of the exhibition only.', 'B. A statement that the invention was displayed at the exhibition, along with the opening date and, if different, the first disclosure date.', 'C. Only the identification of the invention, authenticated by any authority.', 'D. The dates when each individual inventor visited the exhibition.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The applicant for European patent application EP-1 has granted an exclusive license under the application. The exclusive licensee wishes to make its rights known by recording the license in the European Patent Register. \\nIs it possible to record the exclusive license?\",\n",
      "        \"options\": [\n",
      "            \"A. No, exclusive licenses cannot be recorded in the European Patent Register.\",\n",
      "            \"B. Yes, exclusive licenses can be recorded in the European Patent Register at the joint request of both the applicant and the licensee.\",\n",
      "            \"C. Yes, exclusive licenses can be recorded in the European Patent Register, but only by the applicant.\",\n",
      "            \"D. Yes, exclusive licences can be recorded in the European Patent Register by either the applicant or the licensee.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Is the following statement true or false?\\n\\nWhen proceedings for grant of a European patent application are stayed following the institution of entitlement proceedings, renewal fees which fall due during the period of stay can be paid up to the date of resumption of the proceedings for grant.\",\n",
      "        \"options\": [\n",
      "            \"A. True\",\n",
      "            \"B. False\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. As no renewal fees have been paid, the application is deemed to be withdrawn .\",\n",
      "            \"B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .\",\n",
      "            \"C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .\",\n",
      "            \"D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 48: {'question': 'If an applicant grants a sub-license under a European patent application, under which condition can this license be recorded in the European Patent Register?', 'options': ['A. The licensee alone must request its recording.', 'B. Both the applicant and the licensee must request its recording.', 'C. It can only be recorded if approved by a court.', 'D. It is automatically recorded upon grant of the sub-license.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"An international application is published , together  with the search report drawn up by the CNIPA , 18 m onths + 1 day after the filing date (no priority claimed). The application has no more than 35 pages and 15 claims. Which statement reflects all actions the CN  applicant  needs to take for entry into the EP phase 25 months  after the filing date ? A request for early processing has been filed.\",\n",
      "        \"options\": [\n",
      "            \"A. Complete and file Form 1200 and pay the filing fee and the search fee\",\n",
      "            \"B. Complete and file Form 1200 and pay the filing fee, the search fee and the renewal fee for the third year\",\n",
      "            \"C. Complete and file Form 1200, pay the filing fee and the search fee and appoint a representative\",\n",
      "            \"D. None of the above statements\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The first communication from the examining division concerning a European patent application is unexpectedly negative. The applicant decides not to proceed further with the application. Can the applicant get a refund of fees in this situation?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"It is permitted to file observations under Article 115 EPC in respect of a patent undergoing limitation proceedings. However, there is no provision under Article 105b EPC or Rule 95 EPC for examination as to patentability, \\nand Article 115 EPC specifically refers to observations concerning patentability. \\nIs there any reason why a third party might nevertheless file observations under Article 115 EPC in respect of a patent undergoing limitation proceedings?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, the examining division may be persuaded to consider patentability as part of the limitation proceedings.\",\n",
      "            \"B. Yes, patentability can be considered in the broader sense as including issues relating to Articles 84 and 123(2) EPC.\",\n",
      "            \"C. No, there is no point in filing observations on patentability because they will not be taken into consideration.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 49: {'question': 'According to Article 115 EPC, which of the following statements about third-party observations is correct?', 'options': ['A. Third parties must pay an official fee when filing such observations.', 'B. Any third party may present observations concerning the patentability of an invention without fees or deadlines after publication of the application.', 'C. Third-party observations are not open to inspection under Article 128 EPC.', 'D. The applicant is obligated to respond to all third-party observations.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"You represent an individual applicant from Spain who has filed a European patent application in Spanish and satisfied all the requirements for filing. Examination was requested in Spanish at the time of filing the application. The examination and designation fees are due by 7 November 2023 and the applicant has asked you whether he is entitled to a reduction of 20% in the examination fee. What is the correct answer?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant is entitled to a reduction of 20% in the examination fee under Rule 6(3) EPC and Article 14(1) RFees.\",\n",
      "            \"B. The applicant is entitled to a reduction in the examination fee under Rule 6(3)EPC and Article 14(1) RFees, but the reduction is not 20%.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"During the examination proceedings the applicant notes that claim 1 contains a typographical error. What is the last point in time for requesting correction of the error under Rule 139 EPC?\",\n",
      "        \"options\": [\n",
      "            \"A. One day before the decision to grant a European patent is handed over to the EPO postal service\",\n",
      "            \"B. Date  of publication of the mention of the grant of the European patent\",\n",
      "            \"C. Date of notification of the decision to grant\",\n",
      "            \"D. Date of the communication under Rule 71(3) EPC\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 50: {'question': 'If an applicant has filed a European patent application in French, but only one of multiple applicants needs to fulfill the requirements of Article 14(4) EPC for language-related fee reductions, which of the following statements is correct according to the guidelines provided?', 'options': ['A. The requirement must be fulfilled by each applicant individually.', 'B. Only one of the multiple applicants needs to fulfill the Article 14(4) EPC requirements for a reduction in fees.', 'C. There are no language-related fee reductions available under EPC.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The applicant received a communication pursuant to Article 90(3) EPC and Rule  60 EPC, requesting them to file a designation of inventor but missed the time limit for filing a response. After expiry of the time limit, the Receiving Section issued a decision to refuse the European patent application, dated 10  October 2024. What can the applicant do to remedy the situation?\",\n",
      "        \"options\": [\n",
      "            \"A. File a notice of appeal against the decision within four months of notification of the decision\",\n",
      "            \"B. File a request for further processing within two months of notification of the decision\",\n",
      "            \"C. File, within two months of notification of the decision, a request for re-establishment of rights in respect of the time limit for filing the designation of inventor\",\n",
      "            \"D. A, B and C are correct\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?\",\n",
      "        \"options\": [\n",
      "            \"A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO\",\n",
      "            \"B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application\",\n",
      "            \"C. File an electronic certified copy of the Luxembourg patent application with the EPO\",\n",
      "            \"D. File a certified copy of the Luxembourg patent application with the International Bureau\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Errors and mistakes in any document filed with the European Patent Office may be corrected on request under Rule 139 EPC. What is the last date in written proceedings prior to grant that such a request can be made?\",\n",
      "        \"options\": [\n",
      "            \"A. Up to the time the decision to grant has been received by the applicant or their representative.\",\n",
      "            \"B. Up to the time the decision to grant has been handed over to the EPO internal postal service.\",\n",
      "            \"C. Up to the expiry of the time limit for replying to the communication under Rule 71(3) EPC.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 51: {'question': 'If an applicant fails to provide a certified copy of a previously filed application within two months as required under Rule 40(3), what happens according to the Guidelines for Examination in the EPO?', 'options': ['A. The European Patent Office automatically grants the patent.', 'B. A communication is sent requesting further processing or rectification of the deficiency.', 'C. The application is immediately rejected without any further notice.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent application EP-A is refused in a decision dated 1 June 2023. Today is 15 July 2023. Is it still possible to file a divisional application from EP-A?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes.\",\n",
      "            \"B. No.\",\n",
      "            \"C. Only if the decision to refuse the application is appealed.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application is filed on 13.01.2023, not claiming priority. After receiving the EESR, the applicant wishes to proceed as soon as possible with examination and therefore pays the examination fee, responds to the search opinion and files by fax a request for accelerated examination under PACE. Will the EPO start examination as soon as possible? And will examination be accelerated?\",\n",
      "        \"options\": [\n",
      "            \"A. Examination will start but will not be accelerated.\",\n",
      "            \"B. Examination will not start until the time limit for requesting examination but then it will be accelerated.\",\n",
      "            \"C. Examination will start early and will be accelerated.\",\n",
      "            \"D. No.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You file a European patent application EP-1 in February 2023 on behalf of the applicant. In October 2023 you are informed that EP-1 should have claimed priority from United States patent application US-1 filed in March 2022. Is it possible to add the priority declaration to EP-1?\",\n",
      "        \"options\": [\n",
      "            \"A. No. More than 16 months have elapsed since the filing of US-1.\",\n",
      "            \"B. Yes. EP-1 was filed within 12 months of US-1, so is entitled to claim priority.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 52: {'question': 'If an applicant wants their European patent application to be processed under the PACE programme, which of the following actions is required?', 'options': ['A. File the request informally using email.', 'B. Use the dedicated online form EPO Form 1005.', 'C. Submit a written request by post.', 'D. Request accelerated examination only during search phase.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Generally speaking, oral proceedings must be held if any party to proceedings so requests. This does not apply to requests for further oral proceedings \\nbefore the same department where the parties and the subject of the proceedings are the same. Are there any other situations in which the EPO may refuse a request for oral proceedings?\",\n",
      "        \"options\": [\n",
      "            \"A. There are no further exceptions.\",\n",
      "            \"B. The receiving section may refuse a request for oral proceedings.\",\n",
      "            \"C. The opposition division may refuse a request for oral proceedings.\",\n",
      "            \"D. The Legal Division may refuse a request for oral proceedings.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"EP-1 is a regular European patent application (Euro -direct application) .  Which one of the following missed time limits can be remedied for EP -1 before the EPO by requesting re- establishment of rights ?\",\n",
      "        \"options\": [\n",
      "            \"A. T ime limit for pay ing the designation fee\",\n",
      "            \"B. T ime limit for requesting examination\",\n",
      "            \"C. T ime limit for filing the application within the priority period\",\n",
      "            \"D. T ime limit for paying the fee for re- establishment of rights\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The time limit for paying the examination fee for a European patent application ends on 18 August 2023. The applicant wishes to pay by bank transfer and wants to make absolutely sure that no additional fees have to be paid even if the payment is delayed due to unforeseen circumstances. What can he do?\",\n",
      "        \"options\": [\n",
      "            \"A. Nothing. If the payment is received too late by the EPO it will be considered not to have been made.\",\n",
      "            \"B. Effect the payment no later than 13 August 2023.\",\n",
      "            \"C. Effect the payment no later than 8 August 2023.\",\n",
      "            \"D. It is sufficient to effect the payment on the last day for payment, that is on 18 August 2023.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 53: {'question': 'According to the guidelines, when can parties request oral proceedings before a decision has been issued?', 'options': ['A. Oral proceedings cannot be requested until after a decision has been issued.', 'B. Parties can request oral proceedings at any stage of the procedure as long as it is necessary for them.', 'C. Requests for oral proceedings are only allowed during the opposition phase.', 'D. Oral proceedings can only be requested once all written submissions have been submitted.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The EPO as receiving office issues an invitation to the applicant to remedy certain defects in an international application within a time limit of two months from the date of invitation. The invitation is dated as being mailed on 22 September 2023 and is received by the applicant on 2 October 2023. What is the final date for responding to the invitation?\",\n",
      "        \"options\": [\n",
      "            \"A. 22 November 2023\",\n",
      "            \"B. 27 November 2023\",\n",
      "            \"C. 3 December 2023\",\n",
      "            \"D. 4 December 2023\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You are monitoring the progress of an international application and on reviewing the details of the international search report you realize that you know of relevant prior art that has not been cited in the search report, but which is likely to be novelty-destroying in respect of at least some of the claims. \\nYou believe that the international application will enter the national or regional phase in a significant number of countries or regions and it would therefore be time-consuming and costly to file separate observations in respect of each of \\nthe national or regional applications. What can you do?\",\n",
      "        \"options\": [\n",
      "            \"A. File observations online using ePCT.\",\n",
      "            \"B. Send a letter with your observations to the receiving office or the International Bureau.\",\n",
      "            \"C. File observations by letter.\",\n",
      "            \"D. It is not possible to file observations on international applications.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?\",\n",
      "        \"options\": [\n",
      "            \"A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.\",\n",
      "            \"B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.\",\n",
      "            \"C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.\",\n",
      "            \"D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 54: {'question': 'In opposition proceedings, if the patent proprietor does not provide translations of any amended claims in the two official languages other than the language of the proceedings within three months after being requested by the formalities officer, what action can the formalities officer take?', 'options': ['A. The formalities officer can proceed with maintaining the patent without the translations.', 'B. The formalities officer can issue a warning to the patent proprietor and extend the deadline for another three months.', 'C. The formalities officer can invite the patent proprietor to file declarations instead of translations within six months.', 'D. The formalities officer can declare the amended claims invalid and maintain the original version of the claims.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In which of the following cases is the applicant entitled to a reduction of the filing fee  under Rule  6 EPC ? A declaration of such entitlement has  been made by crossing the relevant box on Form  1001.\",\n",
      "        \"options\": [\n",
      "            \"A. A Spanish European patent attorney files a European patent application in Spanish for a natural person who is resident in Andorra and of Andorra n nationality .\",\n",
      "            \"B. A firm whose principal place of business is in Germany and a natural person who is resident in Germany  and of Dutch nationality  jointly file a European patent application in Dutch. The German firm employs 200 people with an annual turnover of EUR 60 million.\",\n",
      "            \"C. A natural person resident in the USA and of Belgian nationality files a European patent application in French.\",\n",
      "            \"D. A natural person resident in the USA and of Swiss nationality files a European patent application in Italian.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Which of the following steps is not a minimum requirement for entry into the European phase?\",\n",
      "        \"options\": [\n",
      "            \"A.  Supplying a translation if the Euro- PCT application was not published in one of the EPO's official languages\",\n",
      "            \"B.  Specifying the application documents on which the European grant procedure is to be based\",\n",
      "            \"C.  Filing the designation of the inventor\",\n",
      "            \"D.  Paying the search fee if a supplementary European search report is to be drawn up\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 55: {'question': 'Under Article 14(4) of the EPC, which of the following applicants would be eligible for reduced fees when filing documents in an admissible non-EPO language?', 'options': ['A. A German company with its principal place of business in Germany, filing a document in English.', 'B. An Italian national resident abroad, filing a document in Italian within 30 days.', 'C. A French citizen residing in France, submitting a document in Russian.', 'D. A Swiss company having its principal place of business in Switzerland, filing a document in Spanish.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?\",\n",
      "        \"options\": [\n",
      "            \"A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.\",\n",
      "            \"B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.\",\n",
      "            \"C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.\",\n",
      "            \"D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A communication under Article 94(3) EPC, setting a four -month time limit for reply is dated 12 September 2024. The applicant receives the letter on 21 September 2024, as evidenced by the postal receipt signed by him.  What is the last day for replying to the communication?\",\n",
      "        \"options\": [\n",
      "            \"A. 13 January 2025\",\n",
      "            \"B. 12 January 2025\",\n",
      "            \"C. 22 January 2025\",\n",
      "            \"D. 14 January 2025\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"International application PCT-1 claims priority from Korean utility model \\napplication KR-U1. Is a translation of the priority document required on \\nentry into the European regional phase?\",\n",
      "        \"options\": [\n",
      "            \"A. A translation into the language of the proceedings is required within two months of the end of the 31-month period for entering \\nthe EPO regional phase.\",\n",
      "            \"B. A translation into one of the official EPO languages is required within two months of the end of the 31-month period for entering the EPO regional phase.\",\n",
      "            \"C. No translation is required unless the validity of the priority claim is relevant to patentability.\",\n",
      "            \"D. No translation is required if a declaration is submitted that the European patent application is a complete translation of the priority application.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 56: {'question': 'During opposition proceedings, if the patent proprietor fails to file translations of all sets of claims for different contracting states within three months after being notified by the formalities officer, what will be the consequence?', 'options': ['A. The opposition division may still consider the arguments based on the missing claims.', 'B. The patent will automatically be revoked.', 'C. The right to oppose is lost.', 'D. The patent proprietor will receive a grace period of one additional month to file the translations.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The European Patent Office as receiving Office for an international patent application invites the applicant to provide a missing abstract within a period of two months. The invitation is dated 2 December 2022 and is received by the applicant on 12 December 2022. The date of receipt stamped on the communication by the mail service provides evidence of the receipt date. What is the final date for responding to the invitation?\",\n",
      "        \"options\": [\n",
      "            \"A. 2 February 2023\",\n",
      "            \"B. 13 February 2023\",\n",
      "            \"C. 5 February 2023\",\n",
      "            \"D. 6 February 2023\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"It is permitted to file observations under Article 115 EPC in respect of a patent undergoing limitation proceedings. However, there is no provision under Article 105b EPC or Rule 95 EPC for examination as to patentability, \\nand Article 115 EPC specifically refers to observations concerning patentability. \\nIs there any reason why a third party might nevertheless file observations under Article 115 EPC in respect of a patent undergoing limitation proceedings?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, the examining division may be persuaded to consider patentability as part of the limitation proceedings.\",\n",
      "            \"B. Yes, patentability can be considered in the broader sense as including issues relating to Articles 84 and 123(2) EPC.\",\n",
      "            \"C. No, there is no point in filing observations on patentability because they will not be taken into consideration.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A communication pursuant to Article 94(3) EPC is dated 7 December 2022. In the communication a time limit of four months is set for replying to objections raised by the examining division.  Which of the following statements is not  correct?\",\n",
      "        \"options\": [\n",
      "            \"A.  The communication is deemed to be delivered on 17 December 2022\",\n",
      "            \"B. The time limit for replying to the communication expires on 17 April 2023\",\n",
      "            \"C.  Further processing for replying to the communication can be validly requested on 19 June 2023 at the latest\",\n",
      "            \"D.  An extension of the time limit for filing the reply can be validly requested on 14 April 2023\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 57: {'question': 'Under Article 115 EPC, who can present observations concerning the patentability of an invention after publication of the European patent application?', 'options': ['A. Only the applicant or patent proprietor', 'B. Any third party at any time without fees or deadlines', 'C. Only during opposition and appeal proceedings', 'D. Any third party, but only within a specified period']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Last week Greta validly filed the international patent application PCT -G with the German Patent and Trade mark Office ( DPMA ) and appointed Hassan to represent her. Hassan is entitled to act before the DPMA  but he is not a European patent attorney. Greta and Hassan are resident in Germany.  Which of the following statements is not correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Hassan can represent Greta before the EPO acting as the International Searching Authority for PCT -G.\",\n",
      "            \"B. In order for Hassan to be able to act before the EPO acting as the International Searching Authority , he needs to submit a power of attorney signed by Greta.\",\n",
      "            \"C. According to the provisions of the PCT, it is mandatory that the d emand for international preliminary examination is signed by Greta or Hassan.\",\n",
      "            \"D. According to the provisions of the PCT, an international application can only be withdrawn by the applicant or an agent appointed by a power of attorney.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In which of the following situations does the EPO recommend using the EPO Contingency Upload Service?\",\n",
      "        \"options\": [\n",
      "            \"A. When you submit documents after business hours\",\n",
      "            \"B. When the EPO filing systems are functioning correctly, but you encounter a technical issue at your end\",\n",
      "            \"C. When there is a system outage at the EPO that prevents document submission via the standard filing systems\",\n",
      "            \"D. When the EPO is closed due to an official holiday\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 58: {'question': 'On 15 March 2023, you filed an international patent application PCT -X with the International Bureau (IB) of WIPO claiming priority from a German national application filed on 15 September 2022. You now wish to add another priority claim to this application for the same invention. According to the PCT rules, by which date must you submit your notice to the receiving Office or the IB to be in compliance with Rule 26bis.1(a)?', 'options': ['A. 15 March 2024', 'B. 15 September 2023', 'C. 15 July 2023', 'D. 15 January 2024']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"International application PCT-1 enters the European regional phase as EP-1 today. Independent claims 1 and 10 of the international application were considered to lack unity in the international phase and a partial search report was drawn up by the EPO as ISA in respect of the invention of claim 1. The applicant wishes to have the opportunity to protect the invention of claim 10 during the EPO regional phase, but wants to keep costs to a minimum, at least at the beginning. What can the applicant do?\",\n",
      "        \"options\": [\n",
      "            \"A. File a divisional application to the invention of independent claim 10 after entry into the EPO regional phase.\",\n",
      "            \"B. Pay an additional search fee in respect of the invention of independent claim 10 within two months of entry into the EPO regional phase.\",\n",
      "            \"C. Pay an additional search fee in respect of the invention of independent claim 10 within two months of notification by the EPO.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Your client filed an international patent application in 2021. In which of the following countries can they (directly) enter the national phase?\",\n",
      "        \"options\": [\n",
      "            \"A. Lithuania\",\n",
      "            \"B. France\",\n",
      "            \"C. Italy\",\n",
      "            \"D. None of the above\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On receipt of the decision to grant its European patent application EP-1 under Rule 71a(1) EPC the applicant realizes that they have made a significant typographical error in claim 1. \\nWhat action can they take before the EPO to correct the error?\",\n",
      "        \"options\": [\n",
      "            \"A. None\",\n",
      "            \"B. Seek correction under Rule 140 EPC\",\n",
      "            \"C. Seek correction under Rule 139 EPC\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 59: {'question': 'If an applicant wishes to include an additional invention, not previously searched by the EPO during the international phase, what action can they take once their application has entered the European phase?', 'options': ['A. Request a supplementary European search without any fees.', 'B. Pay an additional search fee and choose any invention that was not searched in the international phase as the basis for further prosecution.', 'C. Amend the claims to include the new invention and request a re-examination by the EPO.', 'D. File a divisional application with the newly added invention.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 10 October 2024, an applicant files a request for entry into the European phase, together with a debit order, according to which the filing fee, the designation fee, the examination fee and the renewal fee for the third year are to be debited from the applicant's deposit account. It is specified that the debit order is to be executed on 18 October 2024. On the evening of 10 October 2024, the applicant notices that the renewal fee is not yet due and should not be debited from the deposit account. What is the latest point in time for revoking the order to debit the renewal fee in Central Fee Payment (CFP)?\",\n",
      "        \"options\": [\n",
      "            \"A. 10 October 2024\",\n",
      "            \"B. 17 October 2024\",\n",
      "            \"C. 18 October 2024\",\n",
      "            \"D. A debit order cannot be revoked in part\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You receive an email on 30 October 2023 from a United States patent attorney asking you to enter the regional phase before the EPO in respect of international application PCT-1. The international application was filed at the United States Patent and Trademark Office on 14 March 2022 claiming priority from United States patent application US-1 filed 14 March 2021. Can you effect entry into the EPO regional phase?\",\n",
      "        \"options\": [\n",
      "            \"A. No, the 31-month period has expired.\",\n",
      "            \"B. Yes, provided the priority of US-1 is withdrawn.\",\n",
      "            \"C. Yes, provided use is made of the provisions for further processing.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The EPO as receiving office issues an invitation to the applicant to remedy certain defects in an international application within a time limit of two months from the date of invitation. The invitation is dated as being mailed on 22 September 2023 and is received by the applicant on 2 October 2023. What is the final date for responding to the invitation?\",\n",
      "        \"options\": [\n",
      "            \"A. 22 November 2023\",\n",
      "            \"B. 27 November 2023\",\n",
      "            \"C. 3 December 2023\",\n",
      "            \"D. 4 December 2023\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 60: {'question': 'If an applicant receives a debit order from the EPO for a Euro-PCT application entering the European phase, which includes the designation fee, when must the applicant pay this fee to avoid having the designation of certain contracting states deemed withdrawn under Rule 159(1)(d)?', 'options': ['A. Within 31 months from the filing or priority date if the time limit specified in Rule 39(1) has expired earlier.', 'B. Within 40 months from the filing or priority date regardless of any other deadlines.', 'C. Before the EPO sends a notification of loss of rights according to Rule 112(1).', 'D. There is no specific deadline; it can be paid at any time.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"International application PCT-1 was filed by applicant A on 5 January 2020 and the requirements for entry into the European regional phase were completed on 19 July 2022. European patent application EP-1 was filed by applicant B on 19 June 2022 validly claiming priority from Italian patent application IT-1 filed on 20 June 2021. PCT-1, EP-1 and IT-1 all relate to the same invention. What is the prior art effect of PCT-1 on EP-1?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT-1 has no prior art effect on EP-1.\",\n",
      "            \"B. PCT-1 will be part of the state of the art according to Article 54(3) EPC.\",\n",
      "            \"C. PCT-1 will be part of the state of the art according to Article 54(2) EPC.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The European Patent Office as receiving Office for an international patent application invites the applicant to provide a missing abstract within a period of two months. The invitation is dated 2 December 2022 and is received by the applicant on 12 December 2022. The date of receipt stamped on the communication by the mail service provides evidence of the receipt date. What is the final date for responding to the invitation?\",\n",
      "        \"options\": [\n",
      "            \"A. 2 February 2023\",\n",
      "            \"B. 13 February 2023\",\n",
      "            \"C. 5 February 2023\",\n",
      "            \"D. 6 February 2023\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Two applicants resident in Germany jointly file an international application with the EPO as receiving office. No agent or common representative is appointed. Following receipt of the international search report, the applicants both agree that the international application should be withdrawn, so the first-named applicant on Form PCT/RO/101 sends a letter, signed by him, to the EPO as receiving office specifically withdrawing the international application. Will the application be withdrawn?\",\n",
      "        \"options\": [\n",
      "            \"A. No\",\n",
      "            \"B. Yes\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 61: {'question': 'If an international application for patent protection is filed directly with the European Patent Office as the receiving office, which languages are acceptable according to Rule 157 of the EPC?', 'options': ['A. Only English', 'B. Only French and German', 'C. English, French, or German', 'D. Any language accepted by the Contracting States']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Company C files a European patent application for an invention which has been displayed at an officially recognised international exhibition. The exhibition closes two weeks after the invention was first displayed. Rule 25(d) EPC states that a suitable certificate must be filed within four months of the filing of the European patent application. Three months after filing the application, the applicant approaches the authority responsible for the protection of industrial property at the exhibition and obtains a certificate stating the information required according to Rule 25 EPC. The certificate is filed within the four-month period together with the authenticated identification of the invention. Will the certificate be accepted by the EPO?\",\n",
      "        \"options\": [\n",
      "            \"A. No, the certificate was not issued at the exhibition.\",\n",
      "            \"B. Yes, the certificate was filed within the specified four-month period.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?\",\n",
      "        \"options\": [\n",
      "            \"A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO\",\n",
      "            \"B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application\",\n",
      "            \"C. File an electronic certified copy of the Luxembourg patent application with the EPO\",\n",
      "            \"D. File a certified copy of the Luxembourg patent application with the International Bureau\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 62: {'question': 'According to Rule 25 EPC, which of the following must be stated on the certificate issued by the authority responsible for the protection of industrial property at an exhibition?', 'options': ['A. The name of the inventor and the detailed description of the invention.', 'B. The date when the invention was first publicly disclosed before filing the European patent application.', 'C. The location, dates, and names of the inventors of the invention displayed at the exhibition.', 'D. The information required by Rule 25 EPC including the dates when the invention was first publicly disclosed.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"You represent a client whose European patent has been opposed. The opposition division decides to maintain the patent in amended form. The invitation with the three-month time limit under Rule 82(2) EPC is sent on 16 August 2021, but proceedings are interrupted under Rule 142 EPC on 20 October 2021. The problems are resolved and the proceedings resume on 16 January 2022. When does the time limit under Rule 82(2)EPC end?\",\n",
      "        \"options\": [\n",
      "            \"A. 19 April 2022\",\n",
      "            \"B. 30 April 2022\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"International application PCT-1 was filed by applicant A on 5 January 2020 and the requirements for entry into the European regional phase were completed on 19 July 2022. European patent application EP-1 was filed by applicant B on 19 June 2022 validly claiming priority from Italian patent application IT-1 filed on 20 June 2021. PCT-1, EP-1 and IT-1 all relate to the same invention. What is the prior art effect of PCT-1 on EP-1?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT-1 has no prior art effect on EP-1.\",\n",
      "            \"B. PCT-1 will be part of the state of the art according to Article 54(3) EPC.\",\n",
      "            \"C. PCT-1 will be part of the state of the art according to Article 54(2) EPC.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The applicant for European patent application EP-1 has granted an exclusive license under the application. The exclusive licensee wishes to make its rights known by recording the license in the European Patent Register. \\nIs it possible to record the exclusive license?\",\n",
      "        \"options\": [\n",
      "            \"A. No, exclusive licenses cannot be recorded in the European Patent Register.\",\n",
      "            \"B. Yes, exclusive licenses can be recorded in the European Patent Register at the joint request of both the applicant and the licensee.\",\n",
      "            \"C. Yes, exclusive licenses can be recorded in the European Patent Register, but only by the applicant.\",\n",
      "            \"D. Yes, exclusive licences can be recorded in the European Patent Register by either the applicant or the licensee.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 63: {'question': 'According to Rule 24(a) EPC, under what condition can a licence in respect of a European patent application be recorded as an exclusive licence?', 'options': ['A. If the applicant alone requests it.', 'B. If both the applicant and the licensee so request.', 'C. If any third party requests it.', 'D. If the European Patent Office decides to do so.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The applicant for international application PCT-1 wishes to prevent publication of the application. What is the last day for withdrawing the application and \\npreventing publication?\",\n",
      "        \"options\": [\n",
      "            \"A. The 15th day prior to the date of publication.\",\n",
      "            \"B. Any time prior to the date of publication.\",\n",
      "            \"C. The end of the day five weeks before the end of the 18th month from the priority or filing date as appropriate.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Company M, which has  its principal place of business in Tijuana, Mexico, validly filed an international patent application PCT -M with the Mexican Institute of Industrial Property. The application was filed in Spanish. A few days later, the applicant files an English translati on of the application.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant can choose the EPO as ISA and the USPTO as IPEA.\",\n",
      "            \"B. The applicant can choose the USPTO as ISA and the EPO as IPEA.\",\n",
      "            \"C. The applicant can choose the Austrian Patent Offic e as ISA and the\",\n",
      "            \"EPO as IPEA.\",\n",
      "            \"D. The applicant can choose the EPO as ISA and the Intellectual Property\",\n",
      "            \"Office of Singapore as IPEA.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. As no renewal fees have been paid, the application is deemed to be withdrawn .\",\n",
      "            \"B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .\",\n",
      "            \"C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .\",\n",
      "            \"D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 64: {'question': 'An international application PCT-XYZ was filed on September 15, 2022. The applicant wishes to add an additional priority claim. According to Rule 26bis.1(a), by what latest date must the applicant submit a notice adding the priority claim?', 'options': ['A. September 30, 2022', 'B. November 30, 2022', 'C. March 15, 2023', 'D. January 15, 2024']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"In response to a Rule 71(3) communication you have filed, on the 2 April 2023, the required translations of the claims and paid the grant fee. Today, the 3 May 2023, you receive the decision to grant, dated 28 April 2023. The decision states that the mention of the grant will be published on the 24 May 2023. What is/was the last day a divisional application may be filed?\",\n",
      "        \"options\": [\n",
      "            \"A. 2 April 2023\",\n",
      "            \"B. 28 April 2023\",\n",
      "            \"C. 8 May 2023\",\n",
      "            \"D. 23 May 2023\",\n",
      "            \"E. 24 May 2023\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Your client filed an international patent application in 2021. In which of the following countries can they (directly) enter the national phase?\",\n",
      "        \"options\": [\n",
      "            \"A. Lithuania\",\n",
      "            \"B. France\",\n",
      "            \"C. Italy\",\n",
      "            \"D. None of the above\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Entry into the European phase of an international application can be effected early provided an express request for early processing is made at the time the requirements of Rule 159(1) EPC are complied with. International application PCT-1 was filed 28 months ago with no claim to priority. The application consists of 20 pages, including 16 claims. The international search was carried out by the EPO acting as ISA and the international search report was published with the international application. Which of the following fees must be paid in order to effect early entry into the European phase?\",\n",
      "        \"options\": [\n",
      "            \"A. The filing fee.\",\n",
      "            \"B. The filing fee, the examination fee and the designation fee.\",\n",
      "            \"C. The filing fee, the examination fee, the designation fee and the renewal fee.\",\n",
      "            \"D. The filing fee, the claims fee, the examination fee, the designation fee and the renewal fee.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 65: {'question': 'For an European patent application filed on 15 March 2023, by when must the filing fee and search fee be paid to avoid any delay in processing?', 'options': ['A. By 15 April 2023', 'B. By 15 May 2023', 'C. By 15 June 2023', 'D. By 15 December 2024']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"European patent application EP -X was filed on 1  October 2020, claiming the priority of a Belgian application filed on 16 October 2019. The mention of the grant of European patent EP -X was published on 2  October 2024. The proprietor filed a request for unitary effect and was informed by communication dated 10  October 2024, that unitary effect had been registered for EP -X-C0 on the same date. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. A renewal fee still has to be paid by 31 October 2024 in respect of the 5th year for EP -X\",\n",
      "            \"B. A renewal fee is due on 31 October 2024 in respect of the 5th year for EP -X-C0\",\n",
      "            \"C. A renewal fee is due on 31 October 2024 in respect of the 6th year for EP -X-C0\",\n",
      "            \"D. No renewal fee has to be paid on 31 October 2024\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Following entry into the EPO regional phase, a translation of the international \\napplication is not filed at the EPO in due time. How can this be remedied?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant can request reinstatement of rights under Rule 49.6 PCT.\",\n",
      "            \"B. The applicant can file the translation, request further processing and pay the further processing fee under Rule 135 EPC within two months \\nof notification by the EPO.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Entry into the European phase of an international application can be effected early provided an express request for early processing is made at the time the requirements of Rule 159(1) EPC are complied with. International application PCT-1 was filed 28 months ago with no claim to priority. The application consists of 20 pages, including 16 claims. The international search was carried out by the EPO acting as ISA and the international search report was published with the international application. Which of the following fees must be paid in order to effect early entry into the European phase?\",\n",
      "        \"options\": [\n",
      "            \"A. The filing fee.\",\n",
      "            \"B. The filing fee, the examination fee and the designation fee.\",\n",
      "            \"C. The filing fee, the examination fee, the designation fee and the renewal fee.\",\n",
      "            \"D. The filing fee, the claims fee, the examination fee, the designation fee and the renewal fee.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 66: {'question': 'An applicant filed an international application under PCT (PCT-App) at the International Bureau on 15 January 2023, claiming priority from a previous application filed on 16 January 2022. The application entered the regional phase in the European Patent Office on 15 December 2024. Which of the following fees must be paid by the applicant to effect entry into the European phase according to Rule 159(1) EPC, considering that no early processing was requested?', 'options': ['A. The filing fee and the claims fee.', 'B. The filing fee, the examination fee, and the designation fee.', 'C. The claims fee, the examination fee, and the designation fee.', 'D. The filing fee and the renewal fee.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The first communication from the examining division concerning a European patent application is unexpectedly negative. The applicant decides not to proceed further with the application. Can the applicant get a refund of fees in this situation?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"International application PCT-1 was not filed within 12 months of its priority application, the priority period being missed by 25 days. The applicant filed a request for restoration of the priority right at the receiving office and this was granted under the \\\"unintentional\\\" criterion before publication of the international application.\\nThe applicant realises that this is not sufficient for the EPO to grant restoration of the priority right and asks you to file a request for restoration after entry \\ninto the EPO regional phase. When does the request for restoration have to be filed at the EPO\",\n",
      "        \"options\": [\n",
      "            \"A. Within one month of the expiry of 31 months from the filing date of the priority right to be restored.\",\n",
      "            \"B. Within one month of the date on which the requirements of Rule 159(1) EPC are satisfied.\",\n",
      "            \"C. Within two months of the date on which the requirements of \\nRule 159(1) EPC are satisfied.\",\n",
      "            \"D. Within one month of the expiry of 31 months from the filing date of \\nthe international application.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 20  June 2023, applicant P validly filed an international patent application PCT-P, claiming priority from European patent application EP -I filed on 7 July 2022. Today, 12 October 2023, he discovers that he should also have claimed priority from EP -II filed on 3 July 2022. Can the missing priority claim still be validly added?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, the time  limit for adding the priority claim expires on 3  November 2023.\",\n",
      "            \"B. Yes, the time limit for adding the priority claim expires on 7  November 2023.\",\n",
      "            \"C. Yes, the time  limit for adding the priority claim expires on 20 October 2023.\",\n",
      "            \"D. No, the time  limit for adding the priority claim expired on 3 July 2023.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 67: {'question': 'If an international application was filed on 15 June 2021, claiming priority from an earlier application filed on 17 May 2020, within what time frame must the applicant file a request for restoration of the priority right to be considered by the EPO under Rule 49ter.2(b)(i) PCT and Article 22 PCT?', 'options': ['A. Within one month from 15 June 2023', 'B. Within two months from 17 May 2021', 'C. Within one month from 16 July 2023', 'D. Within two months from 15 June 2021']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"European patent application EP -X was filed on 1  October 2020, claiming the priority of a Belgian application filed on 16 October 2019. The mention of the grant of European patent EP -X was published on 2  October 2024. The proprietor filed a request for unitary effect and was informed by communication dated 10  October 2024, that unitary effect had been registered for EP -X-C0 on the same date. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. A renewal fee still has to be paid by 31 October 2024 in respect of the 5th year for EP -X\",\n",
      "            \"B. A renewal fee is due on 31 October 2024 in respect of the 5th year for EP -X-C0\",\n",
      "            \"C. A renewal fee is due on 31 October 2024 in respect of the 6th year for EP -X-C0\",\n",
      "            \"D. No renewal fee has to be paid on 31 October 2024\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"International patent application PCT- 1 was filed on 6 May 2021 without claiming priority. The application consists of 21 pages, including 17 claims. The international search was carried out by the EPO acting as ISA, and the international application was published together with the international search report after 18 months. On 12 December 2022, early entry into the European phase is requested. Which minimum requirement(s) must be fulfilled to validly effect early entry into the European phase according to Article 23(2) PCT?\",\n",
      "        \"options\": [\n",
      "            \"A. Payment of the filing fee\",\n",
      "            \"B. Payment of the filing fee and claims fees\",\n",
      "            \"C. Payment of the filing fee, the claims fees, the examination fee, the designation fee and the renewal fee for the third year\",\n",
      "            \"D. Payment of the filing fee, the designation fee and the examination fee\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In response to an opposition, the patentee introduces the features of claim 12 as granted into claim 1. Claim 12 was dependent on claim 1 and is phrased as a result to be achieved. The opponent argues that the amendment introduces a lack of clarity. Will the opposition division agree with the opponent?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes. A claim feature may not be phrased as a result to be achieved.\",\n",
      "            \"B. Perhaps. It depends on whether or not the feature phrased as a result to be achieved is considered to be clear.\",\n",
      "            \"C. No. Since the feature was already in the claims set the amendment does not introduce a lack of clarity.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 68: {'question': 'A European patent application EP-Y, filed on 15 June 2023, claimed priority from an earlier French application filed on 14 July 2022. The applicant wishes to enter the European phase early by paying the required fees before the normal deadline. Which of the following steps must be completed by the applicant to validly effect early entry into the European phase according to Article 89(1) EPC?', 'options': ['A. Payment of the designation fee only', 'B. Payment of the claims fees and examination fee only', 'C. Payment of the filing fee, claims fees, and examination fee', 'D. Payment of the filing fee, claims fees, examination fee, and designation fee']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Where an assumed infringer intervenes in opposition appeal proceedings, which of the following fees are payable?\",\n",
      "        \"options\": [\n",
      "            \"A. The opposition fee.\",\n",
      "            \"B. The appeal fee.\",\n",
      "            \"C. The opposition fee and the appeal fee.\",\n",
      "            \"D. The assumed infringer must pay the opposition fee and may choose whether to pay the appeal fee.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The opposition division revoked European patent EP -B1. The patent proprietor filed an appeal  in time . The b oard of appeal forwarded a copy of the appeal to the o pponent/ respondent with a communication dated 1 June 2023 giving it an opportunity to file comments within a period of four  months.  The opponent/respondent files comments today, 12 October 2023. What further action has to be taken ?\",\n",
      "        \"options\": [\n",
      "            \"A. The opponent/ respondent needs  to request an extension of the period for comment.\",\n",
      "            \"B. The opponent/respondent needs to pay a fee for further processing.\",\n",
      "            \"C. The opponent/respondent needs to file a substantiated request for reestablishment of rights and pay the associated fee.\",\n",
      "            \"D. None of the above.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Applicant X filed European patent application EP -X on 23 August 2019 as a first filing. The applicant filed application EP -Y as a divisional application of EP- X on 26 September 2022. Please consider the following statements:   2 I. The renewal fee for the fourth year for EP -X was due on 31 August 2022; the renewal fees for the third and fourth years for EP -Y were due on 26 September 2022 II. The renewal fee for the fourth year for EP -X can be validly paid on 28 February 2023 together with the necessary additional fee; the renewal fees for the third and fourth years for EP -Y can be validly paid without additional fee up to 31 January 2023  Which of the following items applies?\",\n",
      "        \"options\": [\n",
      "            \"A. Only statement I is correct\",\n",
      "            \"B. Only statement II is correct\",\n",
      "            \"C. Both statements I and II are correct\",\n",
      "            \"D. Both statements I and II are incorrect\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 69: {'question': 'If an intervener files during appeal proceedings and requests appellant status, which of the following fees must they pay according to the case law?', 'options': ['A. The opposition fee.', 'B. The appeal fee.', 'C. Both the opposition fee and the appeal fee.', 'D. No additional fee is required.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Company C files a European patent application for an invention which has been displayed at an officially recognised international exhibition. The exhibition closes two weeks after the invention was first displayed. Rule 25(d) EPC states that a suitable certificate must be filed within four months of the filing of the European patent application. Three months after filing the application, the applicant approaches the authority responsible for the protection of industrial property at the exhibition and obtains a certificate stating the information required according to Rule 25 EPC. The certificate is filed within the four-month period together with the authenticated identification of the invention. Will the certificate be accepted by the EPO?\",\n",
      "        \"options\": [\n",
      "            \"A. No, the certificate was not issued at the exhibition.\",\n",
      "            \"B. Yes, the certificate was filed within the specified four-month period.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Entry into the European phase of an international application can be effected early provided an express request for early processing is made at the time the requirements of Rule 159(1) EPC are complied with. International application PCT-1 was filed 28 months ago with no claim to priority. The application consists of 20 pages, including 16 claims. The international search was carried out by the EPO acting as ISA and the international search report was published with the international application. Which of the following fees must be paid in order to effect early entry into the European phase?\",\n",
      "        \"options\": [\n",
      "            \"A. The filing fee.\",\n",
      "            \"B. The filing fee, the examination fee and the designation fee.\",\n",
      "            \"C. The filing fee, the examination fee, the designation fee and the renewal fee.\",\n",
      "            \"D. The filing fee, the claims fee, the examination fee, the designation fee and the renewal fee.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Most fees for European patent applications cannot be paid before their due date. One exception is renewal fees, which can always be paid up to:\",\n",
      "        \"options\": [\n",
      "            \"A. Three months before the due date.\",\n",
      "            \"B. Six months before the due date.\",\n",
      "            \"C. One year before the due date.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 70: {'question': 'If an applicant wishes to file a European patent application for an invention that has been claimed with priority, within how many months of the filing date must they pay the search fee if early processing is not explicitly requested?', 'options': ['A. Within one month.', 'B. Before the 31-month period expires.', 'C. No payment required as it is waived for inventions with priority claims.', 'D. Within three months.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Following entry into the EPO regional phase, a translation of the international \\napplication is not filed at the EPO in due time. How can this be remedied?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant can request reinstatement of rights under Rule 49.6 PCT.\",\n",
      "            \"B. The applicant can file the translation, request further processing and pay the further processing fee under Rule 135 EPC within two months \\nof notification by the EPO.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A communication pursuant to Rule 71(3) EPC was issued for a European patent application. The applicant fulfilled all the necessary requirements . The related decision to grant a European patent was dispatched based on the text intended for grant transmitted to the applicant with the communication under Rule 71(3) EPC. The mention of the grant of the European patent was published in the European Patent Bulletin. During the preparation of the publication of the patent specification an error occurred in that page 2 of the description was omitted from the published specification of this European patent. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. This error in the published specification of this European patent may never be corrected\",\n",
      "            \"B. This error in the published specification of this European patent may be corrected at any time\",\n",
      "            \"C. This error in the published specification of this  European patent may not be corrected during the opposition period or if opposition proceedings are pending\",\n",
      "            \"D. The error may only be corrected if opposition proceedings are pending\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Which of the following statements about filing third- party observations is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The person that filed third- party observations will be a party to the proceedings before the EPO, and the applicant is obliged to respond to third- party observations\",\n",
      "            \"B. Third -party observations must be filed in writing and may not be filed anonymously\",\n",
      "            \"C. Third -party observations are considered by the examining division only if they include a statement of the grounds on which they are based, and an official fee is paid\",\n",
      "            \"D. Third -party observations can be filed after the publication of a European patent application and must be filed in an official language of the EPO\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 71: {'question': 'According to the Guidelines for Examination in the EPO, if documents are not filed in an official language of the EPO, which of the following statements is true?', 'options': ['A. They will be disregarded by the EPO and deemed not received.', 'B. They will be corrected by the EPO before further processing.', 'C. They will still be considered for examination purposes as long as they are submitted in a timely manner.', 'D. They may be published if the stage of preparations for B publication allows, even after being submitted late.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Antonia, an applicant living in Argentina and having Argentinian nationality, intends to file a European patent application EP -A and an international patent application PCT- A.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Antonia can validly file PCT- A with the International Bureau of WIPO\",\n",
      "            \"B. Antonia can validly file PCT -A with the EPO\",\n",
      "            \"C. Antonia can validly file EP -A with the EPO\",\n",
      "            \"D. None of the above\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"European patent application EP-1 is filed on 10 December 2020, but the inventor is not designated. The designation of the inventor is filed on 25 February 2022. Will the application be refused?\",\n",
      "        \"options\": [\n",
      "            \"A. No. The designation of the inventor was filed in due time.\",\n",
      "            \"B. Yes. The designation of the inventor was not filed in due time.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"International application PCT-1 is filed on 31 October 2023. It seeks to claim priority from European patent application EP-1 filed on 27 October 2022. Can the claim to priority be restored in the international phase so as to be effective in a subsequent EPO regional phase?\",\n",
      "        \"options\": [\n",
      "            \"A. No, the 12-month period has expired.\",\n",
      "            \"B. Yes, the applicant can request further processing.\",\n",
      "            \"C. Yes, the applicant can restore the priority claim provided that they can show that the date was missed unintentionally.\",\n",
      "            \"D. Yes, the applicant can restore the priority date provided that they \\ncan show that they were unable, despite taking all due care, to meet the time limit for claiming priority.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 72: {'question': 'If an international application has not designated any inventor by the 31-month deadline, what is the EPOs next step according to the Guidelines for Examination in the EPO, E-IX, 2.3.4?', 'options': ['A. The application is automatically refused without further notice.', 'B. The applicant is invited to file the designation of inventor within two months.', 'C. The application is considered withdrawn and cannot be rectified.', 'D. The EPO waives the requirement for designating an inventor.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"In the case of applicants entitled to a fee reduction under Rule 6(3) EPC, does the fee reduction include the additional fee for pages in excess of 35?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?\",\n",
      "        \"options\": [\n",
      "            \"A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO\",\n",
      "            \"B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application\",\n",
      "            \"C. File an electronic certified copy of the Luxembourg patent application with the EPO\",\n",
      "            \"D. File a certified copy of the Luxembourg patent application with the International Bureau\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You receive an email on 30 October 2023 from a United States patent attorney asking you to enter the regional phase before the EPO in respect of international application PCT-1. The international application was filed at the United States Patent and Trademark Office on 14 March 2022 claiming priority from United States patent application US-1 filed 14 March 2021. Can you effect entry into the EPO regional phase?\",\n",
      "        \"options\": [\n",
      "            \"A. No, the 31-month period has expired.\",\n",
      "            \"B. Yes, provided the priority of US-1 is withdrawn.\",\n",
      "            \"C. Yes, provided use is made of the provisions for further processing.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 73: {'question': 'According to the guidelines, within which time frame must the certified copy of the previous application (priority document) be filed for a European patent application?', 'options': ['A. Within 16 months from the filing date of the European patent application', 'B. Within 16 months from the priority date', 'C. Within 12 months from the priority date', 'D. Within 30 days from the filing date of the European patent application']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent application EP-A is refused in a decision dated 1 June 2023. Today is 15 July 2023. Is it still possible to file a divisional application from EP-A?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes.\",\n",
      "            \"B. No.\",\n",
      "            \"C. Only if the decision to refuse the application is appealed.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"International application PCT-1 was filed by applicant A on 5 January 2020 and the requirements for entry into the European regional phase were completed on 19 July 2022. European patent application EP-1 was filed by applicant B on 19 June 2022 validly claiming priority from Italian patent application IT-1 filed on 20 June 2021. PCT-1, EP-1 and IT-1 all relate to the same invention. What is the prior art effect of PCT-1 on EP-1?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT-1 has no prior art effect on EP-1.\",\n",
      "            \"B. PCT-1 will be part of the state of the art according to Article 54(3) EPC.\",\n",
      "            \"C. PCT-1 will be part of the state of the art according to Article 54(2) EPC.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 74: {'question': 'If a European divisional application is filed for subject-matter contained in a pending Euro-PCT application, which of the following conditions must be met according to the Guidelines for Examination in the EPO?', 'options': ['A. The divisional application can be filed before the Euro-PCT application enters the European phase.', 'B. The divisional application must be filed on the same day as the parent application.', 'C. The divisional application may only be filed after the time limit under Rule 159(1) (in conjunction with Art. 22(1) PCT and Art. 22(3) PCT) has expired, provided any requirement of Art. 22(1) PCT which must be fulfilled within that time limit is met.', 'D. The divisional application can be filed at any time as long as it relates to subject-matter contained in a pending Euro-PCT application.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"European patent EP-B is granted with a claim directed to a method of operating a heart pacemaker in dependence upon the required cardiac output while a person is exercising, the pacemaker including a pressure sensing means mounted on a pacing lead and adapted to be implanted in a heart and used to sense the right ventricular systolic pressure, which pressure is used to control the pacer rate. Is it permissible in opposition or opposition appeal proceedings to amend the claim to be directed to a heart pacemaker in order to address problems relating to Article 53(c) EPC?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, a change in claim category is permitted.\",\n",
      "            \"B. No, a change in claim category would contravene Article 123(3) EPC.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In the case of applicants entitled to a fee reduction under Rule 6(3) EPC, does the fee reduction include the additional fee for pages in excess of 35?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The applicant received a communication pursuant to Article 90(3) EPC and Rule  60 EPC, requesting them to file a designation of inventor but missed the time limit for filing a response. After expiry of the time limit, the Receiving Section issued a decision to refuse the European patent application, dated 10  October 2024. What can the applicant do to remedy the situation?\",\n",
      "        \"options\": [\n",
      "            \"A. File a notice of appeal against the decision within four months of notification of the decision\",\n",
      "            \"B. File a request for further processing within two months of notification of the decision\",\n",
      "            \"C. File, within two months of notification of the decision, a request for re-establishment of rights in respect of the time limit for filing the designation of inventor\",\n",
      "            \"D. A, B and C are correct\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 75: {'question': \"If an original claim for a method of operating a pacemaker containing both 'device features' and 'method features' is amended to include only 'device features', would such an amendment be permissible under Article 123(3) EPC?\", 'options': ['A. Yes, because the amendment clarifies the scope of protection.', 'B. No, because it would broaden the claim and contravene Article 123(3) EPC.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"International application PCT-1 was filed by applicant A on 5 January 2020 and the requirements for entry into the European regional phase were completed on 19 July 2022. European patent application EP-1 was filed by applicant B on 19 June 2022 validly claiming priority from Italian patent application IT-1 filed on 20 June 2021. PCT-1, EP-1 and IT-1 all relate to the same invention. What is the prior art effect of PCT-1 on EP-1?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT-1 has no prior art effect on EP-1.\",\n",
      "            \"B. PCT-1 will be part of the state of the art according to Article 54(3) EPC.\",\n",
      "            \"C. PCT-1 will be part of the state of the art according to Article 54(2) EPC.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You are monitoring the progress of an international application and on reviewing the details of the international search report you realize that you know of relevant prior art that has not been cited in the search report, but which is likely to be novelty-destroying in respect of at least some of the claims. \\nYou believe that the international application will enter the national or regional phase in a significant number of countries or regions and it would therefore be time-consuming and costly to file separate observations in respect of each of \\nthe national or regional applications. What can you do?\",\n",
      "        \"options\": [\n",
      "            \"A. File observations online using ePCT.\",\n",
      "            \"B. Send a letter with your observations to the receiving office or the International Bureau.\",\n",
      "            \"C. File observations by letter.\",\n",
      "            \"D. It is not possible to file observations on international applications.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 76: {'question': 'If an applicant fails to pay the designation fee for a Euro-PCT application entering the European phase within 31 months from the filing or priority date, what consequence will occur according to Rule 157(2) EPC?', 'options': ['A. The application will be automatically withdrawn and cannot proceed further.', 'B. The designation of those Contracting States that are Member States of the European Union shall be deemed to be withdrawn in accordance with Rule 39, paragraph 2a.', 'C. The applicant has a grace period of six months from the due date to pay the fee without any consequences.', 'D. The application will proceed as normal and no action is required.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"In response to a Rule 71(3) communication you have filed, on the 2 April 2023, the required translations of the claims and paid the grant fee. Today, the 3 May 2023, you receive the decision to grant, dated 28 April 2023. The decision states that the mention of the grant will be published on the 24 May 2023. What is/was the last day a divisional application may be filed?\",\n",
      "        \"options\": [\n",
      "            \"A. 2 April 2023\",\n",
      "            \"B. 28 April 2023\",\n",
      "            \"C. 8 May 2023\",\n",
      "            \"D. 23 May 2023\",\n",
      "            \"E. 24 May 2023\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"International patent application PCT- 1 was filed on 6 May 2021 without claiming priority. The application consists of 21 pages, including 17 claims. The international search was carried out by the EPO acting as ISA, and the international application was published together with the international search report after 18 months. On 12 December 2022, early entry into the European phase is requested. Which minimum requirement(s) must be fulfilled to validly effect early entry into the European phase according to Article 23(2) PCT?\",\n",
      "        \"options\": [\n",
      "            \"A. Payment of the filing fee\",\n",
      "            \"B. Payment of the filing fee and claims fees\",\n",
      "            \"C. Payment of the filing fee, the claims fees, the examination fee, the designation fee and the renewal fee for the third year\",\n",
      "            \"D. Payment of the filing fee, the designation fee and the examination fee\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Company X wishes to file an opposition to European patent EP-B, which was recently granted to its main competitor, company Y. To avoid retaliation, company X would prefer not to file the opposition in its own name. It therefore asks a European patent attorney to file the opposition in her name. Will the EPO accept this?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\",\n",
      "            \"C. Only if the patentee does not object\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 77: {'question': 'For an applicant filing a Euro-PCT application, when must the filing fees and search fees be paid?', 'options': ['A. Within one month of filing the European patent application', 'B. Upon entry into the regional phase, regardless of language', 'C. Before the EPO receives Form 1200 or a separate letter with all required information', \"D. According to Rule 159(1)(a) EPC, upon entering the European phase if published in 'another language'\", 'E. With the request for early processing']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"You are informed that one of the inventors named in an international application is incorrect. The application names Mr Y, but the correct inventor is Mrs Z. What should you do?\",\n",
      "        \"options\": [\n",
      "            \"A. Obtain the consent of Mr Y to rectification of the inventor before filing a request at the International Bureau with details of the correct inventor.\",\n",
      "            \"B. File a request for rectification at the International Bureau with details of the correct inventor.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"International patent application PCT-1 is filed on 16 June 2019 without any claim to priority. Steps are taken to enter the EPO regional phase on 26 December 2021. When should the renewal fee in respect of the third year be paid (without surcharge)?\",\n",
      "        \"options\": [\n",
      "            \"A. 30 June 2021\",\n",
      "            \"B. 26 December 2021\",\n",
      "            \"C. 2 January 2022\",\n",
      "            \"D. 17 January 2022\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Claim 1 of European patent application EP-1 originally defines a polymer blend XY containing, as a filler, graphite, talc, asbestos or silica. \\nThe European search report identifies prior art disclosing a polymer blend XY containing asbestos. Is it permissible under Article 123(2) EPC to restrict the list of fillers by simply omitting asbestos, i.e., to claim a polymer blend XY containing, as a filler, graphite, talc or silica?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 78: {'question': 'If an inventor has not been named in the international application at the expiry of the 31-month time limit, what action can the EPO take?', 'options': ['A. The application will be automatically withdrawn.', 'B. The EPO will refuse the application according to Rule 163(6).', 'C. The applicant will be given an indefinite period to rectify the deficiency.', 'D. The EPO will name a default inventor.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"You filed an international patent application on 6 June 2024, claiming the priority of a European patent application filed on 7  July 2023. You received a communication dated 25 September 2024 from the EPO acting as International Searching Authority (ISA), stating that the requirement of unity of invention has not been complied with. The ISA identifies three inventions. You are invited to pay two additional search fees. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. You must pay two additional search fees by 25 October 2024\",\n",
      "            \"B. You do not need to file a response to the provisional opinion accompanying the partial search results\",\n",
      "            \"C. If you pay two additional search fees under protest, you must pay two protest fees within the time limit\",\n",
      "            \"D. If you do not pay any additional search fees within the time limit, the international patent application will be deemed to be withdrawn\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"European patent application EP -X was filed on 1  October 2020, claiming the priority of a Belgian application filed on 16 October 2019. The mention of the grant of European patent EP -X was published on 2  October 2024. The proprietor filed a request for unitary effect and was informed by communication dated 10  October 2024, that unitary effect had been registered for EP -X-C0 on the same date. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. A renewal fee still has to be paid by 31 October 2024 in respect of the 5th year for EP -X\",\n",
      "            \"B. A renewal fee is due on 31 October 2024 in respect of the 5th year for EP -X-C0\",\n",
      "            \"C. A renewal fee is due on 31 October 2024 in respect of the 6th year for EP -X-C0\",\n",
      "            \"D. No renewal fee has to be paid on 31 October 2024\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 79: {'question': 'You filed a European patent application on 5 February 2023, claiming the priority of an earlier filed European application on 7 March 2022. The EPO sent you a communication dated 15 August 2023, stating that the requirement for unity of invention has not been complied with and identifying four distinct inventions. You are invited to pay additional search fees. According to the guidelines provided, which statement is correct?', 'options': ['A. You must pay all four additional search fees by 15 September 2023', 'B. You can submit a request for unitary effect before paying any additional search fees', 'C. If you decide to file a response, it should be submitted within two months from the date of receipt of the communication or within the time limit for paying the additional search fees, whichever is later', 'D. The application will automatically proceed with all identified inventions without your input']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Company M, which has  its principal place of business in Tijuana, Mexico, validly filed an international patent application PCT -M with the Mexican Institute of Industrial Property. The application was filed in Spanish. A few days later, the applicant files an English translati on of the application.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant can choose the EPO as ISA and the USPTO as IPEA.\",\n",
      "            \"B. The applicant can choose the USPTO as ISA and the EPO as IPEA.\",\n",
      "            \"C. The applicant can choose the Austrian Patent Offic e as ISA and the\",\n",
      "            \"EPO as IPEA.\",\n",
      "            \"D. The applicant can choose the EPO as ISA and the Intellectual Property\",\n",
      "            \"Office of Singapore as IPEA.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The first communication from the examining division concerning a European patent application is unexpectedly negative. The applicant decides not to proceed further with the application. Can the applicant get a refund of fees in this situation?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You represent an individual applicant from Spain who has filed a European patent application in Spanish and satisfied all the requirements for filing. Examination was requested in Spanish at the time of filing the application. The examination and designation fees are due by 7 November 2023 and the applicant has asked you whether he is entitled to a reduction of 20% in the examination fee. What is the correct answer?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant is entitled to a reduction of 20% in the examination fee under Rule 6(3) EPC and Article 14(1) RFees.\",\n",
      "            \"B. The applicant is entitled to a reduction in the examination fee under Rule 6(3)EPC and Article 14(1) RFees, but the reduction is not 20%.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 80: {'question': 'An applicant from Italy wishes to file a European patent application in Italian, which is an admissible non-EPO language. According to the guidelines, what must be done regarding the translation of the request for examination?', 'options': ['A. The translation must be filed simultaneously with the request.', 'B. No translation is required if the applicant selects the request for examination in Italian on EPO Forms 1001 or 1200.', 'C. A translation must be filed before the request for examination can be processed.', 'D. The applicant must file a separate declaration stating that no translation is needed.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"In the case of applicants entitled to a fee reduction under Rule 6(3) EPC, does the fee reduction include the additional fee for pages in excess of 35?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Antonia, an applicant living in Argentina and having Argentinian nationality, intends to file a European patent application EP -A and an international patent application PCT- A.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Antonia can validly file PCT- A with the International Bureau of WIPO\",\n",
      "            \"B. Antonia can validly file PCT -A with the EPO\",\n",
      "            \"C. Antonia can validly file EP -A with the EPO\",\n",
      "            \"D. None of the above\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 81: {'question': 'For international applications filed between July 1, 2020, and October 31, 2022, how do corrections made by the receiving Office under Rule 20.5bis(d) PCT affect their validity in proceedings before the EPO as designated or elected Office?', 'options': ['A. Corrections are effective', 'B. Corrections are not effective', 'C. Corrections are only effective if the applicant requests early processing', 'D. Corrections are always effective regardless of filing date']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"What is the last point in time for an effective withdrawal of a European patent application?\",\n",
      "        \"options\": [\n",
      "            \"4 A.  Date of receipt of the communication under Rule 71(3) EPC\",\n",
      "            \"B.  The latest of the date of payment of the fee for grant and publishing and the date of filing of the translations of the claims in the two other official languages of the EPO\",\n",
      "            \"C.  Date of publication of the mention of the grant in the European Patent Bulletin\",\n",
      "            \"D.  One day before the date of publication of the mention of the grant in the European Patent Bulletin\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .\",\n",
      "            \"B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .\",\n",
      "            \"C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .\",\n",
      "            \"D. Ms Smith can only be deleted as inventor with her consent .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You filed a European patent application which discloses a new amino acid sequence. This sequence is however only used in a single example and is not part of the claims. No sequence listing was filed.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. If you are invited by the EPO to file a sequence listing, you need to file it and pay a late furnishing fee to the EPO\",\n",
      "            \"B. If you are invited by the EPO to file a sequence listing and do not react to this invitation in due time, the application is deemed to be withdrawn\",\n",
      "            \"C. If you are invited by the EPO to file a sequence listing, you need to file it in PDF format\",\n",
      "            \"D. You do not need to file any sequence listing because the amino acid sequence is not claimed\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 82: {'question': 'If an applicant wishes to withdraw their European patent application before publication, which of the following actions must they take according to Rule 67(2) EPC?', 'options': ['A. Send an oral declaration to the EPO', 'B. File a written declaration using EPO Form 1018 for clarity and unambiguity', 'C. Submit a signed letter stating their intent without specific form requirements', 'D. Publish a public notice in the European Patent Bulletin']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"International application PCT-1 enters the European regional phase as EP-1 today. Independent claims 1 and 10 of the international application were considered to lack unity in the international phase and a partial search report was drawn up by the EPO as ISA in respect of the invention of claim 1. The applicant wishes to have the opportunity to protect the invention of claim 10 during the EPO regional phase, but wants to keep costs to a minimum, at least at the beginning. What can the applicant do?\",\n",
      "        \"options\": [\n",
      "            \"A. File a divisional application to the invention of independent claim 10 after entry into the EPO regional phase.\",\n",
      "            \"B. Pay an additional search fee in respect of the invention of independent claim 10 within two months of entry into the EPO regional phase.\",\n",
      "            \"C. Pay an additional search fee in respect of the invention of independent claim 10 within two months of notification by the EPO.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A professional representative acts as agent for the following actions:  I.  Withdrawing an international patent application at the European Patent Office as receiving Office  II.  Filing a demand for international preliminary examination for an international patent application at the European Patent Office as International Preliminary Examining Authority   Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A.  For both I and II a power of attorney signed by each applicant is always required\",\n",
      "            \"B.  For I a power of attorney signed by each applicant is always required\",\n",
      "            \"C.  For II a power of attorney signed by each applicant is always required\",\n",
      "            \"D.  For both I and II the requirement to submit a power of attorney signed by each applicant may be waived   3\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 83: {'question': 'For an Euro-PCT application where the EPO acted as both the International Searching Authority (ISA) and the International Preliminary Examining Authority (IPEA), what must the applicant do if they wish to address any objections raised in the WO-ISA or IPER?', 'options': ['A. File a response with amendments and/or observations within six months from receipt of the communication under Rule 161(1).', 'B. Pay an additional fee for supplementary international search before responding.', 'C. Request a delay in the processing timeline to gather more information.', 'D. Submit a new application with revised claims separately.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Company C files a European patent application for an invention which has been displayed at an officially recognised international exhibition. The exhibition closes two weeks after the invention was first displayed. Rule 25(d) EPC states that a suitable certificate must be filed within four months of the filing of the European patent application. Three months after filing the application, the applicant approaches the authority responsible for the protection of industrial property at the exhibition and obtains a certificate stating the information required according to Rule 25 EPC. The certificate is filed within the four-month period together with the authenticated identification of the invention. Will the certificate be accepted by the EPO?\",\n",
      "        \"options\": [\n",
      "            \"A. No, the certificate was not issued at the exhibition.\",\n",
      "            \"B. Yes, the certificate was filed within the specified four-month period.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In opposition proceedings a patent proprietor has proposed amendments to claims 1, 3 and 4 of its patent to overcome issues of novelty and inventive step. The proprietor has also noted a problem with the clarity of claim 2 and has additionally proposed an amendment to this claim. Is the amendment of claim 2 permitted?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 84: {'question': 'Company XYZ files a European patent application for an invention disclosed at an international exhibition, which closed three months after the initial display of the invention. According to Rule 25 EPC, what must Company XYZ do within four months of filing the application to ensure compliance with the certificate requirements?', 'options': ['A. File a certificate issued by any authority stating that the invention was displayed.', \"B. Obtain and file a certificate from the exhibition's authority confirming the display and first disclosure date.\", 'C. Wait for the EPO to issue a notification regarding the need for a certificate.', 'D. Submit a declaration of compliance with Rule 25 instead of obtaining an official certificate.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"European patent application EP-1 is filed on 10 December 2020, but the inventor is not designated. The designation of the inventor is filed on 25 February 2022. Will the application be refused?\",\n",
      "        \"options\": [\n",
      "            \"A. No. The designation of the inventor was filed in due time.\",\n",
      "            \"B. Yes. The designation of the inventor was not filed in due time.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?\",\n",
      "        \"options\": [\n",
      "            \"A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO\",\n",
      "            \"B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application\",\n",
      "            \"C. File an electronic certified copy of the Luxembourg patent application with the EPO\",\n",
      "            \"D. File a certified copy of the Luxembourg patent application with the International Bureau\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You represent an individual applicant from Spain who has filed a European patent application in Spanish and satisfied all the requirements for filing. Examination was requested in Spanish at the time of filing the application. The examination and designation fees are due by 7 November 2023 and the applicant has asked you whether he is entitled to a reduction of 20% in the examination fee. What is the correct answer?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant is entitled to a reduction of 20% in the examination fee under Rule 6(3) EPC and Article 14(1) RFees.\",\n",
      "            \"B. The applicant is entitled to a reduction in the examination fee under Rule 6(3)EPC and Article 14(1) RFees, but the reduction is not 20%.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 85: {'question': 'A European patent application was filed with the EPO in Dutch on 15 March 2023, which is an admissible non-EPO language. If additional documents are submitted to support the application and these documents are not in one of the official EPO languages, what will happen according to the guidelines?', 'options': ['A. The documents will be disregarded by the EPO.', 'B. The documents must be translated into an official EPO language before they can be considered.', 'C. The documents are included in the file without note being taken of their content and deemed not filed.', 'D. The applicant is required to submit a valid DAS code to access these documents.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On receipt of the decision to grant its European patent application EP-1 under Rule 71a(1) EPC the applicant realizes that they have made a significant typographical error in claim 1. \\nWhat action can they take before the EPO to correct the error?\",\n",
      "        \"options\": [\n",
      "            \"A. None\",\n",
      "            \"B. Seek correction under Rule 140 EPC\",\n",
      "            \"C. Seek correction under Rule 139 EPC\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You file an international application for an applicant on 6 November 2023, but do not pay the fees because the applicant wishes to delay paying them as long as possible. The fees are due by 6 December 2023, but are not paid until 11 December 2023. What is the most likely outcome?\",\n",
      "        \"options\": [\n",
      "            \"A. The international application will be considered to be withdrawn.\",\n",
      "            \"B. The fees will be accepted as if they had been paid within the one-month period.\",\n",
      "            \"C. The applicant will be sent an invitation to pay a late payment fee of 50% of the fees due.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A communication pursuant to Rule 71(3) EPC was issued for a European patent application. The applicant fulfilled all the necessary requirements . The related decision to grant a European patent was dispatched based on the text intended for grant transmitted to the applicant with the communication under Rule 71(3) EPC. The mention of the grant of the European patent was published in the European Patent Bulletin. During the preparation of the publication of the patent specification an error occurred in that page 2 of the description was omitted from the published specification of this European patent. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. This error in the published specification of this European patent may never be corrected\",\n",
      "            \"B. This error in the published specification of this European patent may be corrected at any time\",\n",
      "            \"C. This error in the published specification of this  European patent may not be corrected during the opposition period or if opposition proceedings are pending\",\n",
      "            \"D. The error may only be corrected if opposition proceedings are pending\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 86: {'question': 'An applicant receives a communication under Rule 71(3) EPC which includes an invitation to pay the fee for grant and publishing along with any claims fees due, as well as file translations of the claims in the two official languages. The applicant pays all these fees but does not file the translation within the specified period. What is the likely consequence according to Rule 71(6) EPC?', 'options': ['A. The European patent application will be deemed to have been abandoned.', 'B. The decision to grant the European patent will still issue, and the applicant can file the missing translation later without any consequences.', 'C. The decision to grant the European patent will not issue until both the payment and the filing of the translation are completed within the specified period.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A patent proprietor requests revocation under Article 105a EPC of its European patent EP-B, which has been validated in Germany, France and Spain. It has an exclusive licensee in Germany. Will the request for revocation be considered to be admissible?\",\n",
      "        \"options\": [\n",
      "            \"A. No, the patent proprietor must file evidence that it is entitled to act on behalf of the exclusive licensee.\",\n",
      "            \"B. Yes, the existence of an exclusive licensee has no bearing on the admissibility of the request for revocation.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application EP-A is refused in a decision dated 1 June 2023. Today is 15 July 2023. Is it still possible to file a divisional application from EP-A?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes.\",\n",
      "            \"B. No.\",\n",
      "            \"C. Only if the decision to refuse the application is appealed.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"EP-1 is a regular European patent application (Euro -direct application) .  Which one of the following missed time limits can be remedied for EP -1 before the EPO by requesting re- establishment of rights ?\",\n",
      "        \"options\": [\n",
      "            \"A. T ime limit for pay ing the designation fee\",\n",
      "            \"B. T ime limit for requesting examination\",\n",
      "            \"C. T ime limit for filing the application within the priority period\",\n",
      "            \"D. T ime limit for paying the fee for re- establishment of rights\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 87: {'question': 'If a European patent proprietor files a request for limitation under Article 105a EPC, which of the following must be true before the request can be processed by the European Patent Office?', 'options': ['A. The proprietor must pay the limitation or revocation fee.', 'B. There must be no pending opposition proceedings against the patent.', 'C. Both A and B must be satisfied.', 'D. The proprietor must provide additional evidence of entitlement to act on behalf of an exclusive licensee.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"On 20  June 2023, applicant P validly filed an international patent application PCT-P, claiming priority from European patent application EP -I filed on 7 July 2022. Today, 12 October 2023, he discovers that he should also have claimed priority from EP -II filed on 3 July 2022. Can the missing priority claim still be validly added?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes, the time  limit for adding the priority claim expires on 3  November 2023.\",\n",
      "            \"B. Yes, the time limit for adding the priority claim expires on 7  November 2023.\",\n",
      "            \"C. Yes, the time  limit for adding the priority claim expires on 20 October 2023.\",\n",
      "            \"D. No, the time  limit for adding the priority claim expired on 3 July 2023.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. As no renewal fees have been paid, the application is deemed to be withdrawn .\",\n",
      "            \"B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .\",\n",
      "            \"C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .\",\n",
      "            \"D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 10 October 2021, European patent attorney X filed European patent application EP -A with the EPO on the applicant's behalf. Application EP -A was published on 12 April 2023, together  with the extended European search report. On 6  October 2023, the applicant contacts a new European patent attorney  Y to replace X as representative and issues Y with its instructions to reply to the extended European search report. The applicant did not inform X that he would be replaced.  What are the steps necessary to validly appoint representative Y and to avoid any loss of rights for European patent application EP -A?\",\n",
      "        \"options\": [\n",
      "            \"A. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 12 October 2023 at the latest and files in good time an authorisation signed by the applicant .\",\n",
      "            \"B. New representative Y requests a change of representative and files a response to the extended European search report with  the EPO by 12 October 2023 at the latest .\",\n",
      "            \"C. New representative Y requests a change of representative and files a response to the extended European search report with the EPO by 23 October 2023 at the latest.\",\n",
      "            \"D. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 23 October 2023 at the latest and files in good time an authorisation signed by the applicant .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 88: {'question': 'On 15 June 2023, applicant Z filed a European patent application EP-B with the EPO. On 1 October 2023, they discovered that they should have also claimed priority from an earlier filing, EP-C, which was filed on 15 January 2023. What is the latest date by which applicant Z can validly add the missing priority claim?', 'options': ['A. By 15 October 2023', 'B. By 15 December 2023', 'C. By 15 May 2024', 'D. The priority can no longer be added as the time limit has expired']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"After receipt of a negative written opinion issued by the EPO acting as ISA, amendments under Art icle 19 PCT were filed during the international phase. No request for international preliminary examination was filed. Form  1200 was used,  and no further amendments were filed with the EPO upon entry into the regional phase.   What communication under Rules  161/162 EPC will be received in the regional phase?\",\n",
      "        \"options\": [\n",
      "            \"A. Form 1226AA ;  if you do not reply to it in time, the application will be deemed to be withdrawn\",\n",
      "            \"B. Form 1226BB offering the opportunity to comment and file amendments\",\n",
      "            \"C. Form 1226CC offering the opportunity to file amendments before the supplementary European search report is drawn up\",\n",
      "            \"D. Form 1226AC stating that the examination has started\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The first communication from the examining division concerning a European patent application is unexpectedly negative. The applicant decides not to proceed further with the application. Can the applicant get a refund of fees in this situation?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. As no renewal fees have been paid, the application is deemed to be withdrawn .\",\n",
      "            \"B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .\",\n",
      "            \"C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .\",\n",
      "            \"D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest .\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 89: {'question': 'If an applicant wishes to withdraw their European patent application before substantive examination has begun, what will happen to the examination fee paid?', 'options': ['A. The examination fee is fully refunded.', 'B. The examination fee is partially refunded.', 'C. No refund of the examination fee will be given.', 'D. The applicant can reclaim the examination fee by filing a legal remedy.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Company M, which has  its principal place of business in Tijuana, Mexico, validly filed an international patent application PCT -M with the Mexican Institute of Industrial Property. The application was filed in Spanish. A few days later, the applicant files an English translati on of the application.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant can choose the EPO as ISA and the USPTO as IPEA.\",\n",
      "            \"B. The applicant can choose the USPTO as ISA and the EPO as IPEA.\",\n",
      "            \"C. The applicant can choose the Austrian Patent Offic e as ISA and the\",\n",
      "            \"EPO as IPEA.\",\n",
      "            \"D. The applicant can choose the EPO as ISA and the Intellectual Property\",\n",
      "            \"Office of Singapore as IPEA.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \\\" Decision to grant a European patent pursuant to Article  97(1) EPC \\\". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.\",\n",
      "            \"B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.\",\n",
      "            \"C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .\",\n",
      "            \"D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest .\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Most fees for European patent applications cannot be paid before their due date. One exception is renewal fees, which can always be paid up to:\",\n",
      "        \"options\": [\n",
      "            \"A. Three months before the due date.\",\n",
      "            \"B. Six months before the due date.\",\n",
      "            \"C. One year before the due date.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 90: {'question': \"You have filed a European patent application EP -X, which claims priority from an earlier filing. Today's date is 15 January 2024. According to Rule 17(1) EPC, the due date for payment of the search fee and the examination fee is one month after the filing date. Which of the following statements is correct regarding these fees?\", 'options': ['A. The fees must be paid by 15 February 2024 at the latest.', 'B. The fees must be paid by 15 March 2024 at the latest.', 'C. The fees must be paid by 31 January 2024 at the latest.', 'D. The fees can be paid anytime within the 31-month period starting from the priority date.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"You represent an individual applicant from Spain who has filed a European patent application in Spanish and satisfied all the requirements for filing. Examination was requested in Spanish at the time of filing the application. The examination and designation fees are due by 7 November 2023 and the applicant has asked you whether he is entitled to a reduction of 20% in the examination fee. What is the correct answer?\",\n",
      "        \"options\": [\n",
      "            \"A. The applicant is entitled to a reduction of 20% in the examination fee under Rule 6(3) EPC and Article 14(1) RFees.\",\n",
      "            \"B. The applicant is entitled to a reduction in the examination fee under Rule 6(3)EPC and Article 14(1) RFees, but the reduction is not 20%.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"In which of the following situations does the EPO recommend using the EPO Contingency Upload Service?\",\n",
      "        \"options\": [\n",
      "            \"A. When you submit documents after business hours\",\n",
      "            \"B. When the EPO filing systems are functioning correctly, but you encounter a technical issue at your end\",\n",
      "            \"C. When there is a system outage at the EPO that prevents document submission via the standard filing systems\",\n",
      "            \"D. When the EPO is closed due to an official holiday\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"EP-1 is a regular European patent application (Euro -direct application) .  Which one of the following missed time limits can be remedied for EP -1 before the EPO by requesting re- establishment of rights ?\",\n",
      "        \"options\": [\n",
      "            \"A. T ime limit for pay ing the designation fee\",\n",
      "            \"B. T ime limit for requesting examination\",\n",
      "            \"C. T ime limit for filing the application within the priority period\",\n",
      "            \"D. T ime limit for paying the fee for re- establishment of rights\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 91: {'question': 'If an applicant files a European patent application in Dutch, which is an official language of a contracting state other than English, French or German, what reduction is applicable according to the Guidelines for Examination in the EPO, A-X, 9.2.1 and A-X, 9.2.2?', 'options': ['A. No filing fee reduction as Dutch is not an official EPO language', 'B. A 30% reduction of the filing and/or examination fee for certain categories of applicants', 'C. A full waiver of both the filing and examination fees', 'D. An additional 20% reduction on top of the standard fee']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The applicant for European patent application EP-1 has granted an exclusive license under the application. The exclusive licensee wishes to make its rights known by recording the license in the European Patent Register. \\nIs it possible to record the exclusive license?\",\n",
      "        \"options\": [\n",
      "            \"A. No, exclusive licenses cannot be recorded in the European Patent Register.\",\n",
      "            \"B. Yes, exclusive licenses can be recorded in the European Patent Register at the joint request of both the applicant and the licensee.\",\n",
      "            \"C. Yes, exclusive licenses can be recorded in the European Patent Register, but only by the applicant.\",\n",
      "            \"D. Yes, exclusive licences can be recorded in the European Patent Register by either the applicant or the licensee.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"During the examination proceedings the applicant notes that claim 1 contains a typographical error. What is the last point in time for requesting correction of the error under Rule 139 EPC?\",\n",
      "        \"options\": [\n",
      "            \"A. One day before the decision to grant a European patent is handed over to the EPO postal service\",\n",
      "            \"B. Date  of publication of the mention of the grant of the European patent\",\n",
      "            \"C. Date of notification of the decision to grant\",\n",
      "            \"D. Date of the communication under Rule 71(3) EPC\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"A communication pursuant to Rule 71(3) EPC was issued for a European patent application. The applicant fulfilled all the necessary requirements . The related decision to grant a European patent was dispatched based on the text intended for grant transmitted to the applicant with the communication under Rule 71(3) EPC. The mention of the grant of the European patent was published in the European Patent Bulletin. During the preparation of the publication of the patent specification an error occurred in that page 2 of the description was omitted from the published specification of this European patent. Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. This error in the published specification of this European patent may never be corrected\",\n",
      "            \"B. This error in the published specification of this European patent may be corrected at any time\",\n",
      "            \"C. This error in the published specification of this  European patent may not be corrected during the opposition period or if opposition proceedings are pending\",\n",
      "            \"D. The error may only be corrected if opposition proceedings are pending\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 92: {'question': 'If an exclusive license for a European patent application is to be recorded as such, what condition must both parties satisfy according to Rule 24(a) EPC?', 'options': ['A. The licensee alone must agree.', 'B. Both the applicant and the licensee must request it.', 'C. The president of the EPO must grant approval.', 'D. The European Patent Office must initiate the recording process.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?\",\n",
      "        \"options\": [\n",
      "            \"A. 18 months from the earliest priority date\",\n",
      "            \"B. 30 months from the earliest priority date\",\n",
      "            \"C. 22 months from the earliest priority date\",\n",
      "            \"D. 26 months from the earliest priority date\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Claim 1 of European patent application EP-1 originally defines a polymer blend XY containing, as a filler, graphite, talc, asbestos or silica. \\nThe European search report identifies prior art disclosing a polymer blend XY containing asbestos. Is it permissible under Article 123(2) EPC to restrict the list of fillers by simply omitting asbestos, i.e., to claim a polymer blend XY containing, as a filler, graphite, talc or silica?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 93: {'question': 'In which of the following scenarios would the European Patent Office require further investigation to determine if there was subject-matter extension under Article 123(2) EPC 1973?', 'options': ['A. When the application documents are a translation of an international application filed in English.', 'B. When reasonable grounds doubt the presumption that the published European application is identical to the published international application.', 'C. When the original application text has been accurately translated into one of the official languages of the EPO.', 'D. When there is no discrepancy between the content of the application as filed and the published European application.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Your client filed an international patent application in 2021. In which of the following countries can they (directly) enter the national phase?\",\n",
      "        \"options\": [\n",
      "            \"A. Lithuania\",\n",
      "            \"B. France\",\n",
      "            \"C. Italy\",\n",
      "            \"D. None of the above\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You are monitoring the progress of an international application and on reviewing the details of the international search report you realize that you know of relevant prior art that has not been cited in the search report, but which is likely to be novelty-destroying in respect of at least some of the claims. \\nYou believe that the international application will enter the national or regional phase in a significant number of countries or regions and it would therefore be time-consuming and costly to file separate observations in respect of each of \\nthe national or regional applications. What can you do?\",\n",
      "        \"options\": [\n",
      "            \"A. File observations online using ePCT.\",\n",
      "            \"B. Send a letter with your observations to the receiving office or the International Bureau.\",\n",
      "            \"C. File observations by letter.\",\n",
      "            \"D. It is not possible to file observations on international applications.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"You are the agent for international application PCT-1. Shortly before the end of the international phase the applicant informs you that they wish to continue only with the regional phase before the EPO and additionally that there was an error in the details of the inventor and that the correct inventor is Ms White and not Mr Black. They ask you whether it would be better to wait until entry \\ninto the EPO regional phase rather than to rush correction of the inventorship details in the international phase. What is your advice?\",\n",
      "        \"options\": [\n",
      "            \"A. Inventorship should be corrected if at all possible in the international phase.\",\n",
      "            \"B. It would be better to wait until after entry into the EPO regional phase.\",\n",
      "            \"C. There is no difference between the two options.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 94: {'question': 'An applicant filed an international PCT application with an erroneous claim element on 10 July 2021. By what date must corrections be submitted to ensure they are effective for the European phase, considering the rule under Rule 20.5bisPCT?', 'options': ['A. 3 October 2022', 'B. 10 November 2022', 'C. 7 August 2023', 'D. No corrections can be submitted for the European phase']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?\",\n",
      "        \"options\": [\n",
      "            \"A. Six months after the date of mention of the publication of the European search report\",\n",
      "            \"B. Date of mention of the publication of the European search report\",\n",
      "            \"C. The designation fee was validly paid and can no longer be refunded\",\n",
      "            \"D. Date of the start of substantive examination\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The opposition division revoked European patent EP -B1. The patent proprietor filed an appeal  in time . The b oard of appeal forwarded a copy of the appeal to the o pponent/ respondent with a communication dated 1 June 2023 giving it an opportunity to file comments within a period of four  months.  The opponent/respondent files comments today, 12 October 2023. What further action has to be taken ?\",\n",
      "        \"options\": [\n",
      "            \"A. The opponent/ respondent needs  to request an extension of the period for comment.\",\n",
      "            \"B. The opponent/respondent needs to pay a fee for further processing.\",\n",
      "            \"C. The opponent/respondent needs to file a substantiated request for reestablishment of rights and pay the associated fee.\",\n",
      "            \"D. None of the above.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Company C files a European patent application for an invention which has been displayed at an officially recognised international exhibition. The exhibition closes two weeks after the invention was first displayed. Rule 25(d) EPC states that a suitable certificate must be filed within four months of the filing of the European patent application. Three months after filing the application, the applicant approaches the authority responsible for the protection of industrial property at the exhibition and obtains a certificate stating the information required according to Rule 25 EPC. The certificate is filed within the four-month period together with the authenticated identification of the invention. Will the certificate be accepted by the EPO?\",\n",
      "        \"options\": [\n",
      "            \"A. No, the certificate was not issued at the exhibition.\",\n",
      "            \"B. Yes, the certificate was filed within the specified four-month period.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 95: {'question': 'If an entitled person files a new European patent application under Article 61, paragraph 1(b), how long does the applicant have to pay the filing fee and search fee after filing the new application?', 'options': ['A. Within one month of filing the new application', 'B. Within six months of filing the new application', 'C. Within two months of filing the new application', 'D. There is no specific time limit mentioned']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. The deficiency cannot be remedied.\",\n",
      "            \"B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .\",\n",
      "            \"C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.\",\n",
      "            \"D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Entry into the European phase of an international application can be effected early provided an express request for early processing is made at the time the requirements of Rule 159(1) EPC are complied with. International application PCT-1 was filed 28 months ago with no claim to priority. The application consists of 20 pages, including 16 claims. The international search was carried out by the EPO acting as ISA and the international search report was published with the international application. Which of the following fees must be paid in order to effect early entry into the European phase?\",\n",
      "        \"options\": [\n",
      "            \"A. The filing fee.\",\n",
      "            \"B. The filing fee, the examination fee and the designation fee.\",\n",
      "            \"C. The filing fee, the examination fee, the designation fee and the renewal fee.\",\n",
      "            \"D. The filing fee, the claims fee, the examination fee, the designation fee and the renewal fee.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"International patent application PCT-1 is filed on 16 June 2019 without any claim to priority. Steps are taken to enter the EPO regional phase on 26 December 2021. When should the renewal fee in respect of the third year be paid (without surcharge)?\",\n",
      "        \"options\": [\n",
      "            \"A. 30 June 2021\",\n",
      "            \"B. 26 December 2021\",\n",
      "            \"C. 2 January 2022\",\n",
      "            \"D. 17 January 2022\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 96: {'question': 'An international PCT application, PCT-App, was filed in Chinese 30 months ago without claiming any priority. The applicant wishes to enter the European phase early by complying with Rule 159(1) EPC requirements. Which of the following steps must the applicant take immediately after filing the request for early processing?', 'options': ['A. Pay only the filing fee.', 'B. Submit a translation of PCT-App into an EPO official language, if not already published in one of them, and pay the filing fee.', 'C. Pay the examination fee, the designation fee, and file the request for examination.', 'D. File the request for early processing, submit a translation of PCT-App into English or another official language (if necessary), and pay the filing fee.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Last week Greta validly filed the international patent application PCT -G with the German Patent and Trade mark Office ( DPMA ) and appointed Hassan to represent her. Hassan is entitled to act before the DPMA  but he is not a European patent attorney. Greta and Hassan are resident in Germany.  Which of the following statements is not correct?\",\n",
      "        \"options\": [\n",
      "            \"A. Hassan can represent Greta before the EPO acting as the International Searching Authority for PCT -G.\",\n",
      "            \"B. In order for Hassan to be able to act before the EPO acting as the International Searching Authority , he needs to submit a power of attorney signed by Greta.\",\n",
      "            \"C. According to the provisions of the PCT, it is mandatory that the d emand for international preliminary examination is signed by Greta or Hassan.\",\n",
      "            \"D. According to the provisions of the PCT, an international application can only be withdrawn by the applicant or an agent appointed by a power of attorney.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"On 27 October 2022 you filed European patent application EP -A claiming priority from FR -A filed on 29 October 2021. Your intention was that both applications would have the same content. On 3 November 2022, however, you noticed that page 3 of the description and claims 7 -12 are missing in EP -A. The fees have not been paid yet.  Which statement is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. If the EPO notes that page 3 of the description and claims 7 -12 are missing, it will invite you to file these missing parts within a time limit of two months\",\n",
      "            \"B. You may of your own volition file page 3 of the description at any time up to 2 January 2023 without the application being re -dated\",\n",
      "            \"C. If the subject -matter of claims 7 -12 is also present in the description, you may add claims 7 -12 at any time\",\n",
      "            \"D. The best solution is to withdraw EP -A and refile it, claiming priority from FR -A\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?\",\n",
      "        \"options\": [\n",
      "            \"A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.\",\n",
      "            \"D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 97: {'question': 'On 15 March 2023, you filed an international patent application PCT-X claiming priority from US-A filed on 15 March 2022. The international preliminary examination was requested and conducted by the International Bureau. Subsequently, you wish to enter the national phase in Japan and have appointed a Japanese patent attorney, Ms. Tanaka, as your representative. According to the PCT rules, which of the following statements is correct?', 'options': ['A. You must file the national phase entry form with the Japanese Patent Office (JPO) before 15 September 2023.', 'B. Ms. Tanaka does not need to submit a power of attorney from you, as she can represent you in the Japanese national phase proceedings.', 'C. The international preliminary report will be forwarded to JPO and can be used during the Japanese examination process.', 'D. You are required to pay the priority claim fee for the Japanese national application within 2 months from the filing date of PCT-X.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"Applicants may request processing of their international application under PCT Direct by filing a letter (\\\"PCT Direct letter\\\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?\",\n",
      "        \"options\": [\n",
      "            \"A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing\",\n",
      "            \"B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0\",\n",
      "            \"C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0\",\n",
      "            \"D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"Company X wishes to file an opposition to European patent EP-B, which was recently granted to its main competitor, company Y. To avoid retaliation, company X would prefer not to file the opposition in its own name. It therefore asks a European patent attorney to file the opposition in her name. Will the EPO accept this?\",\n",
      "        \"options\": [\n",
      "            \"A. Yes\",\n",
      "            \"B. No\",\n",
      "            \"C. Only if the patentee does not object\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The applicants for international application PCT-1 are based in Japan. Having regard to the provisions of the EPC and the PCT, can the applicants themselves comply with the requirements of Rule 159(1) EPC?\",\n",
      "        \"options\": [\n",
      "            \"A. No, a professional representative must be appointed.\",\n",
      "            \"B. No, a professional representative or appropriate legal representative must be appointed.\",\n",
      "            \"C. Yes, the applicants can themselves comply with the requirements of Rule 159(1) EPC.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 98: {'question': 'If an international application filed under the PCT has not been accorded a filing date or deemed withdrawn, which of the following steps must be taken to allow the EPO to review and potentially proceed with the European phase under Art. 25 PCT?', 'options': ['A. The applicant should request the International Bureau to send copies of documents in the files promptly to the EPO as designated Office.', 'B. The applicant must pay a supplementary filing fee, but no translation is required.', 'C. The application can proceed directly without any additional steps being taken by the applicant.', 'D. Both A and B are necessary steps.']}\n",
      "[\n",
      "    {\n",
      "        \"question\": \"The applicants for international application PCT-1 are based in Japan. Having regard to the provisions of the EPC and the PCT, can the applicants themselves comply with the requirements of Rule 159(1) EPC?\",\n",
      "        \"options\": [\n",
      "            \"A. No, a professional representative must be appointed.\",\n",
      "            \"B. No, a professional representative or appropriate legal representative must be appointed.\",\n",
      "            \"C. Yes, the applicants can themselves comply with the requirements of Rule 159(1) EPC.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?\",\n",
      "        \"options\": [\n",
      "            \"A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.\",\n",
      "            \"B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.\",\n",
      "            \"C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.\",\n",
      "            \"D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months.\"\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"question\": \"The applicant for international application PCT-1 wishes to prevent publication of the application. What is the last day for withdrawing the application and \\npreventing publication?\",\n",
      "        \"options\": [\n",
      "            \"A. The 15th day prior to the date of publication.\",\n",
      "            \"B. Any time prior to the date of publication.\",\n",
      "            \"C. The end of the day five weeks before the end of the 18th month from the priority or filing date as appropriate.\"\n",
      "        ]\n",
      "    }\n",
      "]\n",
      "Question 99: {'question': 'If the interlocutory decision of the opposition division under Article 101(3)(a) EPC or Article 106(2) EPC has been based on documents not complying with Rule 50(1), what is required from the patent proprietor?', 'options': ['A. To file translations of any amended claims in the two official languages of the EPO other than the language of the proceedings.', 'B. To pay, within three months, the fee for publishing a new specification of the European patent.', 'C. To file a formally compliant version of the entire description.', 'D. To file a formally compliant version of the paragraph upon which the interlocutory decision was based.']}\n"
     ]
    }
   ],
   "source": [
    "model = 'qwen2.5:7b'\n",
    "\n",
    "knowledge_vector_db = load_rag_embeddings(path='../embeddings/gte_large_en_v1_5/rag_embeddings_Alibaba-NLP_gte-large-en-v1.5', \n",
    "                                          embeddings_model='Alibaba-NLP/gte-large-en-v1.5', \n",
    "                                          device='cuda')\n",
    "\n",
    "evaluate_generate_mcq_question(save_dir='../outputs/evaluation2/', data_dir='../outputs/',\n",
    "                            test_name=f'evaluate_mcq_questions_generation_newembeddings', model=model,\n",
    "                            knowledge_vector_db=knowledge_vector_db, n=100)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
